10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q/A 

Amendment # 2

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2016

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number: 001-35637

ASTA FUNDING, INC.

(Exact name of registrant as specified in its charter)

Delaware	22-3388607
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)
210 Sylvan Ave., Englewood Cliffs, New Jersey	07632
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number: (201) 567-5648

Former name, former address and former fiscal year, if changed since last report: N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   ☐     No   ☒

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes   ☐     No   ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐     (Do not check if a smaller reporting company)	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes   ☐     No   ☒

As of September 14, 2018, the registrant had 6,685,415 common shares outstanding.

EXPLANATORY NOTE

As previously disclosed in the Current Report on Form 8-K filed by Asta Funding, Inc. (“Asta” or the “Company”) with the Securities and Exchange Commission (the “SEC”) on January 18, 2018, the Board of Directors (the “Board”) of the Company, upon the recommendation of the Audit Committee of the Board (the “Audit Committee”), determined that the Company’s previously issued financial statements for each of the years ended September 30, 2016, 2015 and 2014, and the interim periods contained therein, as well as the Company’s unaudited consolidated financial statements for the quarters ended December 31, 2016, March 31, 2017 and June 30, 2017, could no longer be relied upon. 

On September 17, 2018, the Company filed an Annual Report on Form 10-K/A (the “Form 10-K/A”) to amend and restate the Company’s previously issued financial statements for each of the years ended September 30, 2016, 2015 and 2014, as well as the interim periods contained therein. The Company is filing this Amendment No. 2 on Form 10-Q/A (this “Amendment”) to amend and restate the Company’s previously issued financial statements contained in its Quarterly Report on Form 10-Q for the quarter ended December 31, 2016 (the “Non-Reliance Period”), which was originally filed with the SEC on February 9, 2017 (the “Original Form 10-Q”), and restated on May 26, 2017 (the “Restated Form 10-Q/A”). The Company expects to file, at a later time, amendments to its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2017 and June 30, 2017.

Prior period amounts have already been restated in the Company's Form 10-K/A and, accordingly have not been restated in this Amendment.

Restatement Background

On January 11, 2018, after discussions with the Audit Committee, management re-evaluated the Company's historical conclusion to consolidate Pegasus Funding, LLC (“Pegasus”). Management has determined that the Company lacked the requisite control to consolidate Pegasus in its historical periods in accordance with Accounting Standards Codification (“ASC”) 810 “Consolidation.” Management also determined that the Company's previous treatment for certain foreign currency matters under ASC 830 “Foreign Currency Matters” was not appropriate. As such, the Company has subsequently revised its investment in Pegasus to the equity method, including the underlying reserve methodology; and has adjusted its financial statements to reflect the proper accounting for certain foreign currency transactions. Additionally, the Company corrected the financial statements for additional known errors consisting of (i) the adjustment of various accruals, (ii) the fair value of structured settlements, (iii) accounting for unallocated payments, and (iv) the tax effects of the adjustments mentioned above.

The following errors were identified as part of the restatement. See Note 1 – Restatement of Financial Statements in the Company’s notes to consolidated financial statements for further details.

1. In connection with the Company determining it lacked the requisite control to consolidate Pegasus during the Non-Reliance Period, the Company has now accounted for its investment in Pegasus under the equity method in accordance with accounting principles generally accepted in the United States (“US GAAP”).

2. The Company determined that it had not previously accounted for certain foreign currency gains/losses on intercompany balances and transactions in accordance with US GAAP. The Company improperly accounted for the foreign currency effect of certain transactions as if they were long-term investments by including the foreign currency effect in accumulated other comprehensive income instead of properly recording the effect as operating expenses as required under ASC 830.

3. Prior to the sale of its structured settlement business, the Company purchased periodic payments under structured settlements and annuity policies from individuals in exchange for a lump sum payment. The Company did not reflect the quarterly increase in certain underlying benchmark interest rates used in determining fair value of the Company's structured settlements. The Company has elected to carry the structured settlements at fair value in accordance with the guidance of FASB ASC, Recognition and Measurement of Financial Assets and Financial Liabilities (ASC 822-10-50-28 through 50-22).

4. The Company determined that it had not accounted for certain unallocated payments reported on its consolidated balance sheet properly.

5. The Company discovered that it did not properly record an amortizable asset and related liability in conjunction with an asset purchase agreement entered into in June 2015 with a related party.

6. The Company identified other transactions that had not been properly accounted for in the correct period and/or for improper amounts and/or improper accounts.

7. The Company identified the personal injury claims asset balance of Pegasus was determined to be understated.

8. Some of the corrections noted above impacted earnings (loss) before taxes which, in turn, required a calculation of the tax impact.

2

Internal Control and Disclosure Controls Considerations

In connection with this restatement, our Chief Executive Officer and Chief Financial Officer determined that there were deficiencies in the Company’s internal control over financial reporting that constituted material weaknesses at December 31, 2016. Accordingly, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective at December 31, 2016, as discussed in Item 4 of this Amendment.

Items Amended in This Amendment

For the convenience of the reader, this Amendment sets forth the Original Form 10-Q in its entirety, as amended and restated by the Restated Form 10-Q/A, and as further modified and adjusted to reflect the restatement described above. In addition to such changes, this Amendment also includes: (i) revisions in presentation for the discontinued operations of the Company’s structured settlement business, which was sold on December 13, 2017; and (ii) updates to the Company’s subsequent events disclosure included in Note 20 to the Consolidated Financial Statements (collectively, with (i) above, the “Subsequent Events”).

In accordance with applicable SEC rules, this Amendment also includes new certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002, as amended, from our Chief Executive Officer and Chief Financial Officer, dated as of the filing date of this Amendment. Aside from the foregoing items, this Amendment has not modified the Original Form 10-Q, as amended by the Restated Form 10-Q/A, other than to correct immaterial items and certain errors in the exhibit index, and the disclosures contained in this Amendment have not been updated to reflect events occurring subsequent to the date of the Original Form 10-Q, February 9, 2017, except as noted above with respect to the Subsequent Events.

Accordingly, this Amendment amends and restates the following items of the Original Form 10-Q, as amended and restated by the Restated Form 10-Q/A:

● Part I – Item 1. Financial Information.

● Part I – Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

● Part I – Item 3. Quantitative and Qualitative Disclosures About Market Risk.

● Part I – Item 4. Controls and Procedures.

● Part II – Item 1A. Risk Factors.

● Part II – Item 6. Exhibits.

3

ASTA FUNDING, INC. AND SUBSIDIARIES

INDEX TO FORM 10-Q/A

Part I-FINANCIAL INFORMATION	5
Item 1. Consolidated Financial Statements	5
Consolidated Balance Sheets as of December 31, 2016 (restated) (unaudited) and September 30, 2016	5
Consolidated Statements of Operations for the three months ended December 31, 2016 (restated) (unaudited) and 2015 (unaudited)	6
Consolidated Statements of Comprehensive Income (Loss) for the three months ended December 31, 2016 (restated) (unaudited) and 2015 (unaudited)	7
Consolidated Statements of Stockholders’ Equity for the three months ended December 31, 2016 (restated) (unaudited) and 2015 (unaudited)	8
Consolidated Statements of Cash Flows for the three months ended December 31, 2016 (restated) (unaudited) and 2015 (unaudited)	9
Notes to Consolidated Financial Statements (restated) (unaudited)	10
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations (restated)	43
Item 3. Quantitative and Qualitative Disclosures about Market Risk (restated)	53
Item 4. Controls and Procedures (restated)	54
Part II-OTHER INFORMATION	56
Item 1. Legal Proceedings	56
Item 1A. Risk Factors (restated)	56
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	56
Item 3. Defaults Upon Senior Securities	56
Item 4. Mine Safety Disclosures	56
Item 5. Other Information	56
Item 6. Exhibits (restated)	57
Signatures	58

4

PART I. FINANCIAL INFORMATION

Item  1. Financial Statements (restated)

ASTA FUNDING, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

(rounded to the nearest thousands, except share data)

	December 31, 2016 (Unaudited) (Restated)			September 30, 2016
ASSETS
Cash and cash equivalents	$	3,696,000		$	6,282,000
Restricted cash		8,165,000			10,000,000
Available for sale investments (at fair value)		55,045,000			56,763,000
Consumer receivables acquired for liquidation (at net realizable value)		13,462,000			13,427,000
Other investments, net		3,354,000			3,590,000
Due from third party collection agencies and attorneys		1,004,000			1,050,000
Prepaid and income taxes receivable		4,896,000			714,000
Furniture and equipment, net		176,000			196,000
Equity method investment		49,141,000			48,582,000
Deferred income taxes		15,327,000			14,903,000
Goodwill		1,410,000			1,410,000
Other assets		6,281,000			6,585,000
Assets related to discontinued operations		94,526,000			91,506,000
Total assets	$	256,483,000		$	255,008,000
LIABILITIES
Other liabilities	$	4,731,000		$	3,987,000
Liabilities related to discontinued operations		74,169,000			69,238,000
Total liabilities		78,900,000			73,225,000
Commitments and contingencies
STOCKHOLDERS’ EQUITY
Preferred stock, $.01 par value; authorized 5,000,000 shares; issued and outstanding — none		—			—
Common stock, $.01 par value, authorized 30,000,000 shares; issued 13,336,508 at December 31, 2016 and September 30, 2016; and outstanding 11,876,224 at December 31, 2016 and September 30, 2016		133,000			133,000
Additional paid-in capital		67,028,000			67,034,000
Retained earnings		123,792,000			126,738,000
Accumulated other comprehensive (loss) income		(445,000	)		803,000
Treasury stock (at cost) 1,460,284 shares at December 31, 2016 and September 30, 2016		(12,925,000	)		(12,925,000	)
Total stockholders’ equity		177,583,000			181,783,000
Total liabilities and stockholders’ equity	$	256,483,000		$	255,008,000

See accompanying notes to consolidated financial statements

5

ASTA FUNDING, INC. AND SUBSIDIARIES

Consolidated Statements of Operations

(Unaudited)

(rounded to the nearest thousands, except share data)

	Three Months Ended December 31, 2016 (Restated)			Three Months Ended December 31, 2015
Revenues:
Finance income, net	$	4,095,000		$	5,106,000
Disability fee income		1,354,000			659,000
Total revenues		5,449,000			5,765,000
Other income — includes ($45,000) and ($31,000) during the three month periods ended December 31, 2016 and 2015, respectively, of accumulated other comprehensive income reclassification for unrealized net (losses) / gains on available for sale securities		451,000			392,000
		5,900,000			6,157,000
Expenses:
General and administrative		7,295,000			5,729,000
Earnings from equity method investment		(404,000	)		(1,494,000	)
		6,891,000			4,235,000
(Loss) income from continuing operations before income tax		(991,000	)		1,922,000
Income tax expense — includes tax benefit of $18,000 and $11,000 during the three month periods ended December 31, 2016 and 2015, respectively, of accumulated other comprehensive income reclassifications for unrealized net (losses) / gains on available for sale securities		697,000			631,000
Net (loss) income from continuing operations		(1,688,000	)		1,291,000
Net (loss) income from discontinued operations, net of income tax		(1,258,000	)		272,000
Net (loss) income	$	(2,946,000	)	$	1,563,000
Net (loss) income per basic shares:
Continuing operations	$	(0.14	)	$	0.11
Discontinued operations		(0.11	)		0.02
		(0.25	)		0.13
Net (loss) income per diluted shares:
Continuing operations		(0.14	)		0.11
Discontinued operations		(0.11	)		0.02
	$	(0.25	)	$	0.13
Weighted average number of common shares outstanding:
Basic		11,876,224			12,155,421
Diluted		11,876,224			12,431,886

See accompanying notes to consolidated financial statements

6

ASTA FUNDING, INC. AND SUBSIDIARIES

Consolidated Statements of Comprehensive Income (Loss)

December 31, 2016 and 2015

(Unaudited)

(rounded to the nearest thousands)

	Three Months Ended December 31, 2016 (Restated)			Three Months Ended December 31, 2015
Comprehensive (loss) income is as follows:
Net (loss) income	$	(2,946,000	)	$	1,563,000
Net unrealized securities (loss) gain, net of tax benefit/ (expense) of $826,000 and ($190,000) during the three month periods ended December 31, 2016 and 2015, respectively.		(1,239,000	)		330,000
Reclassification adjustments for securities sold, net of tax benefit of $18,000 and $11,000 during the three month periods ended December 31, 2016 and 2015, respectively.		(27,000	)		(20,000	)
Foreign currency translation, net of tax benefit (expense) of ($12,000) and ($9,000) during the three month periods ended December 31, 2016 and 2015, respectively.		18,000			14,000
Other comprehensive (loss) income		(1,248,000	)		324,000
Total comprehensive (loss) income	$	(4,194,000	)	$	1,887,000

See accompanying notes to consolidated financial statements

7

ASTA FUNDING, INC. AND SUBSIDIARIES

Consolidated Statements of Stockholders’ Equity

(Unaudited)

(rounded to the nearest thousands, except share data)

Three months ended December 31, 2016 (restated):

	Common Stock				Additional						Accumulated Other						Non-		Total
	Issued Shares		Amount		Paid-in Capital			Retained Earnings			Comprehensive Income (Loss)			Treasury Stock			Controlling Interests		Stockholders’ Equity
Balance, September 30, 2016, as previously reported		13,336,508	$	133,000	$	67,034,000		$	126,738,000		$	803,000		$	(12,925,000	)	$	—	$	181,783,000
Stock based compensation expense		—		—		(6,000	)		—			—			—			—		(6,000	)
Net loss		—		—		—			(2,946,000	)		—			—			—		(2,946,000	)
Amount reclassified from other comprehensive loss		—		—		—			—			(27,000	)		—			—		(27,000	)
Unrealized (loss) on marketable securities, net		—		—		—			—			(1,239,000	)		—			—		(1,239,000	)
Foreign currency translation, net		—		—		—			—			18,000			—			—		18,000
Balance, December 31, 2016, restated		13,336,508	$	133,000	$	67,028,000		$	123,792,000		$	(445,000	)	$	(12,925,000	)	$	—	$	177,583,000

Three months ended December 31, 2015:

	Common Stock				Additional					Accumulated Other						Non-			Total
	Issued Shares		Amount		Paid-in Capital			Retained Earnings		Comprehensive Income (Loss)			Treasury Stock			Controlling Interests			Stockholders’ Equity
Balance, September 30, 2015		13,061,673	$	131,000	$	65,049,000		$	119,165,000	$	20,000		$	(1,751,000	)	$	793,000		$	183,407,000
Stock based compensation expense		—		—		278,000			—		—			—			—			278,000
Restricted stock		5,000		—		—			—		—			—			—			—
Net income		—		—		—			1,563,000		—			—			—			1,563,000
Amount reclassified from other comprehensive loss		—		—		—			—		(20,000	)		—			—			(20,000	)
Unrealized gain on marketable securities, net		—		—		—			—		330,000			—			—			330,000
Purchase of treasury stock		—		—		—			—		—			(7,180,000	)		—			(7,180,000	)
Foreign currency translation, net		—		—		—			—		14,000			—			—			14,000
Purchase of subsidiary shares from non-controlling interest		—		—		(903,000	)		—		—			—			(793,000	)		(1,696,000	)
Issuance of restricted stock to purchase subsidiary shares from non-controlling interest		123,304		1,000		999,000			—		—			—			—			1,000,000
Balance, December 31, 2015		13,189,977	$	132,000	$	65,423,000		$	120,728,000	$	344,000		$	(8,931,000	)	$	—		$	177,696,000

See accompanying notes to consolidated financial statements

8

ASTA FUNDING, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(Unaudited)

(rounded to the nearest thousands)

	Three Months Ended
	December 31, 2016 (Restated)			December 31, 2015
Cash flows from operating activities:
Net (loss) income from continuing operations	$	(1,688,000	)	$	1,291,000
Net (loss) income from discontinued operations		(1,258,000	)		272,000
Net (loss) income	$	(2,946,000	)	$	1,563,000
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization		26,000			90,000
Deferred income taxes		420,000			95,000
Stock based compensation		(6,000	)		278,000
Loss on sale of available-for-sale securities		45,000			31,000
Unrealized gain on other investments		(18,000	)		(62,000	)
Unrealized foreign exchange loss on other investments		254,000			118,000
Earnings from equity method investment		(404,000	)		(1,494,000	)
Changes in:
Prepaid and income taxes receivable		(4,182,000	)		819,000
Due from third party collection agencies and attorneys		40,000			352,000
Other assets		307,000			(2,360,000	)
Other liabilities		761,000			(493,000	)
Net cash provided by (used in) operating activities of discontinued operations		369,000			(479,000	)
Net cash used in operating activities		(5,334,000	)		(1,542,000	)
Cash flows from investing activities:
Purchase of consumer receivables acquired for liquidation		(2,213,000	)		(6,051,000	)
Principal collected on receivables acquired for liquidation		2,129,000			2,299,000
Purchase of available-for-sale securities		(7,568,000	)		(7,136,000	)
Proceeds from sale of available-for-sale securities		7,132,000			12,303,000
Purchase of non-controlling interest		—			(800,000	)
(Increase) decrease in equity method investment		(155,000	)		5,827,000
Capital expenditures		(6,000	)		—
Net cash used in investing activities of discontinued operations		(2,632,000	)		(2,544,000	)
Net cash (used in) provided by investing activities		(3,313,000	)		3,898,000
Cash flows from financing activities:
Purchase of treasury stock		—			(7,180,000	)
Net cash provided by financing activities of discontinued operations		4,131,000			4,306,000
Net cash provided by (used in) financing activities		4,131,000			(2,874,000	)
Foreign currency effect on cash		52,000			—
Net decrease in cash, cash equivalents and restricted cash including cash, cash equivalents classified within assets related to discontinued operations		(4,464,000	)		(518,000	)
Less: net increase (decrease) in cash, cash equivalents and restricted cash classified within assets related to discontinued operations		43,000			(312,000	)
Net decrease in cash, cash equivalents and restricted cash		(4,421,000	)		(830,000	)
Cash, cash equivalents and restricted cash at beginning of period		16,282,000			19,947,000
Cash, cash equivalents and restricted cash at end of period	$	11,861,000		$	19,117,000
Supplemental disclosure of cash flow information:
Continuing operations:
Cash paid for: Income taxes	$	6,200,000			—
Discontinued operations:
Cash paid for: Interest	$	914,000			763,000
Supplemental disclosure of non-cash flow investing activities:
Discontinued operations:
Issuance of restricted stock to purchase subsidiary shares from non-controlling interest	$	—		$	1,000,000

See accompanying notes to consolidated financial statements

9

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 1— Restatement of Financial Statements

The following tables summarize the effects of the restatements on the specific items presented in the Company’s consolidated financial statements previously included in the Restated Form 10-Q/A:

	Consolidated Balance Sheet
	December 31, 2016
	As Reported			De-Consolidation of Pegasus (1)			Adjustments				Restated
ASSETS
Cash and cash equivalents	$	4,770,000		$	(1,065,000	)	$	(9,000	)	(2)(6)	$	3,696,000
Restricted cash		8,165,000			—			—				8,165,000
Available for sale investments (at fair value)		55,045,000			—			—				55,045,000
Consumer receivables acquired for liquidation (at net realizable value)		13,243,000			—			219,000		(2)		13,462,000
Investment in personal injury claims, net		47,875,000			(47,875,000	)		—				—
Other investments, net		3,354,000			—			—				3,354,000
Due from third party collection agencies and attorneys		1,035,000			—			(31,000	)	(2)		1,004,000
Prepaid and income taxes receivable		5,267,000			—			(371,000	)	(8)		4,896,000
Furniture and equipment, net		176,000			—			—				176,000
Equity method investment		—			48,720,000			421,000		(7)		49,141,000
Deferred income taxes		16,585,000			—			(1,258,000	)	(2)(8)		15,327,000
Goodwill		1,410,000			—			—				1,410,000
Other assets		6,203,000			(109,000	)		187,000		(2)		6,281,000
Assets related to discontinued operations		94,335,000			—			191,000		(5)(6)		94,526,000
Total assets	$	257,463,000		$	(329,000	)	$	(651,000	)		$	256,483,000
LIABILITIES
Other liabilities		5,666,000			(1,133,000	)		198,000		(2)		4,731,000
Liabilities related to discontinued operations		73,516,000			—			653,000		(5)		74,169,000
Total liabilities		79,182,000			(1,133,000	)		851,000				78,900,000
Commitments and contingencies
STOCKHOLDERS’ EQUITY
Preferred stock		—			—			—				—
Common stock		133,000			—			—				133,000
Additional paid-in capital		67,020,000			—			8,000		(6)		67,028,000
Retained earnings		126,406,000			—			(2,614,000	)	(2)(3) (4)(5) (6)(7)(8)		123,792,000
Accumulated other comprehensive loss		(1,549,000	)		—			1,104,000		(2)		(445,000	)
Treasury stock (at cost)		(12,925,000	)		—			—				(12,925,000	)
Non-controlling interest		(804,000	)		804,000			—				—
Total stockholders’ equity		178,281,000			804,000			(1,502,000	)			177,583,000
Total liabilities and stockholders’ equity	$	257,463,000		$	(329,000	)	$	(651,000	)		$	256,483,000

10

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 1— Restatement of Financial Statements (continued)

Consolidated Statement of Operations

For the Three Months Ended December 31, 2016

	As Reported			De-Consolidation of Pegasus (1)			Adjustments				Restated
Revenues:
Finance income, net	$	4,001,000		$	—		$	94,000		(2)	$	4,095,000
Personal injury claims income		2,302,000			(2,302,000	)		—
Disability fee income		1,354,000			—			—				1,354,000
Total revenues		7,657,000			(2,302,000	)		94,000				5,449,000
Other income		544,000			—			(93,000	)	(2)		451,000
		8,201,000			(2,302,000	)		1,000				5,900,000
General and administrative		9,556,000			(2,195,000	)		(66,000	)	(2)(6)		7,295,000
Interest		2,000			(2,000	)		—				—
Earnings from equity method investment		—			(84,000	)		(320,000	)	(7)		(404,000	)
		9,558,000			(2,281,000	)		(386,000	)			6,891,000
(Loss) from continuing operations before income tax		(1,357,000	)		(21,000	)		387,000				(991,000	)
Income tax (benefit)/expense		(555,000	)		—			1,252,000		(8)		697,000
Net (loss) income from continuing operations		(802,000	)		(21,000	)		(865,000	)			(1,688,000	)
Net loss from discontinued operations, net of income tax		(834,000	)		—			(424,000	)	(3)(5)(8)		(1,258,000	)
Less: net income attributable to non-controlling interests		21,000			(21,000	)
Net loss attributable to Asta Funding, Inc.	$	(1,657,000	)	$	—		$	(1,289,000	)		$	(2,946,000	)
Basic and diluted loss per share:
Continuing operations	$	(0.07	)								$	(0.14	)
Discontinued operations		(0.07	)									(0.11	)
	$	(0.14	)								$	(0.25	)

11

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 1— Restatement of Financial Statements (continued)

				Consolidated Statement of Comprehensive Loss
				For the Three Months Ended December 31, 2016
	As Reported			De-Consolidation of Pegasus (1)		Adjustments				Restated
Comprehensive income (loss) is as follows:
Net loss	$	(1,657,000	)	$	—	$	(1,289,000	)		$	(2,946,000	)
Net unrealized securities (loss) gain, net of tax		(1,239,000	)		—		—				(1,239,000	)
Reclassification adjustments for securities sold, net of tax		(27,000	)		—		—				(27,000	)
Foreign currency translation, net of tax		(369,000	)		—		387,000		(2)(6)		18,000
Other comprehensive loss		(1,635,000	)		—		387,000				(1,248,000	)
Total comprehensive loss	$	(3,292,000	)	$	—	$	(902,000	)		$	(4,194,000	)

12

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 1— Restatement of Financial Statements (continued)

Consolidated Statement of Cash Flows For the Three Months Ended December 31, 2016
	As Reported			Adjustments				Restated
Cash flows from operating activities:
Net loss from continuing operations	$	(823,000	)	$	(865,000	)		$	(1,688,000	)
Net loss from discontinued operations		(834,000	)		(424,000	)			(1,258,000	)
		(1,657,000	)		(1,289,000	)			(2,946,000	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		105,000			(79,000	)			26,000
Deferred income taxes		(211,000	)		631,000		(2)(8)		420,000
Stock based compensation		(6,000	)		—				(6,000	)
Loss on sale of available-for-sale securities		45,000			—				45,000
Unrealized gain on other investments		(18,000	)		—				(18,000	)
Unrealized foreign exchange loss on other investments		254,000			—				254,000
Earnings from equity method investment		—			(404,000	)	(7)		(404,000	)
Changes in:
Prepaid and income taxes receivable		(4,387,000	)		205,000		(8)		(4,182,000	)
Due from third party collection agencies and attorneys		(30,000	)		70,000		(2)		40,000
Other assets		498,000			(191,000	)	(2)		307,000
Income tax payable		(252,000	)		252,000		(8)		—
Other liabilities		373,000			388,000		(2)		761,000
Non-controlling interest		21,000			(21,000	)	(1)		—
Net cash used in operating activities of discontinued operations		(391,000	)		760,000		(3)(5)		369,000
Net cash used in operating activities		(5,656,000	)		322,000				(5,334,000	)
Cash flows from investing activities:
Purchase of consumer receivables acquired for liquidation		(2,213,000	)		—				(2,213,000	)
Principal collected on receivables acquired for liquidation		2,641,000			(512,000	)	(2)(4)(5)(6)		2,129,000
Purchase of available-for-sale securities		(7,568,000	)		—				(7,568,000	)
Proceeds from sales of available-for-sale securities		7,132,000			—				7,132,000
Investments in personal injury claims — advances		(5,178,000	)		5,178,000		(1)		—
Investments in personal injury claims — receipts		5,592,000			(5,592,000	)	(1)		—
Increase in equity method investment		—			(155,000	)	(1)		(155,000	)
Capital expenditures		(6,000	)		—				(6,000	)
Cash flows from investing activities related to discontinued operations		(2,632,000	)		—				(2,632,000	)
Net cash used in investing activities		(2,232,000	)		(1,081,000	)			(3,313,000	)
Cash flows from financing activities:
Distributions to non-controlling interest		(180,000	)		180,000		(1)		—
Cash flows from financing activities related to discontinued operations		4,131,000			—				4,131,000
Net cash used in financing activities		3,951,000			180,000				4,131,000
Foreign currency effect on cash		—			52,000		(2)		52,000
Net decrease in cash, cash equivalents and restricted cash including cash, cash equivalents classified within assets related to discontinued operations		(3,937,000	)		(527,000	)			(4,464,000	)
Less: net increase in cash, cash equivalents and restricted cash classified within assets related to discontinued operations		43,000			—				43,000
Net decrease in cash, cash equivalents and restricted cash		(3,894,000	)		(527,000	)	(1)(2)(3)(4)(5)(6)(7)(8)		(4,421,000	)
Cash , cash equivalents and restricted cash at beginning of period		16,829,000			(547,000	)			16,282,000
Cash, cash equivalents and restricted cash at end of period	$	12,935,000		$	(1,074,000	)		$	11,861,000

13

43,000

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 1— Restatement of Financial Statements (continued) 

As previously disclosed in the Current Report on Form 8-K filed by Asta Funding, Inc. (“Asta” or the “Company”) with the Securities and Exchange Commission (the “SEC”) on January 18, 2018, the Board of Directors (the “Board”) of the Company, upon the recommendation of the Audit Committee of the Board (the “Audit Committee”), determined that the Company’s previously issued financial statements for each of the years ended September 30, 2016, 2015 and 2014, and the interim periods contained therein, as well as the Company’s unaudited consolidated financial statements for the quarters ended December 31, 2016, March 31, 2017 and June 30, 2017, could no longer be relied upon. 

On September 17, 2018, the Company filed an Annual Report on Form 10-K/A (the “Form 10-K/A”) to amend and restate the Company’s previously issued financial statements for each of the years ended September 30, 2016, 2015 and 2014, as well as the interim periods contained therein. The Company is filing this Amendment No. 2 on Form 10-Q/A (this “Amendment”) to amend and restate the Company’s previously issued financial statements contained in its Quarterly Report on Form 10-Q for the quarter ended December 31, 2016 (the “Non-Reliance Period”), which was originally filed with the SEC on February 9, 2017 (the “Original Form 10-Q”), and restated on May 26, 2017 (the “Restated Form 10-Q/A”). The Company expects to file, at a later time, amendments to its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2017 and June 30, 2017.

Prior period amounts have already been restated in the Company's Form 10-K/A, and, accordingly have not been restated in this Amendment.

This Amendment

On January 11, 2018, after discussions with the Audit Committee, management re-evaluated the Company's historical conclusion to consolidate Pegasus Funding, LLC (“Pegasus”). Management has determined that the Company lacked the requisite control to consolidate Pegasus in its historical periods in accordance with Accounting Standards Codification (“ASC”) 810 “Consolidation.” Management also determined that the Company's previous treatment for certain foreign currency matters under ASC 830 “Foreign Currency Matters” was not appropriate. As such, the Company has subsequently revised its investment in Pegasus to the equity method, including the underlying reserve methodology; and has adjusted its financial statements to reflect the proper accounting for certain foreign currency transactions. Additionally, the Company corrected the financial statements for additional known errors consisting of (i) the adjustment of various accruals, (ii) the fair value of structured settlements, (iii) accounting for unallocated payments, and (iv) the tax effects of the adjustments mentioned above.

The “As Reported” amounts in the tables above represent the amounts reported in the Restated Form 10-Q/A, adjusted in its presentation for the discontinued operations of the Company's wholly-owned subsidiary CBC Settlement Funding, LLC (“CBC”), which was sold on December 13, 2017 (see Note 8 – Discontinued Operations and Note 20 – Subsequent events).

The following errors were identified as part of the restatement:

     1. In connection with the Company determining it lacked the requisite control to consolidate Pegasus during the Non-Reliance Period, the Company has now accounted for its investment in Pegasus under the equity method in accordance with US GAAP. On the Company’s December 31, 2016 consolidated balance sheet, this resulted in (i) a decrease in cash of $1,065,000; (ii) a decrease in the investment in personal injury claims of $47,875,000; (iii) a decrease in other assets of $109,000; (iv) a decrease in other liabilities of $1,133,000; and, (v) a decrease in non-controlling interest of $804,000, offset by a corresponding increase in the equity method investment of $48,720,000. On the Company’s consolidated statement of operations, this resulted in (i) a reduction in total revenues of $2,302,000; (ii) a reduction in expenses of $2,197,000; (iii) a decrease in the income attributable to the non-controlling interest of $21,000; and (iv) a decrease in earnings from equity method investment of $84,000 for the three months ended December 31, 2016. This change to the equity method of accounting had no effect on net (loss) income attributable to Asta Funding, Inc. during the Non-Reliance Period.

     2. The Company determined that it had not previously accounted for certain foreign currency gains/losses on intercompany balances and transactions in accordance with US GAAP. The Company improperly accounted for the foreign currency effect of certain transactions as if they were long-term investments by including the foreign currency effect in accumulated other comprehensive income instead of properly recording the effect as operating expenses as required under ASC 830. The correction to properly apply US GAAP to these foreign currency matters resulted in increased revenue of $94,000, a decrease in other income of $93,000, and a increase in general and administrative expenses of $204,000 for the three months ended December 31, 2016.

14

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 1— Restatement of Financial Statements (continued)  

The correction of foreign currency transaction on the consolidated balance sheet are as follows:

Increase (decrease) in:	Impact from September 30, 2016 10K/A filing			Current period impact			Cumulative net impact
Cash and cash equivalents	$	3,000		$	(10,000	)	$	(7,000	)
Consumer receivables acquired for liquidation		(245,000	)		464,000			219,000
Due from third party collection agencies and attorneys		45,000			(76,000	)		(31,000	)
Deferred income taxes		(722,000	)		(199,000	)		(921,000	)
Other assets		(33,000	)		220,000			187,000
Other liabilities		(18,000	)		216,000			198,000
Accumulated other comprehensive loss		718,000			386,000			1,104,000
Retained earnings		(1,653,000	)		(203,000	)		(1,856,000	)

3. Prior to the sale of its structured settlement business, the Company purchased periodic payments under structured settlements and annuity policies from individuals in exchange for a lump sum payment. The Company has elected to carry the structured settlements at fair value in accordance with the guidance of FASB ASC, Recognition and Measurement of Financial Assets and Financial Liabilities (ASC 822-10-50-28 through 50-22).

As previously disclosed in the Restated Form 10-Q/A, the Company did not reflect the quarterly increase in certain underlying benchmark interest rates used in determining fair value of the Company’s structured settlements for the quarter ended December 31, 2016 which resulted in a decrease in the fair value of the Company's structured settlements of approximately $2.6 million (reflected in assets related to discontinued operations in this restated consolidated balance sheet) with an associated increase in prepaid income taxes and deferred tax assets of approximately $1.0 million (reflected in the loss from discontinued operations in this consolidated statement of operations).

In connection with the Company’s filing of its Form 10-K/A, the Company adjusted the fair value of its structured settlements to reflect the appropriate benchmark interest rates at September 30, 2016, which resulted in an decrease in net loss attributable to discontinued operations and an increase in assets related to discontinued operations of $727,000. As this increase in fair value was originally recorded during the three month period ended December 31, 2016, this Amendment includes an increase in both the retained earnings and the net loss attributable to discontinued operations of $727,000.

4. The Company determined that it had not accounted for certain unallocated payments reported on its consolidated balance sheet properly during the Non-Reliance Period. The correction of this error resulted in a decrease to consumer receivables acquired for liquidation of $648,000 and retained earnings of $648,000 as of September 30, 2016 and is therefore included in the net adjustment to retained earnings as of December 31, 2016.

     5. The Company discovered that it did not properly record an amortizable asset and related liability in conjunction with an asset purchase agreement entered into in June 2015 with a related party. The correction of this error resulted in a decrease in income from discontinued operations of $60,000 for the three months ended December 31, 2016.

The correction of these errors on the consolidated balance sheet are as follows:

Increase (decrease) in:	Impact from September 30, 2016 10K/A filing			Current period impact			Cumulative net impact
Assets related to discontinued operations	$	307,000		$	(161,000	)	$	146,000
Liabilities related to discontinued operations		756,000			(103,000	)		653,000
Retained earnings		(442,000	)		(60,000	)		(502,000	)

15

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 1— Restatement of Financial Statements (continued)  

     6. The Company identified other transactions that had not been properly accounted for in the correct period and/or for improper amounts and/or improper accounts. The adjustments of these errors were immaterial on an individual basis. The correction of these errors resulted in decreased general and administrative expense of $270,000 for the three months ended December 31, 2016.

The correction of these errors on the consolidated balance sheet are as follows:

Increase (decrease) in:	Impact from September 30, 2016 10K/A filing			Current period impact			Cumulative net impact
Cash and cash equivalents	$	-		$	(2,000	)	$	(2,000	)
Other liabilities		269,000			(269,000	)		-
Retained earnings		(137,000	)		270,000			133,000
Assets related to discontinued operations		45,000			-			45,000
Additional paid in capital		8,000			-			8,000

     7. The Company identified the personal injury claims asset balance of Pegasus was determined to be understated at December 31, 2016 by $400,000. The correction of these error resulted in an increase in equity method investment of $320,000, representing the Company’s 80% financial interest, as of December 31, 2016. As a result of the correction of this error, earnings from the equity investment in Pegasus and income from continuing operations increased $320,000 for the three months ended December 31, 2016. Additionally the equity method investment was increased $101,000 to reflect the impact of related accruals in the Form 10-K/A.

    8. Some of the corrections noted above impacted earnings (loss) before taxes which, in turn, required a calculation of the tax impact. The net impact to the Company’s consolidated balance sheet was a (i) decrease to prepaid and income taxes receivable of $371,000; and (ii) decrease to deferred tax assets of $337,000. On the Company’s consolidated statement of operations, there was (i) a net increase to income tax expense of $1,252,000; and (ii) an increase to income tax benefit from discontinued operations of $363,000 for the three months ended December 31, 2016.

All of the following notes to consolidated financial statements have been revised to reflect the effects of the above mentioned restatements.

Note 2—Business and Basis of Presentation

Business 

Asta Funding, Inc., together with its wholly owned significant operating subsidiaries Palisades Collection, LLC, Palisades Acquisition XVI, LLC (“Palisades XVI”), Palisades Acquisition XIX, LLC (“Palisades XIX”), Palisades Acquisition XXIII, LLC (“Palisades XIX”), VATIV Recovery Solutions LLC (“VATIV”), EMIRIC, LLC (“EMIRIC”), ASFI Pegasus Holdings, LLC (“APH”), Fund Pegasus, LLC (“Fund Pegasus”), GAR Disability Advocates, LLC (“GAR Disability Advocates”), Five Star Veterans Disability, LLC (“Five Star”), Simia Capital, LLC (“Simia”) and other subsidiaries, which are not all wholly owned (the “Company,” “we” or “us”), is engaged in several business segments in the financial services industry including funding of personal injury claims, through our 80% owned, 50% controlled equity investment in Pegasus Funding, LLC (“Pegasus”) and our wholly owned subsidiary Simia, social security and disability advocacy through our wholly owned subsidiaries GAR Disability Advocates and Five Star and the business of purchasing, managing for its own account and servicing distressed consumer receivables, including charged off receivables, and semi-performing receivables. 

Consumer receivables

The Company started out in the consumer receivable business in 1994. Recently, our effort has been in the international areas (mainly South America), as we have curtailed our active purchasing of consumer receivables in the United States. We define consumer receivables as primary charged-off, semi-performing and distressed depending on their collectability. We acquire these consumer receivables at substantial discounts to their face values, based on the characteristics of the underlying accounts of each portfolio.

Personal injury claims

Simia and our equity method investment in Pegasus conduct their business solely in the United States. These companies obtain their business from external brokers and internal sales professionals soliciting individuals with personal injury claims. Business is also obtained from the their websites and through attorneys.

16

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 2—Business and Basis of Presentation (continued)

Business (continued)

Social security benefit advocacy

GAR Disability Advocates provides its disability advocacy services throughout the United States. It relies upon search engine optimization (“SEO”) to bring awareness to its intended market.

Discontinued Operations

US GAAP requires the results of operations of a component of an entity that either has been disposed of or is classified as held for sale to be reported as discontinued operations in the consolidated financial statements if the sale or disposition represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results.

On December 13, 2017, the Company sold all of the issued and outstanding equity capital of CBC, its wholly owned subsidiary engaging in structured settlements. As a result of this sale all prior periods presented in the Company’s consolidated financial statements will account for CBC as a discontinued operation. This determination resulted in the reclassification of assets and liabilities comprising the structured settlements business to assets and liabilities related to discontinued operations in the consolidated balance sheets, and a corresponding adjustment to our consolidated statements of operations to reflect discontinued operations for all periods presented.

Basis of Presentation 

The consolidated balance sheet as of December 31, 2016, the consolidated statements of operations for the three month periods ended December 31, 2016 and 2015, the consolidated statements of comprehensive (loss) income for the three month periods ended December 31, 2016 and 2015, the consolidated statements of stockholders’ equity as of and for the three months ended December 31, 2016 and 2015, and the consolidated statements of cash flows for the three month periods ended December 31, 2016 and 2015, are unaudited. The September 30, 2016 financial information included in this Amendment was derived from our audited financial statements included in our Annual Report on Form 10-K/A for the fiscal year ended September 30, 2016. In the opinion of management, all adjustments necessary to present fairly our financial position at December 31, 2016, the results of operations for the three month periods ended December 31, 2016 and 2015 and cash flows for the three month periods ended December 31, 2016 and 2015 have been made. The results of operations for the three month periods ended December 31, 2016 and 2015 are not necessarily indicative of the operating results for any other interim period or the full fiscal year. The consolidated financial statements are prepared in accordance with US GAAP and industry practices.

The accompanying unaudited consolidated financial statements have been prepared in accordance with Rule 10-01 of Regulation S-X promulgated by the Securities and Exchange Commission and therefore do not include all information and note disclosures required under generally accepted accounting principles. The Company suggests that these financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K/A for the fiscal year ended September 30, 2016 filed with the SEC.

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates including management’s estimates of future cash flows and the resulting rates of return.

Principles of Consolidation  

The consolidated financial statements include the accounts of Asta Funding, Inc. and its wholly owned and majority owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Concentration of Credit Risk – Cash and Restricted Cash

The Company considers all highly liquid investments with a maturity date of three months or less at the date of purchase to be cash equivalents.  

Cash balances are maintained at various depository institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company had cash balances with five banks at December 31, 2016 that exceeded the balance insured by the FDIC by approximately $1.4 million. Additionally, three foreign banks with an aggregate balance of $0.5 million are not FDIC insured. There is an $8.2 million and $10 million aggregate balance in a domestic bank as of December 31, 2016 and September 30, 2016, respectively, that is also not FDIC insured and has been reclassified to restricted cash in the balance sheets since these assets serve as collateral for the line of credit (see Note 7 – Non Recourse Debt). The Company does not believe it is exposed to any significant credit risk due to concentration of cash.

17

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 2—Business and Basis of Presentation (continued)

Equity method investment 

Investee companies that are not consolidated, but over which the Company exercises significant influence, are accounted for under the equity method of accounting. Whether or not the Company exercises significant influence with respect to an investee depends on an evaluation of several factors including, among others, representation on the investee company's board of directors and ownership level, which is generally a 20% to 50% interest in voting securities of the investee company. Under the equity method of accounting, an investee company's accounts are not reflected within the Company's consolidated balance sheets and statements of operations, however, the Company's share of the earnings of the investee company is reflected as earnings and loss from equity method investment in the Company's consolidated statement of operations. The Company's carrying value in an equity method investee company is reflected on the Company's consolidated balance sheet, as equity method investment.

Pegasus is the Company's 50% controlled equity investment with Pegasus Legal Funding (“PLF”). Under the operating agreement, the Company and PLF, each maintain 50% voting rights of the entity, and the Company is 80% owned by Asta. Based on these shared voting rights with PLF, the Company lacks requisite control of Pegasus, and therefore accounts for its investment in Pegasus under the equity method of accounting.

Serlefin BPO&O Peru S.A.C. (“Serlefin Peru”) is the Company's 49% owned joint venture. The other 51% is owned by three individuals who share common ownership with Serlefin BPO&O Serlefin S.A. (“Serlefin”). Each owner maintains voting rights equivalent to their share ownership, and the 51% shareholders collectively manage the operations of the business. Based on the Company's ownership and voting rights, the Company lacks requisite control of Serlefin Peru, and therefore accounts for its investment in Serlefin Peru under the equity method of accounting.

Additionally, the Company and Serlefin jointly purchase international consumer debt portfolios under a purchase agreement. The Company and Serlefin purchase the portfolios on a pro-rata basis of 80% and 20%, respectively. The purchased portfolios are transferred to an administrative and payment trust, where the Company and Serlefin are trustees. Serlefin provides collection services to the trust, and receives a performance fee determined by the parties for each loan portfolio acquired. Serlefin received approximately $0.2 million and $0 in performance fees for the three months ended December 31, 2016 and 2015, respectively.

The carrying value of the investment in Serlefin Peru was $0.2 million as of December 31, 2016 and September 30, 2016. The Company has included the carrying value of this investment in other assets on its consolidated balance sheets. The cumulative net loss from our investment in Serlefin Peru through December 31, 2016 was approximately $0.1 million, and was not significant to the Company's consolidated statement of operations.

When the Company's carrying value in an equity method investee company is reduced to zero, no further losses are recorded in the Company's consolidated financial statements unless the Company guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized. There were no impairment losses recorded on our equity method investments for the three months ended  December 31, 2016 and 2015.

Personal Injury Claim Advances 

Management assesses the quality of the personal injury claims portfolio through an analysis of the underlying personal injury fundings on a case by case basis. Cases are reviewed through periodic updates with attorneys handling the cases, as well as with third party research tools which monitor public filings, such as motions or judgments rendered on specific cases. The Company specifically reserves for those fundings where the underlying cases are identified as uncollectible, due to anticipated non-favorable verdicts and/or settlements at levels where recovery of the advance outstanding is unlikely. For cases that have not exhibited any specific negative collection indicators, the Company establishes reserves based on the historical collection rates of the Company’s fundings. Fee income on advances is reserved for on all cases where a specific reserve is established on the initially funded amount. In addition, management also monitors its historical collection rates on fee income and establishes reserves on fee income consistent with the historically experienced collection rates. Management regularly analyzes and updates the historical collection rates of its initially funded cases as well as its fee income.

18

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 2—Business and Basis of Presentation (continued)

Goodwill

Goodwill represents the excess of the purchase price over the fair value of the net assets acquired in a business combination, and is accounted for under ASC 350. Goodwill has an indefinite useful life and is evaluated for impairment at the reporting-unit level on an annual basis during the fourth quarter or more frequently if events or changes in circumstances indicate potential impairment between annual measurement dates. The Company has the option of performing a qualitative assessment of impairment to determine whether any further quantitative testing for impairment is necessary. The initial qualitative approach assesses whether the existence of events or circumstances lead to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, the Company determines it is more likely than not that the fair value is less than carrying value, a two step quantitative impairment test is performed. A step 1 analysis involves calculating the fair value of the associated reporting unit and comparing it to the reporting unit’s carrying value. If the fair value of the reporting unit exceeds the carrying value of the reporting unit including goodwill and the carrying value of the reporting unit is positive, goodwill is considered not to be impaired and no further analysis is required. If the fair value of the reporting unit is less than its carrying value, step 2 of the impairment test must be performed. Step 2 involves calculating and comparing the implied fair value of the reporting unit’s goodwill with its carrying value. Impairment is recognized if the estimated fair value of the reporting unit is less than its net book value. Such loss is calculated as the difference between the estimated impaired fair value of goodwill and its carrying amount. The goodwill of the Company consists of $1.4 million from the purchase of VATIV. Additionally, the Company has goodwill of $1.4 million from the purchase of CBC, which is included under assets related to discontinued operations on the consolidated balance sheet.

Reclassifications

Certain prior period amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year presentation. These reclassifications had no effect on previously reported net loss or shareholders’ equity.

Recent Accounting Pronouncements   

In May 2014, the FASB issued an update to ASC 606, Revenue from Contracts with Customers, that will supersede virtually all existing revenue guidance. Under this update, an entity is required to recognize revenue upon transfer of promised goods or services to customers, in an amount that reflects the entitled consideration received in exchange for those goods or services. The guidance also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from the customer contracts. This update is effective for annual reporting periods beginning after December 15, 2017 including interim periods within that reporting period. Early application is permitted for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Given the changes in the Company's business management is continuing to assess this new standard and the impact it will have on accounting for its revenues. 

In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The main objective in developing this update is enhancing the reporting model for financial instruments to provide users of financial statements with more decision-useful information. The amendments in this update address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. The effective date for this update is for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. The Company is currently evaluating the impact this update will have on its consolidated financial statements. 

In February 2016, the FASB issued ASU No. 2016-02 Leases (Topic 842) to amend lease accounting requirements and requires entities to generally recognize on the balance sheet operating and financing lease liabilities and corresponding right-of-use assets. The new standard will require significant additional disclosures about the amount, timing and uncertainty of cash flows from leases. The standard update is effective for fiscal years beginning after December 15, 2018 and interim periods within those years and early adoption is permitted. The standard is to be applied using a modified retrospective approach and includes a number of optional practical expedients that entities may elect to apply. The Company is currently evaluating the impact of adopting this update on its consolidated financial statements and expects that most of its operating leases will be subject to the accounting standard update and will recognize as operating lease liabilities and right-of-use assets upon adoption.  

In March 2016, the FASB issued ASU No. 2016-09, Compensation-Stock Compensation (Topic 718): Improvements to Employee Share Based Payment Accounting, to simplify and improve areas of generally accepted accounting principles for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided to users of financial statements. The effective date for this update is for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. The Company is currently evaluating the impact this update will have on its consolidated financial statements.  

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.  The ASU requires an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Additionally, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration.  For the Company, this update will be effective for interim periods and annual periods beginning after December 15, 2019. Upon adoption, the Company will accelerate the recording of its credit losses in its financial statements. 

19

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments.  This ASU will make eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The new standard is effective for fiscal years beginning after December 15, 2017. Early adoption is permitted. The new standard will require adoption on a retrospective basis unless it is impracticable to apply, in which case the Company would be required to apply the amendments prospectively as of the earliest date practicable. The Company is in the process of evaluating the provisions of the ASU, but does not expect it to have a material effect on the Company’s consolidated statements of cash flows.

In November 2016, the FASB issued ASU No. 2016-18, Restricted Cash ("ASU 2016-18"), to require that restricted cash and restricted cash equivalents be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total cash amounts shown on the statement of cash flows. Consequently, transfers between cash and restricted cash will not be presented as a separate line item in the operating, investing or financing sections of the cash flow statement. ASU 2016-18 does not provide a definition of restricted cash or restricted cash equivalents. The new guidance will only be applicable to amounts described by the Company as restricted cash. We adopted ASU 2016-18 on October 1, 2016, the effect of which was a change in presentation on our consolidated statement of cash flows, but not on our consolidated financial results.

In January 2017, the FASB issued ASU 2017-04 Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The objective of this update is to simplify the subsequent measurement of goodwill, by eliminating step 2 from the goodwill impairment test. The amendments in this update are effective for annual periods beginning after December 15, 2019, and interim periods within those fiscal years. The Company does not believe this update will have a material impact on its consolidated financial statements.

Note 3—Available-for-Sale Investments

Investments classified as available-for-sale at December 31, 2016 and September 30, 2016, consist of the following:

	Amortized Cost		Unrealized Gains		Unrealized Losses			Fair Value
December 31, 2016	$	56,115,000	$	29,000	$	(1,099,000	)	$	55,045,000
September 30, 2016	$	55,723,000	$	1,089,000	$	(49,000	)	$	56,763,000

The available-for-sale investments do not have any contractual maturities. The Company sold two investments during the three months ended December 31, 2016, with a realized loss of $45,000. The Company received $177,000 in capital gains distributions during the three months ended December 31, 2016. For the three months ended December 31, 2015, the Company sold two investments with a realized loss of $31,000 and also received $47,000 in capital gains distributions during that period. The Company recorded an aggregate realized gain of $132,000 and $16,000 related to its available-for-sale securities for the three months ended December 31, 2016 and 2015, respectively.

At December 31, 2016, there were seven investments, five of which were in unrealized loss positions that had existed for 12 months or more. All of these securities are considered to be acceptable credit risks. Based on the evaluation of the available evidence, including recent changes in market rates and credit rating information, management believes the aggregate decline in fair value for these instruments is temporary. In addition, management has the ability to hold these investment securities for a period of time sufficient to allow for an anticipated recovery or maturity. Should the impairment of any of these securities become other than temporary, the cost basis of the investment will be reduced and the resulting loss recognized in net income in the period in which the other-than-temporary impairment is identified.  

Unrealized holding gains and losses on available-for-sale securities are included in other comprehensive income within stockholders’ equity. Realized gains (losses) on available-for-sale securities are included in other income and, when applicable, are reported as a reclassification adjustment in other comprehensive income.

Note 4—Consumer Receivables Acquired for Liquidation

Accounts acquired for liquidation are stated at their net estimated realizable value and consist primarily of defaulted consumer loans of individuals primarily throughout the United States and South America.

The Company may account for its investments in consumer receivable portfolios, using either:

• the interest method; or

• the cost recovery method.

20

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 4—Consumer Receivables Acquired for Liquidation (continued)

Prior to October 1, 2013, the Company accounted for certain of its investments in finance receivables using the interest method in accordance with the guidance of ASC 310, Receivables. Under the guidance of ASC 310-30, static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision. Effective October 1, 2013, due to the substantial reduction of portfolios reported under the interest method, and the ability to reasonably estimate cash collections required to account for those portfolios under the interest method, the Company concluded the cost recovery method is the appropriate accounting method in the circumstances.

Although the Company has switched to the cost recovery method on its current inventory of portfolios, the Company must still analyze a portfolio upon acquisition to ensure which method is appropriate, and once a static pool is established for a quarter, individual receivable accounts are not added to the pool (unless replaced by the seller) or removed from the pool (unless sold or returned to the seller).

The Company uses the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method, no income is recognized until the cost of the portfolio has been fully recovered. A pool can become fully amortized (zero carrying balance on the balance sheet) while still generating cash collections. In this case, all cash collections are recognized as revenue when received.

The Company has extensive liquidating experience in the field of distressed credit card receivables, telecommunication receivables, consumer loan receivables, retail installment contracts, consumer receivables, and auto deficiency receivables.

The Company aggregates portfolios of receivables acquired sharing specific common characteristics which were acquired within a given quarter. In addition, the Company uses a variety of qualitative and quantitative factors to estimate collections and the timing thereof. The Company obtains and utilizes, as appropriate, input, including but not limited to, monthly collection projections and liquidation rates, from third party collection agencies and attorneys, as further evidentiary matter, to assist in evaluating and developing collection strategies and in evaluating and modeling the expected cash flows for a given portfolio.

The following tables summarize the changes in the consolidated balance sheet account of consumer receivables acquired for liquidation during the following periods:

	For the Three Months Ended December 31,
	2016 (restated)			2015
Balance, beginning of period	$	13,427,000		$	15,056,000
Acquisitions of receivable portfolios		2,213,000			6,051,000
Net cash collections from collection of consumer receivables acquired for liquidation		(6,015,000	)		(7,377,000	)
Net cash collections represented by account sales of consumer receivables acquired for liquidation		(190,000	)		—
Effect of foreign currency translation		(68,000	)		(27,000	)
Finance income recognized		4,095,000			5,106,000
Balance, end of period	$	13,462,000		$	18,809,000
Finance income as a percentage of collections		66.00	%		69.22	%

 During the three month periods ended December 31, 2016, the Company purchased $35.0 million of face value portfolios at a cost of $2.2 million. During the three months ended December 31, 2015, the Company purchased $97.7 million of face value portfolios, at a cost of $6.1 million.

As of December 31, 2016, the Company held consumer receivables acquired for liquidation from Peru and Colombia of $5.0 million and $4.6 million, respectively. The total amount of foreign consumer receivables acquired for liquidation was $9.6 million, or 71.1% of the total consumer receivables held of $13.5 million at December 31, 2016.

As of December 31, 2015, the Company held consumer receivables acquired for liquidation from Peru and Colombia of $4.7 million and $4.0 million, respectively. The total amount of foreign consumer receivables acquired for liquidation was $8.7 million, or 46.3% of the total consumer receivables held of $18.8 million at December 31, 2015. 

21

 ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 4—Consumer Receivables Acquired for Liquidation (continued)

The following table summarizes collections received by the Company’s third party collection agencies and attorneys, less commissions and direct costs, for the three month periods ended December 31, 2016 and 2015, respectively.

	For the Three Months Ended December 31 ,
	2016 (restated)		2015
Gross collections (1)	$	11,400,000	$	12,245,000
Commissions and fees (2)		5,195,000		4,868,000
Net collections	$	6,205,000	$	7,377,000

(1) Gross collections include: collections from third party collection agencies and attorneys, collections from in-house efforts, and collections represented by account sales.

(2) Commissions are earned by third party collection agencies and attorneys, and include direct costs associated with the collection effort, generally court costs. In December 2007 an arrangement was consummated with one servicer who also receives a 3% fee on gross collections received by the Company in connection with the related Portfolio Purchase.. The fee is charged for asset location, skip tracing and ultimately suing debtors in connection with this portfolio purchase.

Note 5—Litigation Funding

Equity Method Investment 

On December 28, 2011, the Company entered into a joint venture, Pegasus Funding, LLC ("Pegasus") with Pegasus Legal Funding, LLC (“PLF”). The Company has an 80% non-controlling interest in the joint venture. Pegasus purchases interests in claims from claimants who are a party to personal injury litigation. Pegasus advances, to each claimant, funds, on a non-recourse basis at an agreed upon interest rate, in anticipation of a future settlement. The interest in each claim purchased by Pegasus consists of the right to receive, from such claimant, part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claims. Pegasus earned $2.3 million and $3.1 million in interest and fees during the first quarter of fiscal years 2017 and 2016, respectively. The Company had a net invested balance in personal injury claims of $49.1 million and $48.6 million on December 31, 2016 and September 30, 2016, respectively.

Equity method investments as of December 31, 2016 and September 30, 2016 are as follows:

	December 31, 2016					September 30, 2016
	Carrying Value		Ownership Percentage			Carrying Value		Ownership Percentage
Pegasus Funding, LLC	$	49,141,000		80	%	$	48,582,000		80	%

The carrying value of the Company's equity investment at December 31, 2016 was $49,141,000, an increase of $559,000 over the prior year's carrying value of $48,582,000. The increase in carrying value was attributed to the Company's equity earnings of $404,000 for the three months ended December 31, 2016, plus loan advances made to Pegasus classified on its balance sheet as due to Asta of $155,000 for the three months ended December 31, 2016.

The carrying value of the Company's equity investment at September 30, 2016 was $48,582,000, an increase of $7,831,000 over the prior year's carrying value of $40,751,000. The increase in carrying value was attributed to the Company's current year equity earnings of $10,551,000, less loan repayments made to Asta which are classified on its balance sheet as due to Asta of $2,720,000 during fiscal 2016.

On November 8, 2016, the Company entered into a binding Term Sheet (the “Term Sheet”) with ASFI Pegasus Holdings, LLC, Fund Pegasus, LLC, Pegasus Funding, LLC, Pegasus Legal Funding, LLC, Max Alperovich and Alexander Khanas. Pegasus is currently the Company’s personal injury claims funding business and is a joint venture that is 80% owned by the Company and 20% owned by PLF. The Company and PLF have decided not to renew the Pegasus joint venture that, by its terms, terminated on December 28, 2016. The Term Sheet amends certain provisions to Pegasus’ operating agreement dated as of December 28, 2011 (as amended, the “Operating Agreement”) and governs the terms relating to the collection of its existing Pegasus portfolio (the “Portfolio”).

Pursuant to the Term Sheet, the parties thereto have agreed that Pegasus will continue in existence in order to collect advances on its existing Portfolio. The Company will fund overhead expenses relating to the collection of its Portfolio based on a budget agreed upon by the Company and PLF. Any cash received by Pegasus will be distributed to its members in the order provided for in the Operating Agreement. The Company will be repaid an amount equal to 20% of all principal collected on each investment paid back beginning October 1, 2016 and continuing through the collection of the Portfolio, which will be applied against the outstanding balance of overhead expenses previously advanced by the Company to Pegasus. After January 2, 2017, additional overhead expenses advanced will be paid back monthly as incurred by the Company prior to the calculation and distribution of any profits. 

22

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 5—Litigation Funding (continued)

Equity Method Investment (continued)

In connection with the Term Sheet, the parties thereto have also entered into a customary mutual release and non-disparagement agreement as well as a release from the non-competition obligations under the Operating Agreement. See Note 20 - Subsequent Events. 

The results of operations and financial position of the Company’s equity investment in Pegasus are summarized below:

	Condensed Statement of Operations Information
	Three months ended
	December 31, 2016		December 31, 2015
Personal injury claims income	$	2,302,000	$	3,085,000
Operating expenses		1,797,000		1,218,000
Income from operations	$	505,000	$	1,867,000
Earnings from equity method investment	$	404,000	$	1,494,000

	Condensed Balance Sheet Information
	December 31, 2016		September 30, 2016
Cash	$	1,065,000	$	539,000
Investment in personal injury claims		48,275,000		48,289,000
Other assets		109,000		188,000
Total Assets	$	49,449,000	$	49,016,000
Due to Asta	$	34,560,000	$	34,404,000
Other liabilities		1,006,000		1,053,000
Equity		13,883,000		13,559,000
Total Liabilities and Equity	$	49,449,000	$	49,016,000

Matrimonial Claims (included in Other Assets)

On May 8, 2012, the Company formed EMIRIC, LLC, a wholly owned subsidiary of the Company. EMIRIC, LLC entered into a joint venture with California-based Balance Point Divorce Funding, LLC (“BP Divorce Funding”) to create the operating subsidiary BP Case Management, LLC (“BPCM”). BPCM is 60% owned by the Company and 40% owned by BP Divorce Funding. BPCM provides non-recourse funding to a spouse in a matrimonial action. The Company provided a $1.0 million revolving line of credit to partially fund BPCM’s operations, with such loan bearing interest at the prevailing prime rate, with an initial term of twenty-four months. In September 2014, the agreement was revised to extend the term of the loan to August 2016, increase the credit line to $1.5 million and include a personal guarantee of the principal of BP Divorce Funding. Effective August 14, 2016, the Company extended its revolving line of credit with BP Divorce Funding until March 31, 2017, at substantially the same terms as the September 2014 amendment. The loan balance at December 31, 2016 was approximately $1.5 million. The revolving line of credit is collateralized by BP Divorce Funding’s profits share in BPCM and other assets. As of December 31, 2016, the Company’s investment in cases through BPCM was approximately $2.5 million. There was no income recognized in the three month periods ended December 31, 2016 and 2015.   

23

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 6—Furniture & Equipment

Furniture and equipment consist of the following as of the dates indicated:

	December 31, 2016		September 30, 2016
Furniture	$	273,000	$	273,000
Equipment		235,000		235,000
Software		1,356,000		1,350,000
		1,864,000		1,858,000
Less accumulated depreciation and amortization		1,688,000		1,662,000
Balance, end of period	$	176,000	$	196,000

Note 7—Non Recourse Debt

Non-Recourse Debt –Bank of Montreal (“BMO”)

In March 2007, Palisades XVI borrowed approximately $227 million under the Receivables Financing Agreement, as amended in July 2007,  December 2007,  May 2008,  February 2009,  October 2010 and August 2013 (the “RFA”) from BMO, in order to finance the Great Seneca Portfolio Purchase (the “Portfolio Purchase”) which had a purchase price of $300 million. The original term of the agreement was three years. This term was extended by each of the Second, Third, Fourth and Fifth Amendments and the most recent agreement signed in August 2013.

On August 7, 2013, Palisades XVI, a 100% owned bankruptcy remote subsidiary, entered into a Settlement Agreement and Omnibus Amendment (the “Settlement Agreement”) with BMO as an amendment to the RFA. In consideration for a $15 million prepayment funded by the Company, BMO agreed to significantly reduce minimum monthly collection requirements and the interest rate. If and when BMO receives the next $15 million of collections from the Portfolio Purchase or from voluntary prepayments by Asta Funding, Inc., less certain credits for payments made prior to the consummation of the Settlement Agreement (the “Remaining Amount”), Palisades XVI and its affiliates would be automatically released from liability in connection with the RFA (subject to customary exceptions). A condition to the release was Palisade XVI’s agreement to grant BMO, as of the time of the payment of the Remaining Amount, the right to receive 30% of net collections from the Portfolio Purchase once Palisades XVI has received from future net collections, the sum of $15 million plus voluntary prepayments included in the payment of the Remaining Amount (the “Income Interest”). On June 3, 2014, Palisades XVI paid the Remaining Amount. The final principal payment of $2.9 million included a voluntary prepayment of $1.9 million provided from funds of the Company. Accordingly, Palisades XVI was entitled to receive $16.9 million of future collections from the Portfolio Purchase before BMO would be entitled to receive any payments with respect to its Income Interest.

During the month of June, 2016, the Company received the balance of the $16.9 million, and, as of December 31, 2016, the Company recorded a liability to BMO of approximately $179,000, which has been recorded in other liabilities in the Company’s consolidated balance sheet. The funds were subsequently remitted to BMO on January 10, 2017. The liability to BMO is recorded when actual collections are received.

Bank Hapoalim B.M. (“Bank Hapoalim”) Line of Credit

On May 2, 2014, the Company obtained a $20 million line of credit facility from Bank Hapoalim, pursuant to a Loan Agreement (the “Loan Agreement”) among the Company and its subsidiary, Palisades Collection, LLC, as borrowers (the “Borrowers”), and Bank Hapoalim, as agent and lender. The Loan Agreement provides for a $20.0 million committed line of credit and an accordion feature providing an increase in the line of credit of up to $30 million, at the discretion of the lenders. The facility is for a term of three years at an interest rate of either LIBOR plus 275 basis points or prime, at the Company’s option. The Loan Agreement includes covenants that require the Company to maintain a minimum net worth of $150 million and pay an unused line fee. The facility is secured pursuant to a Security Agreement among the parties to the Loan Agreement, with property of the Borrowers serving as collateral. On March 30, 2016, the Company signed the First Amendment to the Loan Agreement (the “First Amendment”) with Bank Hapoalim which amended certain terms of their banking arrangement. The First Amendment includes (a) the reduction of the interest rate to LIBOR plus 225 basis points; (b) a decrease in the minimum net worth requirement by $50 million, to $100 million and (c) modifies the No Net Loss requirement from a quarterly to an annual basis. All other terms of the original agreement remain in effect. There is an $8.2 million and $10 million aggregate balance as of December 31, 2016 and September 30, 2016, respectively, in Bank Hapoalim which has been reclassified as restricted cash in the consolidated balance sheets since these assets serve as collateral for the line of credit (see Note 2 – Business and Basis of Presentation). The Company has not borrowed against the facility and no amounts were outstanding as of December 31, 2016.

24

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 8—Discontinued Operations

On December 31, 2013, the Company acquired 80% ownership of CBC and its affiliate, CBC Management Services, LLC for approximately $5.9 million.

On December 31, 2015, the Company acquired the remaining 20% ownership of CBC for $1,800,000, through the issuance of restricted stock valued at approximately $1,000,000 and $800,000 in cash. Each of the two original principals received 61,652 shares of restricted stock at a fair market value of $7.95 per share and $400,000 in cash. An aggregate of 123,304 shares of restricted stock were issued as part of the transaction. These shares are subject to a one year lock-up period in which the holders cannot sell the shares. In addition, the shares are subject to certain sales restrictions following the initial lock-up period, which expired on December 31, 2016 (see Note 13 – Stock Based Compensation).

On January 1, 2016, the Company renewed the expiring two-year employment agreements of the two CBC principals for one year terms. The employment contracts of the original two principals expired at the end of December 2016. The Company did not renew those contracts. Ryan Silverman has been appointed CEO/General Counsel effective January 1, 2017.

On December 13, 2017, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement) with CBC Holdings LLC, a Delaware limited liability company (the “Buyer”). Under the Purchase Agreement, the Company sold all of the issued and outstanding equity capital of CBC for an aggregate purchase price of approximately $10.5 million. Of the aggregate purchase price, approximately $4.49 million was paid in cash, and $5.75 million was paid under a promissory note at an annual interest rate of 7% to be paid quarterly to the Company and secured by a first priority security interest in and lien on such Buyer’s affiliates’ rights to certain servicing fees. The remaining amount of the aggregate purchase price was paid as reimbursement of certain invoices of CBC. The Company subsequently recognized a loss of approximately $1.9 million on the above sale of CBC as of September 30, 2017.

As a result of this sale all prior periods presented in the Company's consolidated financial statements will account for CBC as a discontinued operation. This determination resulted in the reclassification of the assets and liabilities comprising the structured settlement business to assets related to discontinued operations in the consolidated balance sheets, and a corresponding adjustment to our consolidated statements of operations to reflect discontinued operations for all periods presented.

As of December 31, 2016, the components of the Company designated as discontinued operations had assets and liabilities of $94.5 million and $74.2 million, respectively. As of September 30, 2016, the components of the Company designated as discontinued operations had assets and liabilities of $91.5 million and $69.2 million, respectively. For the three months ended December 31, 2016 and 2015, the Company designated as discontinued operations reported a (loss) income, net of income taxes of ($1.3) million and $0.3 million, respectively.

25

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 8—Discontinued Operations (continued)

The following table presents the operating results, for the three months ended December 31, 2016 and 2015, for the components of the Company designated as discontinued operations:

	Three months ended
	December 31, 2016			December 31, 2015
Revenues:
Unrealized (loss) gain on structured settlements	$	(1,682,000	)	$	1,527,000
Interest income on structured settlements		1,901,000			1,227,000
Total revenues		219,000			2,754,000
Other income		15,000			—
		234,000			2,754,000
Expenses:
General and administrative expenses		1,488,000			1,379,000
Interest expense		932,000			726,000
		2,420,000			2,105,000
(Loss) income from discontinued operations before income tax		(2,186,000	)		649,000
Income tax (benefit) expense from discontinued operations		(928,000	)		273,000
(Loss) income from discontinued operations before non-controlling interest		(1,258,000	)		376,000
Non-controlling interest		—			104,000
(Loss) income from discontinued operations, net of income tax	$	(1,258,000	)	$	272,000

The major components of assets and liabilities related to discontinued operations are summarized below:

	December 31, 2016			September 30, 2016
Cash and cash equivalents	$	1,241,000	(1)	$	1,198,000
Restricted cash		499,000			499,000
Structured settlements		88,277,000			86,091,000
Furniture and equipment, net		43,000			47,000
Goodwill		1,405,000			1,405,000
Other assets		3,061,000			2,266,000
Total assets related to discontinued operations	$	94,526,000		$	91,506,000
Other debt - CBC		71,566,000			67,435,000
Other liabilities		2,603,000			1,803,000
Total liabilities related to discontinued operations	$	74,169,000		$	69,238,000

(1) Cash balance with one bank at December 31, 2016 that exceeded the balance insured by the FDIC by approximately $0.7 million.

26

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 8—Discontinued Operations (continued)

Structured Settlements

Prior to our sale of CBC, CBC purchased periodic payments under structured settlements and annuity policies from individuals in exchange for a lump sum payment. The Company elected to carry the structured settlements at fair value. Unearned income on structured settlements is recognized as interest income using the effective interest method over the life of the related structured settlement. Changes in fair value are recorded in unrealized gain (loss) on structured settlements in the Company’s statements of operations. Unrealized gains on structured settlements is comprised of both unrealized gains resulting from fair market valuation at the date of acquisition of the structured settlements and the subsequent fair value adjustments resulting from the change in the discount rate. Of the $1.7 million of unrealized losses recognized in the three month period ended December 31, 2016, approximately $2.1 million is due to day one gains on new structured settlements financed during the period, offset by a decrease of $0.5 million in realized gains recognized as realized interest income on structured settlements, and a reduction in fair value of $3.3 million during the period.

The Company elected the fair value treatment under ASC 825-10-50-28 through 50-32 to be transparent to the user regarding the underlying fair value of the structured settlement which collateralizes the debt of CBC. The Company believes any change in fair value is driven by market risk as opposed to credit risk associated with the underlying structured settlement annuity issuer.

The purchased personal injury structured settlements result in payments over time through an annuity policy. Most of the annuities acquired involve guaranteed payments with specific defined ending dates. CBC also purchased a small number of life contingent annuity payments with specific ending dates but the actual payments to be received could be less due to the mortality risk associated with the measuring life. CBC records a provision for loss each period. The life contingent annuities are not a material portion of assets at December 31, 2016 and revenue for the three month period ended December 31, 2016.

Structured settlements consist of the following as of December 31, 2016 and September 30, 2016:

	December 31, 2016			September 30, 2016
Maturity (1) (2)	$	143,544,000		$	133,059,000
Unearned income		(55,267,000	)		(46,968,000	)
Structured settlements, net	$	88,277,000		$	86,091,000

(1) The maturity value represents the aggregate unpaid principal balance at December 31, 2016 and September 30, 2016.

(2) There are no amounts of structured settlements that are past due, or in nonaccrual status at December 31, 2016 and September 30, 2016.

Encumbrances on structured settlements as of December 31, 2016 and September 30, 2016 are as follows:

	Interest Rate			December 31, 2016		September 30, 2016
Notes payable secured by settlement receivables with principal and interest outstanding payable until June 2025		8.75	%	$	1,817,000	$	1,862,000
Notes payable secured by settlement receivables with principal and interest outstanding payable until August 2026		7.25	%		4,138,000		4,242,000
Notes payable secured by settlement receivables with principal and interest outstanding payable until April 2032		7.125	%		3,948,000		3,987,000
Notes payable secured by settlement receivables with principal and interest outstanding payable until February 2037		5.39	%		18,601,000		18,978,000
Notes payable secured by settlement receivables with principal and interest outstanding payable until March 2034		5.07	%		14,193,000		14,507,000
Notes payable secured by settlement receivables with principal and interest outstanding payable until February 2043		4.85	%		13,605,000		13,705,000
$25,000,000 revolving line of credit		4.1	%		15,264,000		10,154,000
Encumbered structured settlements					71,566,000		67,435,000
Structured settlements not encumbered					16,711,000		18,656,000
Total structured settlements				$	88,277,000	$	86,091,000

27

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 8—Discontinued Operations (continued)

At December 31, 2016, the expected cash flows of structured settlements based on maturity value are as follows:

September 30, 2017 (9 months)	$	7,635,000
September 30, 2018		8,556,000
September 30, 2019		8,914,000
September 30, 2020		8,371,000
September 30, 2021		9,105,000
Thereafter		100,963,000
Total	$	143,544,000

The Company assumed $25.9 million of debt related to the CBC acquisition on December 31, 2013, including a $12.5 million line of credit with an interest rate floor of 5.5%. Between March 27, 2014 and September 29, 2014, CBC entered into three amendments (Sixth Amendment through Eighth Amendment), resulting in the line of credit increasing to $22.0 million and the interest rate floor reduced to 4.75%. On March 11, 2015, CBC entered into the Ninth Amendment. This amendment, effective March 1, 2015, extended the maturity date on its credit line from February 28, 2015 to March 1, 2017. Additionally, the credit line was increased from $22.0 million to $25.0 million and the interest rate floor was decreased from 4.75% to 4.1%. Other terms and conditions were materially unchanged. On November 26, 2014, CBC completed its fourth private placement, backed by structured settlement and fixed annuity payments. CBC issued, through its subsidiary, BBR IV, LLC, approximately $21.8 million of fixed rate asset-backed notes with a yield of 5.4%. On September 25, 2015, CBC completed its fifth private placement, backed by structured settlement and fixed annuity payments. CBC issued, through its subsidiary, BBR V, LLC, approximately $16.6 million of fixed rate asset-backed notes with a yield of 5.1%. On July 8, 2016, CBC issued, through its subsidiary, BBR VI, approximately $14.8 million of fixed rate asset-backed notes with a yield of 4.85%. 

As of December 31, 2016, the remaining debt amounted to $71.6 million, which consisted of $15.3 million drawdown from a line of credit from an institutional source and $56.3 million notes issued by entities 100%-owned and consolidated by CBC. These entities are bankruptcy-remote entities created to issue notes secured by structured settlements. The fair value of this debt approximates its carrying value.

Note 9—Commitments and Contingencies   

Employment Agreements  

On November 11, 2016, the Company announced that it would continue its personal injury claims funding business through the formation of a wholly owned subsidiary Simia. In connection with its formation, Simia entered into an employment agreement (the “Employment Agreement”) with Patrick F. Preece to serve as its Chief Executive Officer. Under the Employment Agreement, Mr. Preece receives an annual base salary of $250,000, subject to annual increases at the discretion of the compensation committee (the “Compensation Committee”) of the Board of Directors of the Company (the “Board”). Mr. Preece is eligible to receive an annual cash or non-cash bonus in the sole and exclusive discretion of the Compensation Committee. Mr. Preece is also eligible to receive a cash or non-cash profit bonus of an aggregate amount up to 15% of the profit of the business of Simia (the “Business”) for each fiscal year in which the Business achieves an internal rate of return of at least 18%. In the event that the Business is sold to a third party solely for cash consideration during Mr. Preece’s employment period, he will be eligible to receive a cash or non-cash sale profit bonus of up to 15% of the closing consideration received by the Company. He is also entitled to participate in any other benefit plans established by the Company for management employees. The Employment Agreement has a five year term. Under the Employment Agreement, Mr. Preece may be terminated with or without “cause” (as defined in the Employment Agreement) and may resign with or without “good reason” (as defined in the Employment Agreement). If Mr. Preece is terminated without “cause” or resigns for “good reason” he will receive severance equal to two years of his base salary. He is also entitled to a pro-rata share of the profit bonus and his deferred compensation will vest immediately. Mr. Preece is also subject to a non-compete and non-solicitation provision during the term of his employment and, unless his employment is terminated without “cause” or he resigns for “good reason,” for two years thereafter. See Note 20 - Subsequent Events.

The employment contracts of the original two CBC principals expired at the end of December 2016. The Company did not renew those contracts. Ryan Silverman has been appointed CEO/General Counsel effective January 1, 2017.

Leases   

The Company leases its facilities in Englewood Cliffs, NJ, Houston, TX, New York, NY, and Conshohocken, PA.  

28

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 9—Commitments and Contingencies (continued)   

Legal Matters  

In June 2015, a putative class action complaint was filed against the Company, and one of its third party law firm servicers, alleging violation of the federal Fair Debt Collection Practices Act and Racketeer Influenced and Corrupt Organizations Act (“RICO”) and state law arising from debt collection activities and default judgments obtained against certain debtors.  

The Company filed a motion to strike the class action allegations and compel arbitration or, to the extent the court declines to order arbitration, to dismiss the RICO claims. On or about March 31, 2015, the court denied the Company’s motion. The Company filed an appeal with the United States Court of Appeals for the Second Circuit. A mediation session was held in July 2015, at which the Company agreed to settle the action on an individual basis for a payment of $13,000 to each named plaintiff, for a total payment of $39,000. Payment was made on or about July 24, 2015. The third party law firm servicer has not yet settled and remains a defendant in the case.  

The plaintiffs’ attorneys advised that they were contemplating the filing of another putative class action complaint against the Company alleging substantially the same claims as those that were asserted in this matter. In anticipation of such an eventuality, the Company agreed to non-binding mediation in order to reach a global settlement with other putative class members, which would avert the possibility of further individual or class actions with respect to the affected accounts. Through March 31, 2016, the parties had attended two mediation sessions and were continuing to discuss a global settlement. In connection with such discussions, the parties agreed in principle to settle the action for a payment of $3.9 million (which would be split equally between the Company and the law firm servicer). The Company and law firm servicer had also agreed to cease collection activity on the affected accounts. Accordingly, the Company set up a reserve for settlement costs of $2.0 million during the three months ended March 31, 2016, which was included in general and administrative expenses in the Company’s consolidated statement of operations.  

The Company reassessed the situation as of September 30, 2016 and deemed that an additional $0.3 million was necessary to account for legal expenses, which were made during the three month period ended September 30, 2016. The Company reviewed this case as of December 31, 2016 and deemed that the $2.3 million reserve remains valid. See Note 20 - Subsequent Events.

In the ordinary course of the Company’s business, it is involved in numerous legal proceedings. The Company regularly initiates collection lawsuits, using its network of third party law firms, against consumers. Also, consumers occasionally initiate litigation against the Company, in which they allege that the Company has violated a federal or state law in the process of collecting their account. The Company does not believe that these ordinary course matters are material to its business and financial condition. The Company is not involved in any other material litigation in which it is a defendant. 

Note 10—Income Recognition, Impairments, and Commissions and Fees 

Income Recognition 

The Company accounts for certain of its investments in finance receivables using the guidance of FASB Accounting Standards Codification (“ASC”), Receivables — Loans and Debt Securities Acquired with Deteriorated Credit Quality (“ASC 310”). Under the guidance of ASC 310, static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision. Due to the substantial reduction of portfolios reported under the interest method, and the inability to reasonably estimate cash collections required to account for those portfolios under the interest method the Company concluded the cost recovery method is the appropriate accounting method under the circumstances.  

Under the guidance of ASC 310-30, the Company must analyze a portfolio upon acquisition to ensure which method is appropriate, and once a static pool is established for a quarter, individual receivable accounts are not added to the pool (unless replaced by the seller) or removed from the pool (unless sold or returned to the seller).  

The Company uses the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method, no income is recognized until the cost of the portfolio has been fully recovered. A pool can become fully amortized (zero carrying balance on the balance sheet) while still generating cash collections. In this case, all cash collections are recognized as revenue when received. 

29

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 10—Income Recognition, Impairments, and Commissions and Fees (continued)

Income Recognition

The Company accounts for its investments in personal injury claims at an agreed upon interest rate, in anticipation of a future settlement. The interest purchased by Pegasus in each claim consists of the right to receive from such claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. Management assesses the quality of the personal injury claims portfolio through an analysis of the underlying personal injury fundings on a case by case basis. Cases are reviewed through periodic updates with attorneys handling the cases, as well as with third party research tools which monitor public filings, such as motions or judgments rendered on specific cases. The Company specifically reserves for those fundings where the underlying cases are identified as uncollectible, due to anticipated non-favorable verdicts and/or settlements at levels where recovery of the advance outstanding is unlikely. For cases that have not exhibited any specific negative collection indicators, the Company establishes reserves based on the historical collection rates of the Company’s fundings. Fee income on advances is reserved for on all cases where a specific reserve is established on the initially funded amount. In addition, management also monitors its historical collection rates on fee income and establishes reserves on fee income consistent with the historically experienced collection rates. Management regularly analyzes and updates the historical collection rates of its initially funded cases as well as its fee income.

The funding of matrimonial actions is on a non-recourse basis. Revenue from matrimonial actions is recognized under the cost recovery method. 

The Company recognizes revenue for GAR Disability Advocates when disability claimant's cases close with the social security administration and the applicable fees are collected.

Impairments 

The Company accounts for its impairments in accordance with ASC 310, which provides guidance on how to account for differences between contractual and expected cash flows from an investor’s initial investment in loans or debt securities acquired in a transfer if those differences are attributable, at least in part, to credit quality. The recognition of income under ASC 310 is dependent on the Company having the ability to develop reasonable expectations of both the timing and amount of cash flows to be collected. In the event the Company cannot develop a reasonable expectation as to both the timing and amount of cash flows expected to be collected, ASC 310 permits the change to the cost recovery method. The Company will recognize income only after it has recovered its carrying value. If collection projections indicate the carrying value will not be recovered, an impairment is required. The impairment will be equal to the difference between the carrying value at the time of the forecast and the corresponding estimated remaining future collections. 

In October 2014, the Company invested $5.0 million in Class A shares of the Topaz MP Fixed Income Fund (“Topaz Fund”), a closed end fund. The Topaz Fund invests indirectly in various portfolios of Non-Performing Small Consumer Loans. The objective of the fund is to obtain a fixed return cash flow representing interest on the invested capital. According to the investment memorandum of the fund, the Topaz Fund proposed to make semi-annual distributions of 14% annual compounded interest on June and December of each year. Since December 2015, no distribution has been received by the Company. The Company received letters from the fund’s General Partner explaining that the distributions were not made due to the negative performance of the fund for the periods. 

During the fiscal year 2016, the Company recorded an impairment loss on this investment of $1.0 million, which was included in general and administrative expenses in the consolidated statements of operations. The carrying value of this investment amounted to $3.4 million at December 31, 2016.

Commissions and fees

Commissions and fees are the contractual commissions earned by third party collection agencies and attorneys, and direct costs associated with the collection effort, generally court costs. The Company utilizes third party collection agencies and attorney networks.

Note 11—Income Taxes

At the end of each interim reporting period, the Company estimates its effective income tax rate expected to be applicable for the full year. The estimate is used in providing for income taxes on a year-to-date basis and may change in subsequent interim periods. The Company’s effective tax rate from operations for the three months ended December 31, 2016 was 70.3%, compared to 32.8% in the same period of the prior year. The effective rate for fiscal 2017 differed from the U.S. federal statutory rate of 34% due to state income taxes, and other permanent differences. The effective rate for fiscal 2016 differed from the U.S. federal statutory rate of 35% primarily due to state income taxes and other permanent differences.

The Company files income tax returns in the U.S federal jurisdiction, various state jurisdictions, and various foreign countries. The Company does not have any uncertain tax positions. The Company’s amended tax returns for the years ended September 30, 2014 and 2015 are currently being audited by the Internal Revenue Service.

30

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

 Note 12—Net (loss) Income per Share

Basic per share data is calculated by dividing net (loss) income by the weighted average shares outstanding during the period. Diluted earnings per share is calculated similarly, except that it includes the dilutive effect of the assumed exercise of securities, including the effect of shares issuable under the Company’s stock based compensation plans. With respect to the assumed proceeds from the exercise of dilutive options, the treasury stock method is calculated using the average market price for the period.

The following table presents the computation of basic and diluted per share data for the three months ended December 31, 2016 and 2015:

	Three Months Ended December 31, 2016								Three Months Ended December 31, 2015
	Net Loss			Weighted Average Shares		Per Share Amount			Net Income		Weighted Average Shares		Per Share Amount
Net (loss) income from continuing operations	$	(1,688,000	)		11,876,224	$	(0.14	)	$	1,291,000		12,155,421	$	0.11
Net (loss) income from discontinued operations		(1,258,000	)		11,876,224		(0.11	)		272,000		12,155,421		0.02
	$	(2,946,000	)			$	(0.25	)	$	1,563,000			$	0.13
Effect of Dilutive Stock					—		—					276,465		—
Diluted	$	(2,946,000	)		11,876,224	$	(0.25	)	$	1,563,000		12,431,886	$	0.13

For the three months ended December 31, 2015, 454,205 options at a weighted average exercise price of $9.47 were not included in the diluted earnings per share calculation as they were anti-dilutive. 

Note 13—Stock Based Compensation

The Company accounts for stock-based employee compensation under ASC 718, Compensation — Stock Compensation (“ASC 718”). ASC 718 requires that compensation expense associated with stock options and other stock based awards be recognized in the consolidated statement of operations, rather than a disclosure in the notes to the Company’s consolidated financial statements.

On December 16, 2015, the Compensation Committee granted 67,100 stock options to non-officer employees of the Company, of which 9,100 options vested immediately and the remaining 58,000 stock options vest in three equal annual installments and accounted for as one graded vesting award. The exercise price of these options was at the market price on that date. The weighted average assumptions used in the option pricing model were as follows:

Risk-free interest rate	0.24	%
Expected term (years)	6.25
Expected volatility	23.4	%
Dividend yield	0.00	%

On December 16, 2015, the Compensation Committee granted 5,000 restricted shares to a non-officer employee of the Company. These shares vested fully. On December 31, 2015, the Company issued an aggregate of 123,304 shares to the two former CBC principals (see Note 5 – Acquisition of CBC). These shares are subject to a one year lock up period in which the holders cannot sell the shares. In addition, the shares are subject to certain sales restrictions following the initial lock-up period which expired on December 31, 2016 (see Note 5 – Acquisition of CBC).

Note 14—Stock Option Plans

2012 Stock Option and Performance Award Plan

 On February 7, 2012, the Board adopted the Company’s 2012 Stock Option and Performance Award Plan (the “2012 Plan”), which was approved by the stockholders of the Company on March 21, 2012. The 2012 Plan replaced the Equity Compensation Plan (as defined below).

 The 2012 Plan provides the Company with flexibility with respect to equity awards by providing for grants of stock awards (i.e. restricted or unrestricted), stock purchase rights and stock appreciation rights, in addition to the granting of stock options.

 The Company authorized 2,000,000 shares of Common Stock for issuance under the 2012 Plan. Under the 2012 Plan, the Company has granted options to purchase an aggregate of 484,200 shares, an award of 245,625 shares of restricted stock, and has cancelled 66,568 options, leaving 1,336,743 shares available as of December 31, 2016. At December 31, 2016, 129 of the Company’s employees were able to participate in the 2012 Plan.

31

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 14—Stock Option Plans (Continued)

Equity Compensation Plan

On December 1, 2005, the Board adopted the Company’s Equity Compensation Plan (the “Equity Compensation Plan”), which was approved by the stockholders of the Company on March 1, 2006. The Equity Compensation Plan was adopted to supplement the Company’s 2002 Stock Option Plan (as defined below).

In addition to permitting the grant of stock options as are permitted under the 2002 Stock Option Plan, the Equity Compensation Plan allowed the Company flexibility with respect to equity awards by also providing for grants of stock awards (i.e. restricted or unrestricted), stock purchase rights and stock appreciation rights.

The Company authorized 1,000,000 shares of Common Stock for issuance under the Equity Compensation Plan. As of March 21, 2012, no more awards could be issued under this plan.

2002 Stock Option Plan 

On March 5, 2002, the Board adopted the Company’s 2002 Stock Option Plan (the “2002 Plan”), which was approved by the stockholders of the Company on May 1, 2002. The 2002 Plan was adopted in order to attract and retain qualified directors, officers and employees of, and consultants to, the Company. 

The 2002 Plan authorized the granting of incentive stock options (as defined in Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”)) and non-qualified stock options to eligible employees of the Company, including officers and directors of the Company (whether or not employees) and consultants of the Company. 

The Company authorized 1,000,000 shares of Common Stock authorized for issuance under the 2002 Plan. As of March 5, 2012, no more awards could be issued under this plan.

Summary of the Plans

Compensation expense for stock options and restricted stock is recognized over the vesting period. Compensation expense for restricted stock is based upon the market price of the shares underlying the awards on the grant date.

The following table summarizes stock option transactions under the 2012 Plan, the 2002 Plan, and the Equity Compensation Plan:

	Three Months Ended December 31,
	2016					2015
	Number Of Shares			Weighted Average Exercise Price		Number of Shares		Weighted Average Exercise Price
Outstanding options at the beginning of period		949,667		$	8.47		1,043,566	$	8.47
Options granted		—			—		67,100		7.93
Options exercised		—			—		—		—
Options forfeited/cancelled		(52,500	)		14.16		—		—
Outstanding options at the end of period		897,167		$	8.14		1,110,666	$	8.43
Exercisable options at the end of period		844,829		$	8.15		965,325	$	8.46

32

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 14—Stock Option Plans (Continued)

The following table summarizes information about the 2012 Plan, 2002 Plan, and the Equity Compensation Plan outstanding options as of December 31, 2016:

			Options Outstanding						Options Exercisable
Range of Exercise Price			Number of Shares Outstanding		Weighted Remaining Contractual Life (in Years)		Weighted Average Exercise Price		Number of Shares Exercisable		Weighted Average Exercise Price
$2.8751	-	$5.7500		3,800		2.3	$	2.95		3,800	$	2.95
$5.7501	-	$8.6250		768,867		5.2		7.96		716,529		7.96
$8.6251	-	$11.5000		124,500		6.1		9.40		124,500		9.40
				897,167		5.3	$	8.14		844,829	$	8.15

The Company recognized ($6,000) and $196,000 of compensation (benefit) expense related to the stock option grants during the three month periods ended December 31, 2016 and 2015, respectively. As of December 31, 2016, there was $76,000 of unrecognized compensation cost related to stock option awards. The weighted average period over which such costs are expected to be recognized is 1.8 years. The intrinsic value of the outstanding and exercisable options as of December 31, 2016 was approximately $1,490,000 and $1,398,000, respectively. The weighted average remaining contractual life of exercisable options is 5.1 years. There were no options exercised during the three month periods ended December 31, 2016 and 2015. The fair value of the stock options that vested during the three month periods ended December 31, 2016 and 2015 was approximately $657,000 and $830,000, respectively. There were no options granted during the three month period ended December 31, 2016. The fair value of the options granted during the three month period ended December 31, 2015 was approximately $532,000.

The following table summarizes information about restricted stock transactions: 

	Three Months Ended December 31,
	2016				2015
	Number of Shares		Weighted Average Grant Date Fair Value		Number of Shares			Weighted Average Grant Date Fair Value
Unvested at the beginning of period		—	$	—		44,107		$	9.28
Awards granted		—		—		5,000			7.89
Vested		—		—		(34,107	)		9.57
Forfeited		—		—		—			—
Unvested at the end of period		—	$	—		15,000		$	7.92

The Company recognized $0 and $87,000 of compensation expense related to the restricted stock awards during the three month periods ended December 31, 2016 and 2015, respectively. As of December 31, 2016, there was no unrecognized compensation cost related to restricted stock awards. No restricted stock was granted during the three month period ended December 31, 2016. An aggregate of 5,000 shares of restricted stock was granted during the three month period ended December 31, 2015. The fair value of the awards vested during the three month periods ended December 31, 2016 and 2015 was $0 and $40,000, respectively.

The Company recognized an aggregate total of ($6,000) and $283,000 in compensation (benefit) expense for the three month periods ended December 31, 2016 and 2015, respectively, for the stock options and restricted stock grants. As of December 31, 2016, there was a total of $76,000 of unrecognized compensation cost related to unvested stock options and restricted stock grants. The method used to calculate stock based compensation is the straight line pro-rated method.

Note 15—Stockholders’ Equity

Dividends are declared at the discretion of the Board and depend upon the Company’s financial condition, operating results, capital requirements and other factors that the Board deems relevant. In addition, agreements with the Company’s lenders may, from time to time, restrict the ability to pay dividends. As of December 31, 2016, there were no such restrictions. No dividends were declared during the three month periods ended December 31, 2016 and 2015. 

33

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 15—Stockholders’ Equity (Continued)

On August 11, 2015, the Board approved the repurchase of up to $15,000,000 of the Company’s common stock and authorized management of the Company to enter into the Shares Repurchase Plan under Sections 10b-18 and 10b5-1 of the Securities Exchange Act (the “Shares Repurchase Plan”). The Shares Repurchase Plan was to have been effective to December 31, 2015. On December 17, 2015 the Board approved the extension of the Plan to March 31, 2016 and reset the maximum to an additional $15 million in repurchases. On March 17, 2016, having repurchased approximately $9.9 million of the Company’s common stock, the Board approved further extension of the Plan to December 31, 2016 and reset the maximum to $15 million in repurchases. On March 22, 2016, a Company shareholder commenced a tender offer on the Company’s common stock. Per the provisions of the Shares Repurchase Plan, it terminated immediately, and no further purchases were permitted under the Shares Repurchase Plan. Through September 30, 2016, the Company purchased approximately 1,186,000 shares at an aggregate cost of approximately $10.1 million under the Shares Repurchase Plan. 

On May 25, 2016, the Company entered into a Mutual Confidentiality Agreement (the “Agreement”) with MPF InvestCo 4, LLC, a wholly owned subsidiary of The Mangrove Partners Master Fund, Ltd. (“Mangrove”), pursuant to which Mangrove and the Company agreed to (1) provide certain Confidential Information (as defined below) to the other party to the Agreement and the other party’s representatives, (2) the confidentiality of the Confidential Information, and (3) certain restrictions on the activities of the parties to the Agreement.  

As of December 31, 2016, and for the three month periods ended December 31, 2015 and 2016, Mangrove due to their ownership in the Company's common stock, which was acquired in a series of OTC transactions, was deemed to be a related party. 

Pursuant to the Agreement, the Company made available to Mangrove and its representatives certain confidential information relating to the Company or its subsidiaries, and Mangrove agreed to make available to the Company and its representatives certain confidential information relating to Mangrove and its affiliates (collectively, the “Confidential Information”). The Company and Mangrove agreed not to disclose the Confidential Information, and to cause each of their representatives, respectively, not to disclose the Confidential Information, except as required by law. Pursuant to the Agreement, the Company provided information requested by Mangrove to one or more of Mangrove’s representatives and such representatives prepared summaries of such information (the “Summaries”). The Company approved the Summaries, and the approved Summaries were provided to Mangrove. The Company agreed to release the approved Summaries publicly on or prior to the end of the Extended Period (as defined in the Agreement), to the extent that the information contained in the Summaries has not already been disclosed. 

Further, under the terms of the Agreement, Mangrove and the Company agreed to certain restrictions during the Discussion Period, which began on May 25, 2016 and the Extended Period, including that, unless consented to by the other party to the Agreement or required by applicable law, neither party will, and shall cause its affiliates and representatives not to, (i) commence any litigation against the other party, (ii) make any filing with the Securities and Exchange Commission of proxy solicitation materials, preliminary proxy statement, definitive proxy statement or otherwise or call any annual or special meeting of stockholders of the Company, (iii) publicly refer to: (a) the Confidential Information or Discussion Information (as defined in the Agreement), (b) any annual or special meetings of stockholders of the Company or (c) any prior discussions between the parties, including in any filing with the Securities and Exchange Commission (including any proxy solicitation materials, preliminary proxy statement, definitive proxy statement or otherwise), in any press release or in any other written or oral disclosure to a third party, (iv) make any purchases of the Company’s securities, including, but not limited to, pursuant to any stock buyback plans, tender offers, open-market purchases, privately negotiated transactions or otherwise, (v) make any demand under Section 220 of the Delaware General Corporation Law, (vi) make or propose to make any amendments to the Company’s Certificate of Incorporation, as amended, or By-laws, as amended, (vii) adopt, renew, propose or otherwise enter into a Shareholder Rights Plan with respect to the Company’s securities, (viii) adopt or propose any changes to the Company’s capital structure or (ix) negotiate, discuss, enter into, propose or otherwise transact in any extraordinary transactions with respect to the Company, outside the ordinary course of business, including, but not limited to, any mergers, asset sales or asset purchases. 

On November 21, 2016, Mangrove notified the Company that Mangrove was terminating the Agreement with the Company. Under the Agreement, the Company and Mangrove agreed to (1) provide certain Confidential Information (as defined below) to the other party to the Agreement and the other party’s representatives, (2) maintain the confidentiality of the Confidential Information, and (3) certain restrictions on the activities of the parties to the Agreement. Upon termination of the Discussion Period, the agreement provides for a period of 30 days thereafter (the “Extended Period”). Throughout the Extended Period of the Agreement, the parties are subject to the standstill provisions of the Agreement. Following the Discussion Period and the Extended Period, nothing in the Agreement shall prohibit any party from taking any of the activities referred to as the Restricted Activities, and specifically nothing shall restrict Mangrove or its representatives from calling a special meeting, nominating one or more candidates to serve as directors of the Company or commencing, or announcing its intention to commence, a “solicitation” of “proxies” (as such terms are used in Regulation 14A of the Securities Exchange Act of 1934, as amended) to vote with respect to any meeting of stockholders of the Company. The effective termination date of this Agreement was January 6, 2017 (see Note 20 – Subsequent Events).

34

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 16—Fair Value of Financial Measurements and Disclosures 

Fair Value Hierarchy

The Company recorded its available-for-sale investments at estimated fair value on a recurring basis. The accompanying consolidated financial statements include estimated fair value information regarding its available-for-sale investments as of December 31, 2016, as required by FASB ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s level within the fair value hierarchy is based on the lowest level of input significant to the fair value measurement. 

Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to assess at the measurement date. 

Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities in active markets; quoted prices in markets that are not active for identical or similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. 

Level 3 – Unobservable inputs that are supported by little or no market activity and significant to the fair value of the liabilities that are developed using the reporting entities’ estimates and assumptions, which reflect those that market participants would use. 

Disclosures about Fair Value of Financial Instruments 

FASB ASC 825, Financial Instruments, (“ASC 825”), requires disclosure of fair value information about financial instruments, whether or not recognized on the balance sheet, for which it is practicable to estimate that value. Because there are a limited number of market participants for certain of the Company’s assets and liabilities, fair value estimates are based upon judgments regarding credit risk, investor expectation of economic conditions, normal cost of administration and other risk characteristics, including interest rate and prepayment risk. These estimates are subjective in nature and involve uncertainties and matters of judgment, which significantly affect the estimates. 

The estimated fair value of the Company’s financial instruments is summarized as follows:

	December 31, 2016				September 30, 2016
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets
Cash equivalents (Level 1)	$	936,000	$	936,000	$	923,000	$	923,000
Other investment, net (Level 1)		3,354,000		3,354,000		3,590,000		3,590,000
Available-for-sale investments (Level 1)		55,045,000		55,045,000		56,763,000		56,763,000
Consumer receivables acquired for liquidation (Level 3)		13,462,000		45,061,000		13,427,000		47,233,000

The following assets have been reclassified to discontinued operations as of December 31, 2016 and September 30, 2016:

	December 31, 2016				September 30, 2016
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial asset
Structured settlements (Level 3)		88,277,000		88,277,000		86,091,000		86,091,000

35

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 16—Fair Value of Financial Measurements and Disclosures (continued)

Disclosure of the estimated fair values of financial instruments often requires the use of estimates. The Company uses the following methods and assumptions to estimate the fair value of financial instruments: 

Cash equivalents – The Company considers all highly liquid debt instruments purchased with an original maturity of Three months or less to be cash equivalents. The carrying amount of cash equivalents approximates fair value.

Available-for-sale investments – The available-for-sale securities consist of mutual funds that are valued based on quoted prices in active markets. 

Other investments – The Company estimated the fair value using the net asset value per share of the investment. There are no unfunded commitments and the investment cannot be redeemed for 5 years from the date of the initial investment ( October 2014). 

Consumer receivables acquired for liquidation – The Company computed the fair value of the consumer receivables acquired for liquidation using its proprietary forecasting model. The Company’s forecasting model utilizes a discounted cash flow analysis. The Company’s cash flows are an estimate of collections for consumer receivables based on variables fully described in Note 4 - Consumer Receivables Acquired for Liquidation. These cash flows are discounted to determine the fair value. 

Structured settlements – The Company determined the fair value based on the discounted forecasted future collections of the structured settlements. Unrealized gains on structured settlements is comprised of both unrealized gains resulting from fair market valuation at the date of acquisition of the structured settlements and the subsequent fair value adjustments resulting from the change in the discount rate. Of the $1.7 million of unrealized losses recognized in the three month period ended December 31, 2016, approximately $2.1 million is due to day one gains on new structured settlements financed during the period, offset by a decrease of $0.5 million in realized gains recognized as realized interest income on structured settlements and a reduction in fair value of $3.3 million during the period. 

A significant unobservable input used in the fair value measurement of structured settlements is the discount rate. Significant increases and decreases in the discount rate used to estimate the fair value of structured settlements could decrease or increase the fair value measurement of the structured settlements. The discount rate could be affected by factors, which include, but are not limited to, creditworthiness of insurance companies, market conditions, specifically competitive factors, credit quality of receivables purchased, the diversity of the payers of the receivables purchased, the weighted average life of receivables, current benchmark rates (i.e. 10 year treasury or swap rate) and the historical portfolio performance of the originator and/or servicer. 

The Company’s available-for-sale investments are classified as Level 1 financial instruments based on the classifications described above. The Company did not have transfers into or (out of) Level 1 investments during the three month period ended December 31, 2016. The Company had no Level 2 or Level 3 available-for-sale investments during the first three months of fiscal year 2017. 

The following table sets forth the Company’s quantitative information about its Level 3 fair value measurements as of December 31, 2016, (which are classified in the consolidated financial statements as assets related to discontinued operations):

	Fair Value		Valuation Technique	Significant Unobservable Input	Weighted Average Rate
Structured settlements at fair value	$	88,277,000	Discounted cash flow	Discount rate	4.83%	-	5.36%

A significant unobservable input used in the fair value measurement of the Company's structured settlements measured at fair value using unobservable inputs (Level 3) is the discount rate. The inputs comprising the discount rate include A-rated U.S. Financial yield curve, plus illiquidity spread, and cash flows of the portfolio are adjusted to take into consideration survival probabilities, if applicable.

The changes in financial instruments at fair value using significant unobservable inputs (Level 3) during the three months ended December 31, 2016 were as follows:

	Structured Settlement
Balance at September 30, 2016	$	86,091,000
Fair value adjustment		(3,611,000	)
Total gains included in earnings		1,598,000
Purchases		4,595,000
Interest accreted		1,567,000
Payments received		(1,963,000	)
Total	$	88,277,000
The amount of total losses for the three month period included in earnings attributable to the change in unrealized losses relating to assets held at December 31, 2016	$	(1,682,000	)

36

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 16—Fair Value of Financial Measurements and Disclosures (continued)

Realized and unrealized losses included in earnings in the accompanying consolidated statements of operations for the three months ended December 31, 2016 are reported in the following revenue categories:

Total losses included in the three months ended December 31, 2016	$	(1,682,000	)
Change in unrealized losses relating to assets still held at December 31, 2016	$	(1,682,000	)

Note 17—Segment Reporting

The Company operates through strategic business units that are aggregated into three reportable segments: consumer receivables, personal injury claims, and GAR. The three reportable segments consist of the following:

• Consumer receivables -  This segment is engaged in the business of purchasing, managing for its own account and servicing distressed consumer receivables, including judgment receivables, charged off receivables and semi-performing receivables. Judgment receivables are accounts where outside attorneys have secured judgments directly against the consumer. Primary charged-off receivables are accounts that have been written-off by the originators and may have been previously serviced by collection agencies. Semi-performing receivables are accounts where the debtor is currently making partial or irregular monthly payments, but the accounts may have been written-off by the originators. Distressed consumer receivables are the unpaid debts of individuals to banks, finance companies and other credit providers. A large portion of our distressed consumer receivables are MasterCard ® , Visa ® and other credit card accounts which were charged-off by the issuers or providers for non-payment. We acquire these and other consumer receivable portfolios at substantial discounts to their face values. The discounts are based on the characteristics (issuer, account size, debtor location and age of debt) of the underlying accounts of each portfolio. The business conducts its activities primarily under the name Palisades Collection, LLC.

• Personal injury claims (Equity Method of Accounting)   – Pegasus Funding, LLC, purchases interests in personal injury claims from claimants who are a party to personal injury litigation. Pegasus advances to each claimant funds on a non-recourse basis at an agreed upon interest rate, in anticipation of a future settlement. The interest in each claim purchased by Pegasus consists of the right to receive, from such claimant, part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. Effective January 2017, Simia commenced funding personal injury settlement claims while Pegasus will not fund any new advances, and will remain in operation to liquidate its current portfolio of advances.

• Social Security benefit advocacy – GAR Disability Advocates is an advocacy group which represents individuals nationwide in their claims for social security disability and supplemental security income benefits from the Social Security Administration.

Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, available-for-sale securities, property and equipment, goodwill, deferred taxes and other assets. 

37

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 17—Segment Reporting (continued)

The following table shows results by reporting segment for the three month periods ended December 31, 2016 and 2015.

The Company eliminates any revenue between the segments.

(Dollars in millions)	Consumer Receivables		GAR Disability Advocates			(Equity Investment) Personal Injury Claims(2)		Corporate(3)			Total
Three Months Ended December 31, 2016:
Revenues	$	4.1	$	1.4		$	—	$	—		$	5.5
Other income		—		—			—		0.4			0.4
Segment profit (loss)		3.2		(0.9	)		0.4		(3.7	)		(1.0	)
Segment Assets(1)		17.6		1.4			49.2		188.3	(4)		256.5
2015:
Revenues		5.1		0.7			—		—			5.8
Other income		—		—			—		0.4			0.4
Segment profit (loss)		4.7		(1.8	)		1.5		(2.5	)		1.9
Segment Assets(1)		24.8		2.4			36.42		174.2	(4)		237.8

The Company does not have any intersegment revenue transactions.

(1) Includes other amounts in other line items on the consolidated balance sheet.

(2) The Company records Pegasus as an equity investment in its consolidated financial statements. For segment reporting the Company has included its pro-rated share of the earnings and losses from its investment under the Personal Injury Claims segment.

(3) Corporate is not part of the three reportable segments, as certain expenses and assets are not earmarked to any specific operating segment.

(4) Included in Corporate are approximately $94.5 million and $74.6 million of assets related to discontinued operations as of December 31, 2016 and 2015, respectively.

38

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 18 - Accumulated Other Comprehensive (Loss) Income 

Accumulated other comprehensive (loss) income consists of:

	Three Months ended December 31, 2016								Year Ended September 30, 2016
	Unrealized gain (loss) on marketable securities			Foreign currency translation, net		Total			Unrealized gain (loss) on marketable securities			Foreign currency translation, net			Total
Beginning Balance	$	624,000		$	179,000	$	803,000		$	(205,000	)	$	225,000		$	20,000
Change in unrealized (losses) gains on foreign currency translation, net of tax benefit/(expense) of ($12,000) and $25,000 at December 31 2016, and September 30, 2016, respectively.		-			18,000		18,000			-			(46,000	)		(46,000	)
Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense) of $826,000 and ($529,000) at December 31 2016, and September 30, 2016, respectively.		(1,239,000	)		-		(1,239,000	)		867,000			-			867,000
Amount reclassified from accumulated other comprehensive loss, net of tax benefit of $18,000 and $24,000 at December 31 2016, and September 30, 2016, respectively.		(27,000	)		-		(27,000	)		(38,000	)		-			(38,000	)
Net current-period other comprehensive (loss) income		(1,266,000	)		18,000		(1,248,000	)		829,000			(46,000	)	$	783,000
Ending balance	$	(642,000	)	$	197,000	$	(445,000	)	$	624,000		$	179,000		$	803,000

Note 19—Related Party Transactions

On September 17, 2015, the Company and Piccolo Business Advisory (“Piccolo”), which is owned by Louis Piccolo, a director of the Company, entered into a Consulting Agreement, pursuant to which Piccolo provides consulting services which included, but is not limited to, analysis of proposed debt and equity transactions, due diligence and financial analysis and management consulting services (“services”). The Consulting Agreement is for a period of two years, which ends on September 17, 2017. For the three months ended December 31, 2016, the Company booked a liability of $20,000 to Piccolo for such services which was paid on January 6, 2017.

In addition, A. L. Piccolo & Co., Inc. (“ALP”), which is also owned by Louis Piccolo, received a fee from Pegasus which was calculated based on amounts loaned to Pegasus by Fund Pegasus up to maximum of $700,000. The fee is payable over six years including interest at 4% per annum from Pegasus during the term of the Pegasus Operating Agreement that expired on December 28, 2016. Thereafter, it is payable by PLF and its affiliates.  Pegasus paid ALP $33,000 for the three months ended December 31, 2016.

In June 2015, CBC entered into an asset purchase agreement with Fortress Funding, LLC (“Fortress”) to acquire an interest in certain tangible and intangible assets of Fortress, which included customer lists, equipment and other intellectual property. In consideration for these assets CBC agreed to pay Fortress $0.5 million, as well as up to an additional $1.2 million based on conversion of customers from the acquired lists obtained in the transaction. Fortress is owned by Michelle Silverman, the wife of Ryan Silverman, who in connection with the agreement was offered employment as General Counsel of CBC.

For the three months ended December 31, 2016 and 2015, the Company paid Fortress $100,000 and $42,000, respectively. As of December 31, 2016 and September 30, 2016, the Company had a liability due to Fortress of $0.7 million and $0.8 million, respectively.

39

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 20—Subsequent Events 

Mangrove Matter

On March 22, 2016, Mangrove a Company shareholder commenced a tender offer on the Company's common stock. See Note 15 - Stockholders' Equity.

On January 6, 2017, the Company entered into a settlement agreement (the “Settlement Agreement”) with Mangrove and, for limited purposes stated therein, Gary Stern, Ricky Stern, Emily Stern, Arthur Stern, Asta Group, Incorporated and GMS Family Investors LLC (collectively, the “ Stern Family ”). 

The Settlement Agreement provided that, within ten business days following the date of the Settlement Agreement, the Company will commence a self-tender offer (“ Tender Offer ”) to repurchase for cash 5,314,009 shares of its common stock at a purchase price of $10.35 per share. The Tender Offer will expire no later than February 28, 2017. Pursuant to the Settlement Agreement, Mangrove will tender its 4,005,701 shares for purchase by the Company. The Stern Family has agreed not to tender any of their shares in the Tender Offer. In addition, pursuant to a securities purchase agreement dated January 6, 2017 between Mangrove and Gary Stern (the “Purchase Agreement”), Gary Stern will purchase any remaining shares owned by Mangrove eleven business days following the closing of the Tender Offer for $10.35 per share.   

The Settlement Agreement includes customary standstill and related provisions. Mangrove and the Company also agreed on a mutual release of claims. Additionally, the Company indemnified Mangrove from and against any excise tax imposed as a result of this Settlement Agreement.  

The Settlement Agreement was terminable by either the Company or Mangrove by written notice at any time after the close of business on the second anniversary of the Settlement Agreement. The Settlement Agreement will also terminate if the Tender Offer does not close on or before February 28, 2017 or the Company amends the terms of the Tender Offer in a manner adverse to Mangrove.   

In connection with the Settlement Agreement, the Company also entered into a Voting Agreement dated January 6, 2017 (the “ Voting Agreement ”) with Gary Stern, Ricky Stern, Emily Stern, Asta Group, Incorporated and GMS Family Investors LLC (collectively, the “ Stern Stockholders ”). The Voting Agreement provides that the Stern Stockholders will not have the right to vote more than 49% of the Company’s total outstanding shares, and any additional shares held by the Stern Stockholders will be voted in a manner proportionate to the votes of the outstanding shares not held by the Stern Stockholders. 

On January 19, 2017, the Company commenced a self-tender offer to purchase for cash up to 5,314,009 shares of its common stock at a purchase price of $10.35 per share, less applicable withholding taxes and without interest. The Company made the tender offer pursuant to the Settlement Agreement dated as of January 6, 2017, by and among the Company, Mangrove and certain of their respective affiliates, pursuant to which Mangrove and its affiliates would tender their 4,005,701 shares. The tender offer would reduce the number of shares in the public market.  

If more than 5,314,009 shares had been tendered, the Company would have purchased all tendered shares on a pro rata basis, subject to the conditional tender provisions described in the Offer to Purchase. Pursuant to the Settlement Agreement, Gary Stern (or his permitted assignees) had unconditionally agreed to purchase from Mangrove and its affiliates any shares owned by Mangrove and its affiliates that the Company did not purchase in the tender offer. 

The tender offer expired on February 15, 2017, at 11:59 p.m., New York City time. Based on the final count by American Stock Transfer & Trust Company, LLC ("AMSTOCK"), the depositary for the tender offer, a total of approximately 6,022,253 shares of the Company’s common stock were validly tendered and not validly withdrawn. Because the tender offer was oversubscribed by 708,244 shares, the Company purchased only a prorated portion of the shares properly tendered by each tendering stockholder. The depositary had informed the Company that the final proration factor for the tender offer was approximately 88.24% of the shares validly tendered and not validly withdrawn. AMSTOCK promptly issued payment for the 5,314,009 shares accepted pursuant to the tender offer and returned all other shares tendered and not purchased. The shares acquired represented approximately 44.7% of the total number of shares of the Company’s common stock issued and outstanding as of February 6, 2017. As a result of this tender offer, the Company recorded during the second quarter of fiscal year 2017 an additional $54.2 million in treasury stock, and $797,000 was charged to general and administrative expenses in the consolidated statements of operations which represent the excess of the current market price of the Company’s common stock on January 18, 2017 of $10.20 per share. Additionally, the Ricky Stern Family 2012 Trust (as Gary Stern's permitted assignee), acquired 471,086 Shares under the Purchase Agreement on March 10, 2017 for $4.9 million.

40

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 20—Subsequent Events (Continued)

Simia

Effective November 11, 2016, the Company entered into a five year employment agreement with Mr. Preece that may be terminated with or without “cause” (as defined in the Employment Agreement) and may resign with or without “good reason” (as defined in the Employment Agreement). If Mr. Preece is terminated without “cause” or resigns for “good reason” he will receive severance equal to two years of his base salary. See Note 5 - Litigation Funding.

As of July 17, 2017, Mr. Preece was no longer employed as Chief Executive Officer of Simia. On an interim basis Gary Stern, Chairman, Chief Executive Officer and President of the Company, will undertake the responsibilities of Simia’s Chief Executive Officer. No amounts were paid to Mr. Preece under the severance or bonus provisions of his contract.

Pegasus

The Company filed for arbitration with the American Arbitration Association ("AAA") against Pegasus in April 2017 for breaches in the Operating and Term Sheet. On April 18, 2017, the Company was granted an Emergent Award restraining the cash in Pegasus, until a formal arbitration panel is confirmed and can review the case. As of June 30, 2017 there was approximately $24.7 million in cash that was restrained under the Emergent Award, and is classified as restricted on the Company's consolidated balance sheet. The Company has as equity method investment in Pegasus. See Note 5 - Litigation Funding.

On July 17, 2017, an arbitration panel was confirmed, and a hearing date has been scheduled for August 25, 2017 on the Company's motion to have PLF removed from managing Pegasus and replacing them with Company designated representatives, and to permit disbursements to the Company in accordance with the Operating and Liquidation Agreements.

On January 12, 2018, the Company, ASFI and Fund Pegasus entered into a Settlement Agreement and Release (the “Settlement Agreement”) by and among the Company, ASFI, Fund Pegasus, Pegasus, the Seller, Max Alperovich, Alexander Khanas, Larry Stoddard, III, Louis Piccolo and A.L. Piccolo & Co., Inc., a New York corporation. The Settlement Agreement releases certain claims in exchange for, among other things, the parties' entry into the Purchase Agreement.

Additionally, on January 12, 2018, ASFI Pegasus Holdings, LLC (“ASFI”), a Delaware limited liability company and a subsidiary of Asta Funding, Inc. (the “Company” or “Asta”), a Delaware corporation, entered into a Membership Interest Purchase Agreement (the “Purchase Agreement) with Pegasus Legal Funding, LLC, a Delaware limited liability company (the “Seller”). Under the Purchase Agreement, ASFI bought the Seller’s ownership interests of Pegasus Funding, LLC (“Pegasus”), which was 20% of the issued and outstanding limited liability company interests of Pegasus, for an aggregate purchase price of $1,800,000. As a result of the execution of the Purchase Agreement, ASFI became the owner of 100% of the limited liability company interests of Pegasus.

As a result of the purchase of the Seller’s 20% interest in Pegasus on January 12, 2018 under the Purchase Agreement, beginning with the quarter ended March 31, 2018, the Company will consolidate the financial statements of Pegasus. The Company currently accounts for its investment in Pegasus under the equity method of accounting. See Note 5 - Litigation Funding.

Legal Matters

A competitor of the Company’s former subsidiary CBC Settlement Funding, LLC (“CBC”) alleged that CBC had unlawfully purchased certain of the competitor’s trade secrets and customer lists from intermediaries who allegedly arranged and/or paid for said materials from the competitor. CBC denied any wrongdoing and disclaimed liability. The parties settled the matter for a payment by the Company of $500,000 on or about November 22, 2017, in exchange for a complete release.

On November 24, 2017, the Company paid $0.8 million as a settlement in conjunction with the lawsuit filed against the Company in Montana state court alleging, fraud and abuse of process arising from the Company's business relationship with an entity that finances divorce proceedings. 

On January 23, 2018, the Company paid $2.3 million as a global settlement in conjunction with the punitive class action complaint filed against the Company, and one of its third-party law firm servicers. This payment represented the Company's portion of the total settlement of $4.6 million, which was split with the third-party law firm. See Note 9 - Commitments and Contingencies.

Special Dividend

On February 5, 2018, the Board of Directors of the Company declared a special cash dividend in the amount of $5.30 per share with respect to its Common Stock, payable on February 28, 2018 to holders of record of the Company’s Common Stock at the close of business on February 16, 2018, with an ex-dividend date of March 1, 2018. The aggregate payment to shareholders was approximately $35 million.

IRS Examination

The Company's amended federal tax return for the year ended September 30, 2014 and 2015 is currently being audited by the Internal Revenue Service.

41

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited) (Restated)

Note 20—Subsequent Events (Continued)

US Tax Reform 

On December 22, 2017 the Tax Cuts and Jobs Act (the “Act”) was signed into law. Among other provisions, the Act reduces the Federal statutory corporate income tax rate from 35% to 21%. This rate reduction is expected to have a significant impact on our provisions for income taxes for periods beginning after September 30, 2017, including a one-time impact resulting from the revaluation of our deferred tax assets and liabilities to reflect the new lower rate. While we have not yet determined the net amount of the revaluation, we expect that it will be a significant component of our income tax provision for the first quarter of fiscal 2018.

42

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations (restated)

Caution Regarding Forward Looking Statements

This Amendment contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21 E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included or incorporated by reference in this Amendment, including without limitation, statements regarding our future financial position, business strategy, budgets, projected revenues, projected costs and plans and objective of management for future operations, are forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “expects,” “intends,” “plans,” “projects,” “estimates,” “anticipates,” or “believes” or the negative thereof or any variation there on or similar terminology or expressions.

We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Important factors which could materially affect our results and our future performance include, without limitation, the restatement of previously issued financial statements, the identified material weaknesses in our internal control over financial reporting and our ability remediate those material weaknesses, our ability to purchase defaulted consumer receivables at appropriate prices, changes in government regulations that affect our ability to collect sufficient amounts on our defaulted consumer receivables, our ability to employ and retain qualified employees, changes in the credit or capital markets, changes in interest rates, deterioration in economic conditions, negative press regarding the debt collection industry which may have a negative impact on a debtor’s willingness to pay the debt we acquire, and statements of assumption underlying any of the foregoing, as well as other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K/A for the fiscal year ended September 30, 2016.

All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the foregoing. Except as required by law, we assume no duty to update or revise any forward-looking statements.

Overview

All management's discussion and analysis has been revised to reflect the restatements discussed in Note 1 – Restatement of Financial Statements in the Company’s notes to consolidated financial statements.

Asta Funding, Inc., together with its wholly owned significant operating subsidiaries Palisades Collection LLC, Palisades Acquisition XVI, LLC (“Palisades XVI”), Palisades Acquisition XIX, LLC (“Palisades XIX”), Palisades Acquisition XXIII, LLC (“Palisades XIX”), VATIV Recovery Solutions LLC (“VATIV”), ASFI Pegasus Holdings, LLC (“APH”), EMIRIC, LLC (“EMIRIC”), Fund Pegasus, LLC (“Fund Pegasus”), GAR Disability Advocates, LLC (“GAR Disability Advocates”), Five Star Veterans Disability, LLC (“Five Star”), Simia Capital, LLC (“Simia”) and other subsidiaries, not all wholly owned (the “Company”, “we” or “us”), is engaged in several business segments in the financial services industry including funding of personal injury claims, through our 50% controlled, 80% owned, equity investment in Pegasus Funding, LLC (“Pegasus”) and our wholly owned subsidiary Simia, social security and disability advocates through our wholly owned subsidiaries GAR Disability Advocates and Five Star, and the business of purchasing, managing for its own account and servicing distressed consumer receivables, including charged off receivables, and semi-performing receivables. The Company started out in the consumer receivable business in 1995 as a subprime auto lender. The primary charged-off receivables are accounts that have been written-off by the originators and may have been previously serviced by collection agencies. Semi-performing receivables are accounts where the debtor is currently making partial or irregular monthly payments, but the accounts may have been written-off by the originators. Our efforts in this area have been in the international arena as we have discontinued our active purchasing of consumer receivables in the United States since 2010. We acquire these and other consumer receivable portfolios at substantial discounts to their face values. The discounts are based on the characteristics (issuer, account size, debtor location and age of debt) of the underlying accounts of each portfolio. 

GAR Disability Advocates is a social security disability advocacy firm. GAR Disability Advocates assists claimants in obtaining long term disability and supplemental security benefits from the Social Security Administration. 

Pegasus provides funding for individuals in need of short term funds pending insurance settlements of their personal injury claims. The funds are recouped when the underlying insurance settlements are paid. The long periods of time taken by insurance companies to settle and pay such claims resulting from lengthy litigation and the court process is fueling the demand for such funding. 

In November 2016, the Company formed Simia, a 100% owned subsidiary. Simia commenced funding personal injury settlement claims in January 2017. Simia was formed in response to the Company’s decision not to renew its joint venture with Pegasus Legal Funding, LLC (“PLF”), which expired at the end of December 2016. Pegasus continues to remain in operation to collect its current portfolio of advances, but will not fund any new advances after December 28, 2016. Simia is operated by a new management team, with significant experience in the personal injury funding business.

43

On December 13, 2017, the Company sold all of the issued and outstanding equity capital of CBC Settlement Funding, LLC (“CBC”) its wholly owned subsidiary engaging in structured settlements. As a result of this sale all prior periods presented in the Company's consolidated financial statements will account for CBC as a discontinued operation. This determination resulted in the reclassification of the assets and liabilities comprising the structured settlement business to assets and liabilities related to discontinued operations in the consolidated balance sheets, and a corresponding adjustment to our consolidated statements of operations to reflect discontinued operations for all periods presented. See Note 8 - Discontinued Operations in the Company's notes to the consolidated financial statements.

The Company operates principally in the United States in three reportable business segments: consumer receivables (domestic and foreign), personal injury claims and social security benefit advocacy. The Company previously operated a fourth segment when it engaged in the structured settlements business through CBC prior to its sale on December 13, 2017.  

Financial Information About Operating Segments

The Company operates through strategic business units that are aggregated into three reportable segments consisting of the following:

• Consumer receivables  – This segment is engaged in the business of purchasing, managing for its own account and servicing distressed consumer receivables, including charged off and semi-performing receivables, primarily in the international marketplace.  The charged-off receivables are accounts that have been written-off by the originators and may have been previously serviced by collection agencies. Semi-performing receivables are accounts where the debtor is currently making partial or irregular monthly payments, but the accounts may have been written-off by the originators. Distressed consumer receivables are the unpaid debts of individuals to banks, finance companies and other credit providers. These receivables were acquired at substantial discounts to their face values. The discounts are based on the characteristics (issuer, account size, debtor location and age of debt) of the underlying accounts of each portfolio. Litigation related receivables are semi-performing investments whereby the Company is assigned the revenue stream from the proceeds received. The business conducts its activities primarily under the name Palisades Collection, LLC.

• Personal injury claims (Equity Method of Accounting)   – Pegasus Funding, LLC, purchases interests in personal injury claims from claimants who are a party to personal injury litigation. Pegasus advances to each claimant funds on a non-recourse basis at an agreed upon interest rate, in anticipation of a future settlement. The interest in each claim purchased by Pegasus consists of the right to receive, from such claimant, part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. Effective January 2017, Simia commenced funding personal injury settlement claims while Pegasus will not fund any new advances, and will remain in operation to liquidate its current portfolio of advances.

• Social Security benefit advocacy – GAR Disability Advocates is a social security disability advocacy group, which obtains and represents individuals in their claims for social security disability and supplemental security income benefits from the Social Security Administration. The Company generates revenue from fees charged to claimants for securing such benefits.

The consumer receivables segment and the social security benefit advocacy segment each accounted for 10% or more of consolidated net revenue for the three month periods ended December 31, 2016 and December 31, 2015. The personal injury claims segment is accounted for under the equity method. The following table summarizes total revenues by percentage from the two lines of business for the three month periods ended December 31, 2016 and 2015:

	Three Month Periods Ended December 31,
	2016			2015
Finance income (consumer receivables)		75.2	%		88.6	%
Social Security benefit advocacy		24.8	%		11.4	%
Total revenues		100.0	%		100.0	%

44

Information about the results of each of the Company’s reportable segments for the three month periods ended December 31, 2016 and 2015, reconciled to the consolidated results, are set forth below. Separate segment MD&A is not provided, as segment revenue corresponds to the revenue presented in the Company's consolidated statement of operations, and material expense items are not allocable to any specific segment.

(Dollars in millions)	Consumer Receivables		GAR Disability Advocates			(Equity Investment) Personal Injury Claims (2)		Corporate(3)			Total
Three Months Ended December 31, 2016:
Revenues	$	4.1	$	1.4		$	—	$	—		$	5.5
Other income		—		—			—		0.4			0.4
Segment profit (loss)		3.2		(0.9	)		0.4		(3.7	)		(1.0	)
Segment Assets(1)		17.6		1.4			49.2		188.3	(4)		256.5
2015:
Revenues		5.1		0.7			—		—			5.8
Other income		—		—			—		0.4			0.4
Segment profit (loss)		4.7		(1.8	)		1.5		(2.5	)		1.9
Segment Assets(1)		24.8		2.4			36.4		174.2	(4)		237.8

The Company does not have any intersegment revenue transactions.

(1) Includes other amounts in other line items on the consolidated balance sheet.

(2) The Company records Pegasus as an equity investment in its consolidated financial statements. For segment reporting the Company has included its pro-rated share of the earnings and losses from its investment under the Personal Injury Claims segment.

(3) Corporate is not part of the three reportable segments, as certain expenses and assets are not earmarked to any specific operating segment

(4) Included in Corporate are approximately $94.5 million and $74.6 million of assets related to discontinued operations as of December 31, 2016 and 2015, respectively.

Consumer Receivables  

The consumer receivable portfolios generally consist of one or more of the following types of consumer receivables (domestic and foreign): 

• charged-off receivables — accounts that have been written-off by the originators and may have been previously serviced by collection agencies; and

• semi-performing receivables — accounts where the debtor is making partial or irregular monthly payments, but the accounts may have been written-off by the originators.

 We acquire these consumer receivable portfolios at a significant discount to the amount actually owed by the borrowers. We acquire these portfolios after a qualitative and quantitative analysis of the underlying receivables and calculate the purchase price so that our estimated cash flow offers us an adequate return on our investment after servicing expenses. After purchasing a portfolio, we actively monitor its performance and review and adjust our collection and servicing strategies accordingly.  

Currently, we have been purchasing receivables in the international market from credit grantors and others through privately negotiated direct sales, brokered transactions and auctions in which sellers of receivables seek bids from several pre-qualified debt purchasers. We pursue new acquisitions of consumer receivable portfolios on an ongoing basis through:

• our relationships with industry participants, financial institutions, collection agencies, investors and our financing sources;

• brokers who specialize in the sale of consumer receivable portfolios; and

• other sources.

45

Litigation Funding Business 

In 2011, the Company purchased an 80% interest, 50% controlled in Pegasus. “PLF”, an unrelated third party, holds the other 20% interest. The Company accounts for this investment under the equity method of accounting. See Note 5 - Equity Method Investment. The Company is committed to loan up to $22.4 million per year to Pegasus for a term of five years, all of which is secured by the assets of Pegasus. These loans will provide financing for the personal injury litigation claims and operating expenses of Pegasus. 

The Pegasus business model entails the outlay of non-recourse advances to a plaintiff with an agreed-upon fee structure to be repaid from the plaintiff’s recovery. Typically, such advances to a plaintiff approximate 10-20% of the anticipated recovery. These funds are generally used by the plaintiff for a variety of urgent necessities, ranging from surgical procedures to everyday living expenses.  

Pegasus’s profits and losses are distributed at 80% to the Company and 20% to PLF. These distributions are made only after the repayment of Fund Pegasus’ principal amount loaned, plus an amount equal to advances for overhead expenses. 

On November 8, 2016, the Company entered into a binding Term Sheet (the “Term Sheet”) with ASFI Pegasus Holdings, LLC, Fund Pegasus, LLC, Pegasus Funding, LLC, Pegasus Legal Funding, LLC, Max Alperovich and Alexander Khanas. The Company and PLF have decided not to renew the Pegasus joint venture that, by its terms, terminates on December 28, 2016. The Term Sheet amends certain provisions to Pegasus’ Operating Agreement dated as of December 28, 2011 and governs the terms relating to the liquidation of the existing Pegasus portfolio. 

Pursuant to the Term Sheet, the parties agreed that Pegasus will continue in existence to collect advances on its Portfolio. The Company will fund overhead expenses relating to its Portfolio based on a budget agreed upon by the Company and PLF. Any cash received by Pegasus will be distributed to its members in the order provided for in the Operating Agreement. The Company will be allocated an amount equal to 20% of all principal collected on each investment paid back beginning October 1, 2016 and continuing through the collection of the Portfolio, which will be applied against the outstanding balance of overhead expenses previously advanced by the Company to Pegasus. After January 2, 2017, additional overhead expenses advanced will be paid back monthly as incurred by the Company prior to the calculation and distribution of any profits. 

In connection with the Term Sheet, the parties also entered into a customary mutual release and non-disparagement agreement as well as a release from the non-competition obligations under the Operating Agreement.

On November 11, 2016, the Company formed Simia, a wholly owned subsidiary. Simia commenced funding personal injury settlement claims in January 2017. Simia was formed in response to the Company’s decision not to renew its joint venture with PLF. As of December 31, 2016, the carrying value of its equity investment in Pegasus was approximately $49.1 million.

On May 8, 2012, the Company announced the formation of EMIRIC, LLC, a wholly owned subsidiary of the Company. EMIRIC, LLC entered into a joint venture (the “Venture”) with California-based Balance Point Divorce Funding, LLC (“BP Divorce Funding”) to create the operating subsidiary BP Case Management, LLC (“BPCM”). BPCM is 60% owned by the Company and 40% owned by BP Divorce Funding. The Venture provides non-recourse funding to a spouse in a matrimonial action where the marital assets exceed $2,000,000. Such funds can be used for legal fees, expert costs and necessary living expenses. The Venture receives an agreed percentage of the proceeds received by such spouse upon final resolution of the case. BP Divorce Funding's profits and losses will be distributed 60% to BPCM and 40% to BP Divorce Funding, after the return of the Company’s investment on a case by case basis and after a 15% preferred return to the Company. BPCM’s initial investment in the Venture consisted of up to $15 million to fund divorce claims to be fulfilled in three tranches of $5 million each. Each investment tranche is contingent upon a minimum 15% cash-on-cash return to us. At the Company’s option, there could be an additional $35 million investment in divorce claims in tranches of $10 million, $10 million, and $15 million, also with a 15% preferred return and such investments may even exceed a total of $50 million, at BPCM’s sole option. Should the preferred return be less than 15% on any $5 million tranche, the 60%/40% profit and loss split would be adjusted to reflect BPCM’s priority to a 15% preferred return. As of December 31, 2016, BPCM has invested $2.5 million, net of reserve charges, in cases managed by this Venture. 

In 2012, the Company provided a $1.0 million revolving line of credit to partially fund BP Divorce Funding’s operations with such loan bearing interest at the prevailing prime rate with an initial term of twenty four months. In September 2014, the agreement was revised to extend the term of the loan to August 2016, increase the credit line to $1.5 million and include a personal guarantee of the principal of BP Divorce Funding. The revolving line of credit is collateralized by BP Divorce Funding’s profits share in the venture and other assets. At December 31, 2016, the balance in the revolving line of credit was approximately $1.5 million. Effective August 14, 2016, BPCM extended its revolving line of credit with BP Divorce Funding until March 31, 2017, at substantially the same terms as the September 2014 amendment.

46

Social Security Benefit Advocacy Business

GAR Disability Advocates is a social security disability advocacy group, which represents individuals in their claims for social security disability and supplemental security income benefits from the Social Security Administration.

Critical Accounting Policies

We may account for our investments in consumer receivable portfolios, using either:

• The interest method; or

• The cost recovery method.

Our extensive liquidating experience in certain asset classes such as distressed credit card receivables, consumer loan receivables and mixed consumer receivables has matured, we use the interest method when we believe we can reasonably estimate the timing of the cash flows. In those situations where we diversify our acquisitions into other asset classes in which we do not possess the same expertise or history, or we cannot reasonably estimate the timing of the cash flows, we utilize the cost recovery method of accounting for those portfolios of receivables. 

The Company accounts for certain of its investments in finance receivables using the interest method under the guidance of FASB Accounting Standards Codification (“ASC”) Topic 310, Receivables — Loans and Debt Securities Acquired with Deteriorated Credit Quality, (“ASC 310”). Under the guidance of ASC 310, static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision. Due to the substantial reduction of portfolios reported under the interest method, and the inability to reasonably estimate cash collections required to account for those portfolios under the interest method, the Company concluded the cost recovery method is the appropriate accounting method under the circumstances. 

Under the guidance of ASC 310, the Company must analyze a portfolio upon acquisition to ensure which method is appropriate, and once a static pool is established for a quarter, individual receivable accounts are not added to the pool (unless replaced by the seller) or removed from the pool (unless sold or returned to the seller). 

The Company uses the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method, no income is recognized until the cost of the portfolio has been fully recovered. A pool can become fully amortized (zero carrying balance on the balance sheet) while still generating cash collections. In this case, all cash collections are recognized as revenue when received. 

The Company accounts for its investments in personal injury claims at an agreed upon interest rate, in anticipation of a future settlement. The interest purchased by Pegasus in each claim consists of the right to receive from such claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. Management assesses the quality of the personal injury claims portfolio through an analysis of the underlying personal injury fundings on a case by case basis. Cases are reviewed through periodic updates with attorneys handling the cases, as well as with third party research tools which monitor public filings, such as motions or judgments rendered on specific cases. The Company specifically reserves for those fundings where the underlying cases are identified as uncollectible, due to anticipated non-favorable verdicts and/or settlements at levels where recovery of the advance outstanding is unlikely. For cases that have not exhibited any specific negative collection indicators, the Company establishes reserves based on the historical collection rates of the Company’s fundings. Fee income on advances is reserved for on all cases where a specific reserve is established on the initially funded amount. In addition, management also monitors its historical collection rates on fee income and establishes reserves on fee income consistent with the historically experienced collection rates. Management regularly analyzes and updates the historical collection rates of its initially funded cases as well as its fee income.

Prior to our sale of CBC, CBC purchased periodic payments under structured settlements and annuity policies from individuals in exchange for a lump sum payment. The Company elected to carry structured settlements at fair value. Unearned income on structured settlements is recognized as interest income using the effective interest method over the life of the related settlement. Changes in fair value are recorded in unrealized gain (loss) in structured settlements in our statements of income. 

The Company recognizes revenue for GAR Disability Advocates when cases close and fees are collected.

In the following discussions, most percentages and dollar amounts have been rounded to aid in the presentation. As a result, all figures are approximations.  

47

Results of Operations    

Three Months Ended December 31, 2016, Compared to the Three-Months Ended December 31, 2015  

Finance income. For the three months ended December 31, 2016, finance income decreased $1.0 million, or 19.6%, to $4.1 million from $5.1 million for the three months ended December 31, 2015. The decrease in finance income is due to decreasing collections on older zero basis portfolios and the new foreign portfolios purchased in Peru and Colombia that are substantially in the cost recovery stage.   During the three months ended December 31, 2016 and 2015, the Company purchased $35.0 million and $97.7 million of face value portfolios at a cost of $2.2 million and $4.4 million, respectively. Net collections for the three months ended December 31, 2016 decreased 15.9% to $6.2 million from $7.4 million for the three months ended December 31, 2015.  For the three months ended December 31, 2016, gross collections decreased 6.9% or $0.8 million to $11.4 million from $12.2 million for the three months ended December 31, 2015. For the three months ended December 31, 2016 commissions and fees associated with gross collections from our third party collection agencies and attorneys increased 6.7% or $0.3 million to $5.2 million from $4.9 million for the three months ended December 31, 2015. Commissions and fees amounted to 45.6% of gross collections for the three months ended December 31, 2016, compared to 39.8% for the three months ended December 31, 2015 resulting from higher percentage of commissionable collections in the current year.  

Social security benefit advocacy fee income. Disability fee income increased $0.7 million, or 105.5%, to $1.4 million for the three months ended December 31, 2016 from $0.7 million for the three months ended December 31, 2015, due to an increase in disability claimants cases closed with the Social Security Administration during the current year period. 

Earnings (loss) from equity method investee. Earnings from equity method investment decreased $1.1 million, or 73.3%, to earnings of $0.4 million for the three months ended December 31, 2016 from earnings of $1.5 million for the three months ended December 31, 2015, due to reduced interest income and bad debt write downs on personal injury claimant advances.

Other income. The following table summarizes other income for the three months ended December 31, 2016 and 2015:

	December 31,
	2016		2015
Interest and dividend income	$	296,000	$	310,000
Realized gain		133,000		16,000
Other		22,000		66,000
	$	451,000	$	392,000

General and administrative expenses.  For the three months ended December 31, 2016, general and administrative expense increased $1.6 million, or 27.3%, to $7.3 million from $5.7 million for the three months ended December 31, 2015, primarily due to an increase in professional fees of $1.3 million and outside services of $0.3 million, primarily related to the Mangrove matter.  

Segment profit – Consumer Receivables. Segment profit decreased $1.5 million to $3.2 million for the three months ended December 31, 2016 from $4.7 million for the three months ended December 31, 2015, as a result of decreased revenue, $1.0 million, and higher collection expense in the current year period.

Segment loss – GAR Disability Advocates. The Segment loss was $0.9 million for the three months ended December 31, 2016 as compared to a $1.8 million segment loss for the three months ended December 31, 2015. This reduced loss of $0.9 million in the current fiscal year is primarily the result of higher revenues and a reduction in overhead expenses.

Discontinued Operations. Structured settlement income of $0.2 million includes $1.7 million of unrealized losses and $1.9 million of interest income for the three months ended December 31, 2016. Structured settlement income of $2.8 million included $1.5 million of unrealized gains and $1.3 million of interest income for the three months ended December 31, 2015. This decrease in income is the result of a reduction in fair value of $3.3 million during the current year. Unrealized losses on structured settlements is comprised of both unrealized losses resulting from fair market valuation at the date of acquisition of the structured settlements and the subsequent fair value adjustments resulting from the change in the discount rate. Of the $1.7 million of unrealized losses recognized for the three months ended December 31, 2016, approximately $2.1 million is due to day one gains on new structured settlements financed during the period, offset by a decrease of $0.5 million in realized gains recognized as interest income on structured settlements and a reduction in fair value of $3.3 million during the period. There were no other changes in assumptions during the period.  All of the revenue associated with CBC is recorded in income (loss) from discontinued operations in the Company's consolidated statements of operations.

Loss from discontinued operations was $1.3 million for the three months ended December 31, 2016 compared to income from discontinued operations of $0.3 million for the three months ended December 31, 2015. The $1.6 million decrease is a result of higher revenues derived from the increased investment in structured settlements, offset by higher interest costs, reduction in the fair value of structured settlements of $3.3 million and benefit of income taxes of $1.2 million during the current year. 

48

Income tax (benefit) expense. Income tax expense, consisting of federal, state and foreign components, for three months ended December 31, 2016, was $0.7 million as compared to $0.6 million tax expense for the three months ended December 31, 2015.

Net (loss) income. As a result of the above, the Company had a net loss for the three months ended December 31, 2016 of $2.9 million compared to $1.6 million in net income for the three months ended December 31, 2015.

The Company had a net loss from continuing operations for the three months ended December 31, 2016 of $1.7 million compared to $1.3 million in net income from continuing operations for the three months ended December 31, 2015.

The Company had a net loss from discontinued operations for the three months ended December 31, 2016 of $1.3 million compared to $0.3 million in net income from discontinued operations for the three months ended December 31, 2015.

Liquidity and Capital Resources

Our primary source of cash from operations is collections on the receivable portfolios we have acquired and the funds generated from the personal injury claims and structured settlement business segments. Our primary uses of cash include repayments of debt and associated interest payments, purchase of structured settlement and advances of personal injury claims, costs involved in the collection of consumer receivables, taxes and to support day-to-day operations of the Company.

Receivables Financing Agreement

In March 2007, Palisades XVI borrowed approximately $227 million under the Receivables Financing Agreement, as amended in July 2007, December 2007, May 2008, February 2009, October 2010 and August 2013 from BMO, in order to finance the Portfolio Purchase which had a purchase price of $300 million. The original term of the agreement was three years. This term was extended by each of the Second, Third, Fourth, Fifth Amendments and the most recent agreement signed in August 2013, discussed below.

Financing Agreement. The Settlement Agreement and Omnibus Amendment (“Settlement Agreement”) was in effect on August 7, 2013, Palisades XVI, a 100% owned bankruptcy remote subsidiary, entered into a Settlement Agreement with BMO as an amendment to the Receivables Financing Agreement. In consideration for a $15 million prepayment funded by the Company, BMO has agreed to significantly reduce minimum monthly collection requirements and the interest rate. If and when BMO were to receive the next $15 million of collections from the Portfolio Purchase, (the “Remaining Amount”) less certain credits for payments made prior to the consummation of the Settlement Agreement, the Company would be entitled to recover from future net collections the $15 million prepayment that it funded. Thereafter, BMO would have the right to receive 30% of future net collections. Upon repayment of the Remaining Amount to BMO, the Company would be released from the remaining contractual obligation of the Receivables Financing Agreement (“RFA”) and the Settlement Agreement. 

On June 3, 2014, Palisades XVI finished paying the Remaining Amount. The final principal payment of $2.9 million included a voluntary prepayment of $1.9 million provided from funds of the Company. Accordingly, Palisades XVI was entitled to receive $16.9 million of future collections from the Portfolio Purchase before BMO is entitled to receive any payments with respect to its Income Interest. During the month of June 2016, the Company received the balance of the $16.9 million, and, as of December 31, 2016, the Company recorded a liability to BMO of approximately $0.2 million. The funds were subsequently remitted to BMO on January 10, 2017. The liability to BMO is recorded when actual collections are received. 

Bank Hapoalim B.M. (“Bank Hapoalim”) Line of Credit

On May 2, 2014, the Company obtained a $20 million line of credit facility from Bank Hapoalim, pursuant to a Loan Agreement (the “Loan Agreement”) among the Company and its subsidiary, Palisades Collection, LLC, as borrowers, and Bank Hapoalim, as agent and lender. The Loan Agreement provides for a $20 million committed line of credit and an accordion feature providing an increase in the line of credit of up to $30 million, at the discretion of the lenders. The facility is for a term of three years at an interest rate of either LIBOR plus 275 basis points or prime, at the Company’s option. The Loan Agreement includes covenants that require the Company to maintain a minimum net worth of $150 million and pay an unused line fee. The facility is secured pursuant to a Security Agreement among the parties to the Loan Agreement. On March 30, 2016, the Company signed the First Amendment to the Loan Agreement (the “First Amendment”) with Bank Hapoalim which amended certain terms of their banking arrangement. The First Amendment includes (a) the reduction of the interest rate to LIBOR plus 225 basis points; (b) a decrease in the minimum net worth requirement by $50 million, to $100 million and (c) modifies the No Net Loss requirement from a quarterly to an annual basis. All other terms of the original agreement remain in effect. There is a $8.2 million aggregate balance on deposit at Bank Hapoalim which has been reclassified as restricted cash in the consolidated balance sheet since these assets serve as collateral for the line of credit. As of December 31, 2016, the Company had not used this facility. 

Tender Offer of Company Common Shares  

On March 22, 2016, MPF InvestCo 4, LLC, a wholly owned subsidiary of The Mangrove Partners Master Fund, Ltd. (“Mangrove”), filed a Tender Offer Statement with the SEC, announcing the commencement of an unsolicited tender offer to acquire up to 3,000,000 shares of Asta common stock at price of $9.00 per share (“the Mangrove Offer”). The Mangrove Offer was sent to the holders of common stock of the Issuer. If the Offer were subscribed, the Mangrove Offer would represent approximately 25.0% of the issued and outstanding shares and would result in Mangrove owning an aggregate of approximately 5,102,427 shares, which would have represented approximately 42.5% of issued and outstanding shares, based on the 12,011,476 shares, issued and outstanding as of March 31, 2016. 

49

On March 31, 2016, the Company announced that its Board, after careful consideration and in consultation with a special committee of the Board and its financial and legal advisors, unanimously determined to recommend that shareholders reject the Mangrove Offer. Furthermore, the Company announced its intention to commence an issuer tender offer for 3,000,000 shares of Asta common stock pursuant to a “Dutch Auction” format at a price range of $9.50 to $10.25 per share.

On April 11, 2016, the Company commenced a Tender Offer to purchase of up to 3,000,000 shares of its common stock, par value $0.01 per share, pursuant to auction tenders at prices specified by the tendering shareholders of not greater than $10.25 per share nor less than $9.50 per share. The expiration date for the Company’s Tender Offer was May 12, 2016. On that date, the Company repurchased 274,284 shares at a price of $10.25 per share, for an aggregate cost of $2,811,411.  

On April 15, 2016, MPF InvestCo 4, LLC and Mangrove amended its previously announced unsolicited tender offer to acquire up to 3,000,000 shares of Asta’s common stock, increasing the price per share from $9.00 to $9.50, and extending the expiration date to May 9, 2016. In addition, the amendment added certain additional conditions to Mangrove’s obligation to consummate its offer. On April 21, 2016, the Company’s Board unanimously reaffirmed its recommendation to shareholders that they reject the unsolicited offer, citing the fact that the increased offer was still at the bottom of the range in the Company’s self-tender, as described above. On April 26, 2016, Mangrove announced the termination of its Tender Offer, which had been due to expire on May 9, 2016. Mangrove stated that it had terminated its offer because it determined that a condition of the offer would not be satisfied. None of the shares of the Company’s common stock were purchased under the Mangrove offer. 

On May 25, 2016, the Company entered into a Mutual Confidentiality Agreement (the “Agreement”) with Mangrove Partners (“Mangrove”), pursuant to which Mangrove and the Company agreed to (1) provide certain Confidential Information (as defined below) to the other party to the Agreement and the other party’s representatives, (2) the confidentiality of the Confidential Information, and (3) certain restrictions on the activities of the parties to the Agreement. 

Pursuant to the Agreement, the Company agreed to make available to Mangrove and its representatives certain confidential information relating to the Company or its subsidiaries, and Mangrove has agreed to make available to the Company and its representatives certain confidential information relating to Mangrove and its affiliates (collectively, the “Confidential Information”). The Company and Mangrove agreed not to disclose the Confidential Information, and to cause each of their representatives, respectively, not to disclose the Confidential Information, except as required by law. Pursuant to the Agreement, the Company provided information requested by Mangrove to one or more of Mangrove’s representatives and such representatives prepared summaries of such information (the “Summaries”). Following the Company’s approval of the Summaries, the approved Summaries were provided to Mangrove. The Company has agreed to release the approved Summaries publicly on or prior to the end of the Extended Period (as defined in the Agreement), to the extent that the information contained in the Summaries has not already been disclosed.  

Further, under the terms of the Agreement, Mangrove and the Company have agreed to certain restrictions during the Discussion Period, which began on May 25, 2016 and the Extended Period (each as defined in the Agreement), including that, unless consented to by the other party to the Agreement or required by applicable law, neither party will, and shall cause its affiliates and representatives not to, (i) commence any litigation against the other party, (ii) make any filing with the Securities and Exchange Commission of proxy solicitation materials, preliminary proxy statement, definitive proxy statement or otherwise or call any annual or special meeting of stockholders of the Company, (iii) publicly refer to: (a) the Confidential Information or Discussion Information (as defined in the Agreement), (b) any annual or special meetings of stockholders of the Company or (c) any prior discussions between the parties, including in any filing with the Securities and Exchange Commission (including any proxy solicitation materials, preliminary proxy statement, definitive proxy statement or otherwise), in any press release or in any other written or oral disclosure to a third party, (iv) make any purchases of the Company’s securities, including, but not limited to, pursuant to any stock buyback plans, tender offers, open-market purchases, privately negotiated transactions or otherwise, (v) make any demand under Section 220 of the Delaware General Corporation Law, (vi) make or propose to make any amendments to the Company’s Certificate of Incorporation, as amended, or By-laws, as amended, (vii) adopt, renew, propose or otherwise enter into a Shareholder Rights Plan with respect to the Company’s securities, (viii) adopt or propose any changes to the Company’s capital structure or (ix) negotiate, discuss, enter into, propose or otherwise transact in any extraordinary transactions with respect to the Company, outside the ordinary course of business, including, but not limited to, any mergers, asset sales or asset purchases. 

On November 21, 2016, Mangrove notified the Company that they were terminating the Agreement with the Company. Upon termination of the Discussion Period, the Agreement provides for a period of thirty (30) days thereafter, the Extended Period. Throughout the Extended Period of the Agreement, the parties are subject to the standstill provisions of the Agreement. Following the Discussion Period and the Extended Period, nothing in the Agreement shall prohibit any party from taking any of the activities referred to as the Restricted Activities, and specifically nothing shall restrict Mangrove or its representatives from calling a special meeting, nominating one or more candidates to serve as directors of the Company or commencing, or announcing its intention to commence, a “solicitation” of “proxies” (as such terms are used in Regulation 14A of the Securities Exchange Act of 1934, as amended) to vote with respect to any meeting of stockholders of the Company. The effective termination date of this Agreement was January 6, 2017.  

On January 19, 2017 the Company commenced a self-tender offer to purchase for cash up to 5,314,009 shares of its common stock at a purchase price of $10.35 per share, less applicable withholding taxes and without interest. The NASDAQ closing price of the Company's common stock on January 18, 2017, was $10.20 per share. 

50

If more than 5,314,009 shares had been tendered, the Company would have purchased all tendered shares on a pro rata basis, subject to the conditional tender provisions described in the Offer to Purchase. Pursuant to the Settlement Agreement, Gary Stern (or his permitted assignees) had unconditionally agreed to purchase from Mangrove and its affiliates any shares owned by Mangrove and its affiliates that the Company did not purchase in the tender offer. 

Personal Injury Claims  

On December 28, 2011, we formed a joint venture Pegasus Funding, LLC (“Pegasus”) with Pegasus Legal Funding, LLC (“PLF”). Pegasus purchases interests in personal injury claims from claimants who are a party to personal injury litigation with the expectation of a settlement in the future. Pegasus advances to each claimant funds on a non-recourse basis at an agreed upon interest rate in anticipation of a future settlement. The interest purchased by Pegasus in each claim will consist of the right to receive from such claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. The profits from the joint venture are distributed based on the ownership percentage of the parties — Asta Funding, Inc. 80% and PLF, 20%. The Company accounts for this investment under the equity method of accounting.

On November 8, 2016, the Company entered into a binding Term Sheet (the “Term Sheet”) with Pegasus and PLF. The Company and PLF have decided not to renew the Pegasus joint venture that by its terms terminates on December 28, 2016. The Term Sheet amends certain provisions to Pegasus’ operating agreement dated as of December 28, 2011 (as amended, the “Operating Agreement”) and governs the terms relating to the collection of its existing Pegasus portfolio (the “Portfolio”).  

Pursuant to the Term Sheet, the parties agreed that Pegasus will continue in existence in order to collect advances on its existing Portfolio. The Company will fund overhead expenses relating to the collection of the Portfolio based on a budget agreed upon by the Company and PLF. Any cash received by Pegasus will be distributed to its members in the order provided for in the Operating Agreement. The Company will be allocated an amount equal to 20% of all principal collected on each investment paid back beginning October 1, 2016 and continuing through the collection of the Portfolio, which will be applied against the outstanding balance of overhead expenses previously advanced by the Company to Pegasus. After January 2, 2017, additional overhead expenses advanced will be paid back monthly as incurred by the Company prior to the calculation and distribution of any profits.

In connection with the Term Sheet, the parties also entered into a customary mutual release and non-disparagement agreement as well as a release from the non-competition obligations under the Operating Agreement. Additionally, on January 12, 2018, ASFI , a subsidiary of the Company, entered into a Membership Interest Purchase Agreement with PLF. Under the Purchase Agreement, ASFI bought the Seller’s ownership interests of Pegasus, which was 20% of the issued and outstanding limited liability company interests of Pegasus, for an aggregate purchase price of $1,800,000. As a result of the execution of the Purchase Agreement, ASFI became the owner of 100% of the limited liability company interests of Pegasus.

On November 11, 2016, the Company announced that it will continue its personal injury claims funding business through the formation of a wholly owned subsidiary, Simia. In connection with its formation, Simia entered into an employment agreement with Patrick F. Preece to serve as its Chief Executive Officer.

Divorce Funding

On May 8, 2012, the Company formed EMIRIC, a wholly owned subsidiary of the Company. EMIRIC entered into a joint venture with California-based Balance Point Divorce Funding, LLC (“BP Divorce Funding”) to create BP Case Management, LLC (“BPCM”). BPCM is 60% owned by the Company and 40% owned by BP Divorce Funding. BPCM provides non-recourse funding to a spouse in a matrimonial action. The Company provides a $1.5 million revolving line of credit to partially fund BP Divorce Funding’s operations, with such loan bearing interest at the prevailing prime rate, with an initial term of twenty-four months. The term of the loan was to end in May 2014, but had been extended to August 2016. Effective August 14, 2016, the Company extended its revolving line of credit with Balance Point until March 31, 2017, at substantially the same terms as the September 14, 2014 amendment. The revolving line of credit is collateralized by BP Divorce Funding’s profit share in BPCM and other assets.

51

Discontinued Operations – CBC Acquisition

On December 31, 2013, the Company acquired 80% ownership of CBC and its affiliate, CBC Management Services, LLC for approximately $5.9 million. At the closing, the operating principals of CBC, namely William J. Skyrm, Esq. and James Goodman, were each issued a 10% interest in CBC. In addition, the Company agreed to provide financing to CBC of up to $5 million, amended to $7.5 million in March 2015. Through the transaction we acquired structured settlements valued at $30.4 million and debt that totaled $23.4 million, consisting of $9.6 million of a revolving line of credit with a financial institution and $13.8 million of non-recourse notes issued by CBC’s subsidiaries. On December 31, 2015, the Company acquired the remaining 20% ownership of CBC for $1,800,000, through the issuance of restricted stock valued at approximately $1,000,000 and $800,000 in cash. Each of the two original principals received 61,652 shares of restricted stock at fair market value of $7.95 per share and $400,000 in cash. An aggregate of 123,304 shares of restricted stock was issued. As of December 31, 2016, CBC had structured settlements valued at $88.3 million and debt of $71.6 million, consisting of a $15.3 million line of credit and an aggregate of 56.3 million of non-recourse notes.

Cash Flow  

At December 31, 2016, our cash, including restricted cash decreased $4.4 million to $11.9 million from $16.3 million at September 30, 2016 .

Net cash used in operating activities was $5.3 million during the three month period ended December 31, 2016, as compared to $1.5 million used in operating activities for the three month period ended December 31, 2015, primarily resulting from a $5.0 million change in income taxes receivable. Net cash used in investing activities was $3.3 million during the three month period ended December 31, 2016, as compared to $3.9 million provided by investing activities during the three month period ended December 31, 2015. The change in cash in investing activities is primarily due to higher proceeds from sale of available for sale Securities in the prior year period. Net cash provided by financing activities was $4.1 million during the three month period ended December 31, 2016, as compared to $2.9 million used in financing activities in the same 2015 period. The change is primarily related to the purchase of $7.2 million in treasury stock during 2015.

Our cash requirements have been and will continue to be significant and include external financing to operate various lines of business. Significant requirements include investment in personal injury claims, costs involved in the collections of consumer receivables and investment in consumer receivable portfolios. Acquisitions recently have been financed through cash flows from operating activities. We believe we may secure credit facilities with financial institutions as we look to grow the Company, support current operations, and execute on our short and long term business initiatives. In the short term, our cash balances will be sufficient to invest in personal injury claims, purchase portfolios and finance the disability advocacy business.

We believe our available cash resources and expected cash flows from operations will be sufficient to fund operations for the next twelve months. We do not expect to incur any material capital expenditures during the next twelve months.  The Company will use a portion of its cash and cash equivalents on hand to fund the purchase of shares in the tender offer.

We are cognizant of the current market fundamentals in the debt purchase and company acquisition markets which, because of significant supply and tight capital availability, could result in increased buying opportunities. The outcome of any future transaction(s) is subject to market conditions. In addition, due to these opportunities, we continue to seek opportunities with banking organizations and others on a possible financing loan facility.

Off Balance Sheet Arrangements  

As of December 31, 2016, we did not have any relationships with unconsolidated entities or financial partners, established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As such, we are not materially exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.

Additional Supplementary Information:

We do not anticipate collecting the majority of the purchased principal amounts of our various portfolios. Accordingly, the difference between the carrying value of the portfolios and the gross receivables is not indicative of future revenues from these accounts acquired for liquidation. Since we purchased these accounts at significant discounts, we anticipate collecting only a portion of the face amounts. 

For additional information regarding our methods of accounting for our investment in finance receivables, the qualitative and quantitative factors we use to determine estimated cash flows, and our performance expectations of our portfolios, see “ Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies ” above.

52

Recent Accounting Pronouncements

In May 2014, the FASB issued an update to ASC 606, Revenue from Contracts with Customers, that will supersede virtually all existing revenue guidance. Under this update, an entity is required to recognize revenue upon transfer of promised goods or services to customers, in an amount that reflects the entitled consideration received in exchange for those goods or services. The guidance also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from the customer contracts. This update is effective for annual reporting periods beginning after December 15, 2017 including interim periods within that reporting period. Early application is permitted for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Given the changes in the Company's business management is continuing to assess this new standard and the impact it will have on accounting for its revenues. 

In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments-Overall (Subtopic 825-10) Recognition and Measurement of Financial Assets and Financial Liabilities. The main objective in developing this update is enhancing the reporting model for financial instruments to provide users of financial statements with more decision-useful information. The amendments in this update address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. The effective date for this update is for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. The Company is currently evaluating the impact this update will have on its consolidated financial statements.

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) to amend lease accounting requirements and requires entities to generally recognize on the balance sheet operating and financing lease liabilities and corresponding right-of-use assets. The new standard will require significant additional disclosures about the amount, timing and uncertainty of cash flows from leases. The standard update is effective for fiscal years beginning after December 15, 2018 and interim periods within those years and early adoption is permitted. The standard is to be applied using a modified retrospective approach and includes a number of optional practical expedients that entities may elect to apply. The Company is currently evaluating the impact of adopting this update on its consolidated financial statements and expects that most of its operating leases will be recognized as operating lease liabilities and right-of-use assets upon adoption.  

In March 2016, the FASB issued ASU No. 2016-09, Compensation - Stock Compensation (Topic 718) Improvements to Employee Share Based Payment Accounting, to simplify and improve areas of generally accepted accounting principles for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided to users of financial statements. The effective date for this update is for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. The Company is currently evaluating the impact this update will have on its consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.  The ASU requires an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Additionally, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration.  For the Company, this update will be effective for interim periods and annual periods beginning after December 15, 2019. Upon adoption, the Company will accelerate the recording of its credit losses in its financial statements.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments.  This ASU will make eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The new standard is effective for fiscal years beginning after December 15, 2017. Early adoption is permitted. The new standard will require adoption on a retrospective basis unless it is impracticable to apply, in which case the Company would be required to apply the amendments prospectively as of the earliest date practicable. The Company is in the process of evaluating the provisions of the ASU, but does not expect it to have a material effect on the Company’s consolidated statements of cash flows.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We are exposed to various types of market risk in the normal course of business, including the impact of interest rate changes and foreign exchange rates and changes in corporate tax rates. At December 31, 2016, the debt associated with our acquisition of CBC, had a balance of approximately $71.6 million, consisting of $15.3 million through a line of credit, at a rate of LIBOR plus 3%, with a floor of 4.1%, from a financial institution, and $56.3 million of notes at varying rates, from 4.85% to 8.75%, issued by CBC’s subsidiaries. At December 31, 2016, the LIBOR rate was 0.77167%. Thus, a 25 basis point change in the LIBOR rate would have had an immaterial impact on the CBC line of credit interest expense, while above the floor rate (4.02167%) would have an effect less than a month. The Company sold CBC on December 13, 2017, and presents the entity as a discontinued operation in its consolidated financial statements.. We do not currently invest in derivative financial or commodity instruments.

The Company sold CBC on December 13, 2017, and presents the entity as a discontinued operation in its consolidated financial statements.

53

Item 4. Controls and Procedures (restated)

a. Disclosure Controls and Procedures

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosures.

In connection with the preparation of this Amendment, our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, re-evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2016. Based on that re-evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of December 31, 2016 due to the existence of the material weaknesses in internal control over financial reporting described below (which we view as an integral part of our disclosure controls and procedures). 

1.          The Company lacked a process to review key inputs into the period end valuation using underlying benchmark interest rates in determining fair value of the Company’s structured settlements. The material weakness was first reported by the Company in its Quarterly Report on Form 10-Q/A (Amendment No. 1) for the quarter ended December 31, 2016, which was filed with the SEC on May 26, 2017, and was also identified as a material weakness in connection with the preparation of this Amendment.

Planned Remedial Actions:

● Since the original determination regarding this material weakness, the Company retained and intends to continue to retain third-party specialists to perform independent valuations of its assets and liabilities, when warranted, particularly with respect to, those assets and liabilities which involve specific complex or intricate valuation techniques, and/or are outside the Company's traditional business model.

● The Company plans on hiring additional personnel with financial reporting experience to supplement its existing accounting/finance department. Additionally, management will develop and train accounting/finance personnel in the use of formalized checklists, to identify key inputs associated with period end valuations.

2.          The Company did not maintain effective internal controls over financial reporting disclosures specifically associated with concentrations, foreign transactions, significant entities and related party transactions. The material weaknesses related to financial reporting disclosures associated with significant and related party transactions at the subsidiary level, were first reported by the Company in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2017, which was filed with the SEC on August 9, 2017, and was also identified as a material weakness in connection with the preparation of this Amendment.

Planned Remedial Actions:

● The Company has retained and intends to continue to retain the services of outside consultants, with relevant accounting experience, skills and knowledge, working under the supervision and direction of the Company’s management, to supplement the Company’s existing accounting personnel.

● The Company plans to develop policies, procedures, and controls for the specific areas identified in this material weakness. The Company will also hire additional accounting and finance personnel with significant accounting and SEC reporting experience to join its finance team to ensure consistent application of these accounting principles and adherence to the Company’s newly adopted policies, procedures, and controls. The Company plans to review the current financial controls to assess if additional management review controls are necessary and work with all finance personnel to establish the appropriate documentation criteria for the existing controls including evidence of review, timeliness and variance thresholds.

● The Company plans to have the Disclosure Committee, which now meets on a quarterly basis, meet more frequently throughout the year to assure that our SEC filings and other public disclosures are complete, accurate, and otherwise comply with applicable accounting principles and regulations. The Company’s Disclosure Committee reports to our Chief Executive Officer with oversight provided by our Audit Committee, and includes individuals knowledgeable about, among other things, SEC rules and regulations, financial reporting, and internal control matters. The Company will also document a formal disclosure policy and procedures to govern the work of the Disclosure Committee.

● Since the original determination regarding the material weakness associated with significant and related party transactions at the subsidiary level, the Company has installed contract management software to manage all of its contracts and associated obligations under those contracts. Management from each department has been trained on the software, and all contracts require approvals of designated managers and the accounting department prior to execution. All contracts are reviewed by accounting personnel with requisite experience in identifying complex accounting transactional and disclosure issues,

54

3.          The Company did not maintain effective internal controls over regulatory compliance; specifically the Company did not have an effective whistleblower hotline or a formalized Foreign Corrupt Practices Act Policy.

Planned Remedial Actions:

● While the Company has implemented a whistleblower hotline it believes will be effective, management will develop a formalized plan to test the independent system on a regular basis to ensure regulatory compliance.

● The Company will formalize its Foreign Corrupt Practices Act Policy, and will ensure all employees are trained on, and adhere to the policy.

4.          The Company lacks a formal policy to assess the adequacy of the design and operating effectiveness of controls related to certain of the Company’s subsidiaries, third party service providers and third party advocates.

Planned Remedial Actions:

● The Company will increase the frequency of onsite inspections of third party servicers and advocates throughout the year, utilizing existing accounting/finance personnel familiar with the specific accounting processes involved at each location.

● The Company will provide training to accounting personnel at subsidiary locations, and will develop detailed checklist and processes that can be used, and reviewed by management during period ends. Additionally, management will routinely visit subsidiary locations to ensure that the processes and guidelines developed are being strictly adhered to.

 5.          The Company did not maintain effective internal controls over accounting for complex transactions specifically associated with equity method investments.

Planned Remedial Actions:

● The Company plans to develop policies, procedures, and controls to ensure the proper accounting for complex technical issues are identified, researched and brought to management's attention. The Company will also ensure that the appropriate personnel are appropriately trained on new and existing accounting pronouncements, Company policies, procedures, and controls.

6.          The Company did not maintain effective internal controls over accounting for foreign transactions specifically associated with accounting for transaction and translation adjustments, unallocated payments and cutoff.

Planned Remedial Actions:

● The Company plans to develop and implement improved policies, procedures, processes and controls, as well as, conduct trainings to ensure the proper accounting for foreign currency matters in accordance with ASC 830, Foreign Currency Matters

● The Company plans to utilize an accounting system to ensure that all transactions are systematically re-measured and translated at the applicable foreign currency exchange rate and the associated gain or loss is appropriately recognized in earnings.

● The Company plans to appropriately reconcile the AOCI account in a timely manner to ensure that the proper amounts for foreign currency transactions are being recorded in the Company's financial statements.

b. Changes in Internal Controls over Financial Reporting.

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, re-evaluated our internal control over financial reporting to determine whether any changes occurring during the first quarter of fiscal year 2017 that have materially affected, or are reasonably likely to affect, our internal control over financial reporting, and have concluded that there have been no changes that occurred during such quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

55

PART II. OTHER INFORMATION

Item  1.    Legal Proceedings

In the ordinary course of our business, we are involved in numerous legal proceedings. We regularly initiate collection lawsuits, using third party law firms, against consumers. Also, consumers occasionally initiate litigation against us, in which they allege that we have violated a federal or state law in the process of collecting on their account. We do not believe that these ordinary course matters are material to our business and financial condition. As of the date of this report, we were not involved in any material litigation in which we were a defendant.

Originators, debt purchasers and third party collection agencies and attorneys in the consumer credit industry are frequently subject to putative class action lawsuits and other litigation. Claims include failure to comply with applicable laws and regulations and improper or deceptive origination and servicing practices. Being a defendant in such class action lawsuits or other litigation could materially adversely affect our results of operations and financial condition. Currently, the Company has set up a reserve for settlement costs of $2.3 million to cover a class action lawsuit.

Legal proceedings are subject to substantial uncertainties concerning the outcome of material factual and legal issues relating to the litigation. Accordingly, we cannot currently predict the manner and timing of the resolution of some of these matters and may be unable to estimate a range of possible losses or any minimum loss from such matters.

Item  1A.  Risk factors (restated)

For a discussion of our potential risks and uncertainties, see the information previously disclosed in Part I, Item 1A. “Risk Factors” in our Form 10-K/A. There have been no material changes to the risk factors disclosed in our Form 10-K/A. 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None

Item 3. Default Upon Senior Securities

None

Item 4. Mine Safety Disclosures

Not applicable

Item 5. Other Information

None

56

Item 6.	Exhibits (restated)
	(a) Exhibits.

2.1	Term Sheet, dated November 8, 2016, by and among Asta Funding, Inc., ASFI Pegasus Holdings, LLC, Fund Pegasus, LLC, Pegasus Funding, LLC, Pegasus Legal Funding, LLC, Max Alperovich and Alexander Khanas (incorporated by reference to Exhibit 10.1 to Asta Funding, Inc.’s Current Report on Form 8-K filed November 15, 2016).
3.1	Certificate of Incorporation of Asta Funding, Inc. (incorporated by reference to Exhibit 3.1 to Asta Funding, Inc.’s Quarterly Report on Form 10-Q filed August 9, 2016).
3.2	Certificate of Amendment to Certificate of Incorporation of Asta Funding, Inc. (incorporated by reference to Exhibit 3.1(a) to Asta Funding, Inc.’s Quarterly Report on Form 10-QSB filed May 15, 2002).
3.3	Certificate of Designation of Series A Junior Preferred Stock of Asta Funding, Inc. (incorporated by reference to Exhibit 3.1 to Asta Funding, Inc.’s Current Report on Form 8-K filed August 24, 2012).
3.4	Amended and Restated By-laws of Asta Funding, Inc. (incorporated by reference to Exhibit 3.3 to Asta Funding, Inc.’s Quarterly Report on Form 10-Q filed August 9, 2016).
3.5	Amendment to Amended and Restated Bylaws of Asta Funding, Inc. (incorporated by reference to Exhibit 3.1 to Asta Funding, Inc.’s Current Report on Form 8-K filed January 9, 2017).
31.1*	Certification of Gary Stern, Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Bruce R. Foster, Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**	Certification of Gary Stern, Chief Executive Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**	Certification of Bruce R. Foster, Chief Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance.
101.SCH	XBRL Taxonomy Extension Schema.
101.CAL	XBRL Taxonomy Extension Calculation.
101.DEF	XBRL Taxonomy Extension Definition.
101.LAB	XBRL Taxonomy Extension Labels.
101.PRE	XBRL Taxonomy Extension Presentation.

*         Filed herewith.

**       This certification is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act.

57

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ASTA FUNDING, INC. (Registrant)
Date: September 17, 2018	By:	/s/ Gary Stern
		Gary Stern, President, Chief Executive Officer
		(Principal Executive Officer)
Date: September 17, 2018	By:	/s/ Bruce R. Foster
		Bruce R. Foster, Chief Financial Officer
		(Principal Financial Officer and Principal Accounting Officer)

58

EXHIBIT INDEX

Exhibit Number	Description
2.1	Term Sheet, dated November 8, 2016, by and among Asta Funding, Inc., ASFI Pegasus Holdings, LLC, Fund Pegasus, LLC, Pegasus Funding, LLC, Pegasus Legal Funding, LLC, Max Alperovich and Alexander Khanas (incorporated by reference to Exhibit 10.1 to Asta Funding, Inc.’s Current Report on Form 8-K filed November 15, 2016).
3.1	Certificate of Incorporation of Asta Funding, Inc. (incorporated by reference to Exhibit 3.1 to Asta Funding, Inc.’s Quarterly Report on Form 10-Q filed August 9, 2016).
3.2	Certificate of Amendment to Certificate of Incorporation of Asta Funding, Inc. (incorporated by reference to Exhibit 3.1(a) to Asta Funding, Inc.’s Quarterly Report on Form 10-QSB filed May 15, 2002).
3.3	Certificate of Designation of Series A Junior Preferred Stock of Asta Funding, Inc. (incorporated by reference to Exhibit 3.1 to Asta Funding, Inc.’s Current Report on Form 8-K filed August 24, 2012).
3.4	Amended and Restated By-laws of Asta Funding, Inc. (incorporated by reference to Exhibit 3.3 to Asta Funding, Inc.’s Quarterly Report on Form 10-Q filed August 9, 2016).
3.5	Amendment to Amended and Restated Bylaws of Asta Funding, Inc. (incorporated by reference to Exhibit 3.1 to Asta Funding, Inc.’s Current Report on Form 8-K filed January 9, 2017).
31.1*	Certification of Gary Stern, Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Bruce R. Foster, Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**	Certification of Gary Stern, Chief Executive Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**	Certification of Bruce R. Foster, Chief Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance.
101.SCH	XBRL Taxonomy Extension Schema.
101.CAL	XBRL Taxonomy Extension Calculation.
101.DEF	XBRL Taxonomy Extension Definition.
101.LAB	XBRL Taxonomy Extension Labels.
101.PRE	XBRL Taxonomy Extension Presentation.

*         Filed herewith.

**       This certification is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act.

59

EX-31.1

Exhibit 31.1

CERTIFICATION OF PERIODIC REPORT UNDER SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Gary Stern, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q/A of Asta Funding, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: September 17, 2018

/s/ Gary Stern

Gary Stern

Chairman, President and Chief Executive Officer

(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF PERIODIC REPORT UNDER SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Bruce R. Foster, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q/A of Asta Funding, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: September 17, 2018

/s/ Bruce R. Foster

Bruce R. Foster

Chief Financial Officer and Chief Accounting Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 In connection with the Quarterly Report of Asta Funding, Inc. (the “Company”) on Form 10-Q/A for the quarter ended December 31, 2016, filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gary Stern, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and the results of operations of the Company for the periods presented.

Date: September 17, 2018

/s/ Gary Stern

Gary Stern

Chairman, President and Chief Executive Officer (Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 In connection with the Quarterly Report of Asta Funding, Inc. (the “Company”) on Form 10-Q/A for the quarter ended December 31, 2016, filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Bruce R. Foster, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and the results of operations of the Company for the periods presented.

Dated: September 17, 2018

/s/ Bruce R. Foster

Bruce R. Foster

Chief Financial Officer and Chief Accounting Officer

XML

Document And Entity Information - shares	3 Months Ended
	Dec. 31, 2016	Sep. 14, 2018
Document Information [Line Items]
Entity Registrant Name	ASTA FUNDING INC
Entity Central Index Key	0001001258
Trading Symbol	asfi
Current Fiscal Year End Date	--09-30
Entity Filer Category	Accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		6,685,415
Document Type	10-Q/A
Document Period End Date	Dec. 31, 2016
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q1
Amendment Flag	true
Amendment Description	As previously disclosed in the Current Report on Form 8-K filed by Asta Funding, Inc. ("Asta” or the “Company") with the Securities and Exchange Commission (the "SEC") on January 18, 2018, the Board of Directors (the "Board") of the Company, upon the recommendation of the Audit Committee of the Board (the "Audit Committee"), determined that the Company's previously issued financial statements for each of the years ended September 30, 2016, 2015 and 2014, and the interim periods contained therein, as well as the Company’s unaudited consolidated financial statements for the quarters ended December 31, 2016, March 31, 2017 and June 30, 2017, could no longer be relied upon. On September 17, 2018, the Company filed an Annual Report on Form 10-K/A (the "Form 10-K/A") to amend and restate the Company's previously issued financial statements for each of the years ended September 30, 2016, 2015 and 2014, as well as the interim periods contained therein. The Company is filing this Amendment No. 2 on Form 10-Q/A (this "Amendment") to amend and restate the Company's previously issued financial statements contained in its Quarterly Report on Form 10-Q for the quarter ended December 31, 2016 (the "Non-Reliance Period"), which was originally filed with the SEC on February 9, 2017 (the "Original Form 10-Q"), and restated on May 26, 2017 (the "Restated Form 10-Q/A"). The Company expects to file, at a later time, amendments to its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2017 and June 30, 2017. Prior period amounts have already been restated in the Company's 10-K/A filed on September 17, 2018, and, accordingly have not been restated in this Amendment.

XML

Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Dec. 31, 2016		Sep. 30, 2016	Dec. 31, 2015		Sep. 30, 2015
ASSETS
Cash and cash equivalents	$ 3,696,000		$ 6,282,000
Restricted cash	8,165,000	[1]	10,000,000
Available for sale investments (at fair value)	55,045,000		56,763,000
Consumer receivables acquired for liquidation (at net realizable value)	13,462,000		13,427,000	$ 18,800,000
Other investments, net	3,354,000		3,590,000
Due from third party collection agencies and attorneys	1,004,000		1,050,000
Prepaid and income taxes receivable	4,896,000		714,000
Furniture and equipment, net	176,000		196,000
Equity method investment	49,141,000		48,582,000
Deferred income taxes	15,327,000		14,903,000
Goodwill	1,410,000		1,410,000
Other Assets, Total	6,281,000		6,585,000
Assets related to discontinued operations	94,526,000		91,506,000
Total assets	256,483,000		255,008,000	237,800,000	[2]
LIABILITIES
Other Liabilities, Total	4,731,000		3,987,000
Liabilities related to discontinued operations	74,169,000		69,238,000
Total liabilities	78,900,000		73,225,000
Commitments and contingencies
STOCKHOLDERS’ EQUITY
Preferred stock, $.01 par value; authorized 5,000,000 shares; issued and outstanding — none
Common stock, $.01 par value, authorized 30,000,000 shares; issued 13,336,508 at December 31, 2016 and September 30, 2016; and outstanding 11,876,224 at December 31, 2016 and September 30, 2016	133,000		133,000
Additional paid-in capital	67,028,000		67,034,000
Retained earnings	123,792,000		126,738,000
Accumulated other comprehensive (loss) income	(445,000)		803,000
Treasury stock (at cost) 1,460,284 shares at December 31, 2016 and September 30, 2016	(12,925,000)		(12,925,000)
Total stockholders’ equity	177,583,000		181,783,000	$ 177,696,000		$ 183,407,000
Total liabilities and stockholders’ equity	$ 256,483,000		$ 255,008,000

[1] In connection with the Company determining it lacked the requisite control to consolidate Pegasus during the Non-Reliance Period, the Company has now accounted for its investment in Pegasus under the equity method in accordance with US GAAP. On the Company's December 31, 2016 consolidated balance sheet, this resulted in (i) a decrease in cash of $1,065,000; (ii) a decrease in the investment in personal injury claims of $47,875,000; (iii) a decrease in other assets of $109,000; (iv) a decrease in other liabilities of $1,133,000; (v) an decrease in non-controlling interest of $804,000, offset by a corresponding increase in the equity method investment of $48,720,000. On the Company's consolidated statement of operations, this resulted in (i) a reduction in total revenues of $2,302,000; (ii) a reduction in expenses of $2,197,000; (iii) a decrease in the income attributable to the non-controlling interest of $21,000; and (iv) a decrease in earnings from equity method investment of $84,000 for the three months ended December 31, 2016. This change to the equity method of accounting had no effect on net (loss) income during the Non-Reliance Period.

[2] Includes other amounts in other line items on the consolidated balance sheet.

XML

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Dec. 31, 2016	Sep. 30, 2016
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	5,000,000	5,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	30,000,000	30,000,000
Common stock, issued (in shares)	13,336,508	13,336,508
Common stock, outstanding (in shares)	11,876,224	11,876,224
Treasury stock, shares (in shares)	1,460,284	1,460,284

XML

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Revenues:
Finance income, net	$ 4,095,000	$ 5,106,000
Disability fee income	1,354,000	659,000
Total revenues	5,449,000	5,765,000
Other income — includes ($45,000) and ($31,000) during the three month periods ended December 31, 2016 and 2015, respectively, of accumulated other comprehensive income reclassification for unrealized net (losses) / gains on available for sale securities	451,000	392,000
	5,900,000	6,157,000
Expenses:
General and administrative	7,295,000	5,729,000
Earnings from equity method investment	(404,000)	(1,494,000)
	6,891,000	4,235,000
(Loss) income from continuing operations before income tax	(991,000)	1,922,000
Income tax expense — includes tax benefit of $18,000 and $11,000 during the three month periods ended December 31, 2016 and 2015, respectively, of accumulated other comprehensive income reclassifications for unrealized net (losses) / gains on available for sale securities	697,000	631,000
Net (loss) income from continuing operations	(1,688,000)	1,291,000
Net (loss) income from discontinued operations, net of income tax	(1,258,000)	272,000
Net (loss) income	$ (2,946,000)	$ 1,563,000
Net (loss) income per basic shares:
Continuing operations (in dollars per share)	$ (0.14)	$ 0.11
Discontinued operations (in dollars per share)	(0.11)	0.02
(in dollars per share)	(0.25)	0.13
Net (loss) income per diluted shares:
Continuing operations (in dollars per share)	(0.14)	0.11
Discontinued operations (in dollars per share)	(0.11)	0.02
(in dollars per share)	$ (0.25)	$ 0.13
Weighted average number of common shares outstanding:
Basic (in shares)	11,876,224	12,155,421
Diluted (in shares)	11,876,224	12,431,886

XML

Consolidated Statements of Operations (Unaudited) (Parentheticals) - USD ($)	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Reclassification for unrealized net gain (loss) on available for sale securities	$ (45,000)	$ (31,000)
Income tax (benefit) expense	$ 18,000	$ 11,000

XML

Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Net (loss) income	$ (2,946,000)	$ 1,563,000
Net unrealized securities (loss) gain, net of tax benefit/ (expense) of $826,000 and ($190,000) during the three month periods ended December 31, 2016 and 2015, respectively.	(1,239,000)	330,000
Reclassification adjustments for securities sold, net of tax benefit of $18,000 and $11,000 during the three month periods ended December 31, 2016 and 2015, respectively.	(27,000)	(20,000)
Foreign currency translation, net of tax benefit (expense) of ($12,000) and ($9,000) during the three month periods ended December 31, 2016 and 2015, respectively.	18,000	14,000
Other comprehensive (loss) income	(1,248,000)	324,000
Total comprehensive (loss) income	$ (4,194,000)	$ 1,887,000

XML

Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (Parentheticals) - USD ($)	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Net unrealized securities gain (loss), tax benefit (expense)	$ 826,000	$ (190,000)
Reclassification adjustments for securities, tax (expense) benefit	18,000	11,000
Foreign currency translation, tax benefit	$ (12,000)	$ (9,000)

XML

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Previously Reported [Member] Common Stock [Member]	Previously Reported [Member] Additional Paid-in Capital [Member]	Previously Reported [Member] Retained Earnings [Member]	Previously Reported [Member] AOCI Attributable to Parent [Member]	Previously Reported [Member] Treasury Stock [Member]	Previously Reported [Member] Noncontrolling Interest [Member]	Previously Reported [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Treasury Stock [Member]	Noncontrolling Interest [Member]	Total
Balance (in shares) at Sep. 30, 2015								13,061,673
Balance at Sep. 30, 2015								$ 131,000	$ 65,049,000	$ 119,165,000	$ 20,000	$ (1,751,000)	$ 793,000	$ 183,407,000
Stock based compensation expense									278,000					278,000
Net (loss) income										1,563,000				1,563,000
Amount reclassified from other comprehensive loss											(20,000)			(20,000)
Unrealized (loss) on marketable securities, net											330,000			330,000
Foreign currency translation, net											14,000			14,000
Restricted stock (in shares)								5,000
Purchase of treasury stock												(7,180,000)		(7,180,000)
Purchase of subsidiary shares from non-controlling interest									(903,000)				(793,000)	(1,696,000)
Issuance of restricted stock to purchase subsidiary shares from non-controlling interest (in shares)								123,304
Issuance of restricted stock to purchase subsidiary shares from non-controlling interest								$ 1,000	999,000					1,000,000
Balance (in shares) at Dec. 31, 2015								13,189,977
Balance at Dec. 31, 2015								$ 132,000	65,423,000	120,728,000	344,000	(8,931,000)		177,696,000
Balance (in shares) at Sep. 30, 2016	13,336,508
Balance at Sep. 30, 2016	$ 133,000	$ 67,034,000	$ 126,738,000	$ 803,000	$ (12,925,000)		$ 181,783,000				803,000			181,783,000
Stock based compensation expense									(6,000)					(6,000)
Net (loss) income							(1,657,000)			(2,946,000)				(2,946,000)
Amount reclassified from other comprehensive loss							(27,000)				(27,000)			(27,000)
Unrealized (loss) on marketable securities, net											(1,239,000)			(1,239,000)
Foreign currency translation, net							(369,000)				18,000			18,000
Balance (in shares) at Dec. 31, 2016								13,336,508
Balance at Dec. 31, 2016							$ 178,281,000	$ 133,000	$ 67,028,000	$ 123,792,000	$ (445,000)	$ (12,925,000)		$ 177,583,000

XML

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities:
Net (loss) income from continuing operations	$ (1,688,000)	$ 1,291,000
Net (loss) income from discontinued operations, net of income tax	(1,258,000)	272,000
Net (loss) income	(2,946,000)	1,563,000
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	26,000	90,000
Deferred income taxes	420,000	95,000
Stock based compensation	(6,000)	278,000
Loss on sale of available-for-sale securities	45,000	31,000
Unrealized gain on other investments	(18,000)	(62,000)
Unrealized foreign exchange loss on other investments	254,000	118,000
Earnings from equity method investment	(404,000)	(1,494,000)
Changes in:
Prepaid and income taxes receivable	(4,182,000)	819,000
Due from third party collection agencies and attorneys	40,000	352,000
Other assets	307,000	(2,360,000)
Other liabilities	761,000	(493,000)
Net cash provided by (used in) operating activities of discontinued operations	369,000	(479,000)
Net cash used in operating activities	(5,334,000)	(1,542,000)
Cash flows from investing activities:
Purchase of consumer receivables acquired for liquidation	(2,213,000)	(6,051,000)
Principal collected on receivables acquired for liquidation	2,129,000	2,299,000
Purchase of available-for-sale securities	(7,568,000)	(7,136,000)
Proceeds from sale of available-for-sale securities	7,132,000	12,303,000
Purchase of non-controlling interest		(800,000)
(Increase) decrease in equity method investment	(155,000)	5,827,000
Capital expenditures	(6,000)
Net cash used in investing activities of discontinued operations	(2,632,000)	(2,544,000)
Net cash (used in) provided by investing activities	(3,313,000)	3,898,000
Cash flows from financing activities:
Purchase of treasury stock		(7,180,000)
Net cash provided by financing activities of discontinued operations	4,131,000	4,306,000
Net cash provided by (used in) financing activities	4,131,000	(2,874,000)
Foreign currency effect on cash	52,000
Net decrease in cash, cash equivalents and restricted cash including cash, cash equivalents classified within assets related to discontinued operations	(4,464,000)	(518,000)
Less: net increase (decrease) in cash, cash equivalents and restricted cash classified within assets related to discontinued operations	43,000	(312,000)
Net decrease in cash, cash equivalents and restricted cash	(4,421,000)	(830,000)
Cash, cash equivalents and restricted cash at beginning of period	16,282,000	19,947,000
Cash, cash equivalents and restricted cash at end of period	11,861,000	19,117,000
Supplemental disclosure of cash flow information:
Cash paid for: Income taxes	6,200,000
Cash paid for: Interest	914,000	763,000
Supplemental disclosure of non-cash flow investing activities:
Issuance of restricted stock to purchase subsidiary shares from non-controlling interest		$ 1,000,000

XML

Note 1 - Restatement of Financial Statements

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Accounting Changes and Error Corrections [Text Block]

Note

1—

Restatement of Financial Statements

The following tables summarize the effects of the restatements on the specific items presented in the Company’s consolidated financial statements previously included in the Restated Form

10

-Q/A:

	Consolidated Balance Sheet
	December 31, 2016
	As Reported			De-Consolidation of Pegasus ( 1 )			Adjustments				Restated
ASSETS
Cash and cash equivalents	$	4,770,000		$	(1,065,000	)	$	(9,000	)	(2)(6)	$	3,696,000
Restricted cash		8,165,000			—			—				8,165,000
Available for sale investments (at fair value)		55,045,000			—			—				55,045,000
Consumer receivables acquired for liquidation (at net realizable value)		13,243,000			—			219,000		(2)		13,462,000
Investment in personal injury claims, net		47,875,000			(47,875,000	)		—				—
Other investments, net		3,354,000			—			—				3,354,000
Due from third party collection agencies and attorneys		1,035,000			—			(31,000	)	(2)		1,004,000
Prepaid and income taxes receivable		5,267,000			—			(371,000	)	(8)		4,896,000
Furniture and equipment, net		176,000			—			—				176,000
Equity method investment		—			48,720,000			421,000		(7)		49,141,000
Deferred income taxes		16,585,000			—			(1,258,000	)	(2)(8)		15,327,000
Goodwill		1,410,000			—			—				1,410,000
Other assets		6,203,000			(109,000	)		187,000		(2)		6,281,000
Assets related to discontinued operations		94,335,000			—			191,000		(5)(6)		94,526,000
Total assets	$	257,463,000		$	(329,000	)	$	(651,000	)		$	256,483,000
LIABILITIES
Other liabilities		5,666,000			(1,133,000	)		198,000		(2)		4,731,000
Liabilities related to discontinued operations		73,516,000			—			653,000		(5)		74,169,000
Total liabilities		79,182,000			(1,133,000	)		851,000				78,900,000
Commitments and contingencies
STOCKHOLDERS’ EQUITY
Preferred stock		—			—			—				—
Common stock		133,000			—			—				133,000
Additional paid-in capital		67,020,000			—			8,000		(6)		67,028,000
Retained earnings		126,406,000			—			(2,614,000	)	(2)(3) (4)(5) (6)(7)(8)		123,792,000
Accumulated other comprehensive loss		(1,549,000	)		—			1,104,000		(2)		(445,000	)
Treasury stock (at cost)		(12,925,000	)		—			—				(12,925,000	)
Non-controlling interest		(804,000	)		804,000			—				—
Total stockholders’ equity		178,281,000			804,000			(1,502,000	)			177,583,000
Total liabilities and stockholders’ equity	$	257,463,000		$	(329,000	)	$	(651,000	)		$	256,483,000

Consolidated Statement of Operations

For the Three Months Ended

December 31,

2016

	As Reported			De-Consolidation of Pegasus ( 1 )			Adjustments				Restated
Revenues:
Finance income, net	$	4,001,000		$	—		$	94,000		(2)	$	4,095,000
Personal injury claims income		2,302,000			(2,302,000	)		—
Disability fee income		1,354,000			—			—				1,354,000
Total revenues		7,657,000			(2,302,000	)		94,000				5,449,000
Other income		544,000			—			(93,000	)	(2)		451,000
		8,201,000			(2,302,000	)		1,000				5,900,000
General and administrative		9,556,000			(2,195,000	)		(66,000	)	(2)(6)		7,295,000
Interest		2,000			(2,000	)		—				—
Earnings from equity method investment		—			(84,000	)		(320,000	)	(7)		(404,000	)
		9,558,000			(2,281,000	)		(386,000	)			6,891,000
(Loss) from continuing operations before income tax		(1,357,000	)		(21,000	)		387,000				(991,000	)
Income tax (benefit)/expense		(555,000	)		—			1,252,000		(8)		697,000
Net (loss) income from continuing operations		(802,000	)		(21,000	)		(865,000	)			(1,688,000	)
Net loss from discontinued operations, net of income tax		(834,000	)		—			(424,000	)	(3)(5)(8)		(1,258,000	)
Less: net income attributable to non-controlling interests		21,000			(21,000	)
Net loss attributable to Asta Funding, Inc.	$	(1,657,000	)	$	—		$	(1,289,000	)		$	(2,946,000	)
Basic and diluted loss per share:
Continuing operations	$	(0.07	)								$	(0.14	)
Discontinued operations		(0.07	)									(0.11	)
	$	(0.14	)								$	(0.25	)

				Consolidated Statement of Comprehensive Loss
				For the Three Months Ended December 31, 2016
	As Reported			De-Consolidation of Pegasus (1 )		Adjustments				Restated
Comprehensive income (loss) is as follows:
Net loss	$	(1,657,000	)	$	—	$	(1,289,000	)		$	(2,946,000	)
Net unrealized securities (loss) gain, net of tax		(1,239,000	)		—		—				(1,239,000	)
Reclassification adjustments for securities sold, net of tax		(27,000	)		—		—				(27,000	)
Foreign currency translation, net of tax		(369,000	)		—		387,000		(2)(6)		18,000
Other comprehensive loss		(1,635,000	)		—		387,000				(1,248,000	)
Total comprehensive loss	$	(3,292,000	)	$	—	$	(902,000	)		$	(4,194,000	)

Consolidated Statement of Cash Flows For the Three Months Ended December 31, 2016
	As Reported			Adjustments				Restated
Cash flows from operating activities:
Net loss from continuing operations	$	(823,000	)	$	(865,000	)		$	(1,688,000	)
Net loss from discontinued operations		(834,000	)		(424,000	)			(1,258,000	)
		(1,657,000	)		(1,289,000	)			(2,946,000	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		105,000			(79,000	)			26,000
Deferred income taxes		(211,000	)		631,000		(2)(8)		420,000
Stock based compensation		(6,000	)		—				(6,000	)
Loss on sale of available-for-sale securities		45,000			—				45,000
Unrealized gain on other investments		(18,000	)		—				(18,000	)
Unrealized foreign exchange loss on other investments		254,000			—				254,000
Earnings from equity method investment		—			(404,000	)	(7)		(404,000	)
Changes in:
Prepaid and income taxes receivable		(4,387,000	)		205,000		(8)		(4,182,000	)
Due from third party collection agencies and attorneys		(30,000	)		70,000		(2)		40,000
Other assets		498,000			(191,000	)	(2)		307,000
Income tax payable		(252,000	)		252,000		(8)		—
Other liabilities		373,000			388,000		(2)		761,000
Non-controlling interest		21,000			(21,000	)	(1)		—
Net cash used in operating activities of discontinued operations		(391,000	)		760,000		(3)(5)		369,000
Net cash used in operating activities		(5,656,000	)		322,000				(5,334,000	)
Cash flows from investing activities:
Purchase of consumer receivables acquired for liquidation		(2,213,000	)		—				(2,213,000	)
Principal collected on receivables acquired for liquidation		2,641,000			(512,000	)	(2)(4)(5)(6)		2,129,000
Purchase of available-for-sale securities		(7,568,000	)		—				(7,568,000	)
Proceeds from sales of available-for-sale securities		7,132,000			—				7,132,000
Investments in personal injury claims — advances		(5,178,000	)		5,178,000		(1)		—
Investments in personal injury claims — receipts		5,592,000			(5,592,000	)	(1)		—
Increase in equity method investment		—			(155,000	)	(1)		(155,000	)
Capital expenditures		(6,000	)		—				(6,000	)
Cash flows from investing activities related to discontinued operations		(2,632,000	)		—				(2,632,000	)
Net cash used in investing activities		(2,232,000	)		(1,081,000	)			(3,313,000	)
Cash flows from financing activities:
Distributions to non-controlling interest		(180,000	)		180,000		(1)		—
Cash flows from financing activities related to discontinued operations		4,131,000			—				4,131,000
Net cash used in financing activities		3,951,000			180,000				4,131,000
Foreign currency effect on cash		—			52,000		(2)		52,000
Net decrease in cash, cash equivalents and restricted cash including cash, cash equivalents classified within assets related to discontinued operations		(3,937,000	)		(527,000	)			(4,464,000	)
Less: net increase in cash, cash equivalents and restricted cash classified within assets related to discontinued operations		43,000			—				43,000
Net decrease in cash , cash equivalents and restricted cash		(3,894,000	)		(527,000	)	(1)(2)(3)(4)(5)(6)(7)(8)		(4,421,000	)
Cash , cash equivalents and restricted cash at beginning of period		16,829,000			(547,000	)			16,282,000
Cash , cash equivalents and restricted cash at end of period	$	12,935,000		$	(1,074,000	)		$	11,861,000

As previously disclosed in the Current Report on Form 

8

-K filed by Asta Funding, Inc. (“Asta” or the “Company”) with the Securities and Exchange Commission (the “SEC”) on

January 18, 2018,

the Board of Directors (the “Board”) of the Company, upon the recommendation of the Audit Committee of the Board (the “Audit Committee”), determined that the Company’s previously issued financial statements for each of the years ended

September 30, 2016,

2015

and

2014,

and the interim periods contained therein, as well as the Company’s unaudited consolidated financial statements for the quarters ended

December 31, 2016,

March 31, 2017

and

June 30, 2017,

could

no

longer be relied upon. 

On

September 17,

2018,

the Company filed an Annual Report on Form

10

-K/A (the “Form

10

-K/A”) to amend and restate the Company’s previously issued financial statements for each of the years ended

September 30, 2016,

2015

and

2014,

as well as the interim periods contained therein. The Company is filing this Amendment

No.

2

on Form

10

-Q/A (this “Amendment”) to amend and restate the Company’s previously issued financial statements contained in its Quarterly Report on Form

10

-Q for the quarter ended

December 31, 2016 (

the “Non-Reliance Period”), which was originally filed with the SEC on

February 9, 2017 (

the “Original Form

10

-Q”), and restated on

May 26, 2017 (

the “Restated Form

10

-Q/A”). The Company expects to file, at a later time, amendments to its Quarterly Reports on Form

10

-Q for the quarters ended

March 31, 2017

and

June 30, 2017.

Prior period amounts have already been restated in the Company's Form

10

-K/A, and, accordingly have

not

been restated in this Amendment.

This Amendment

On

January 11, 2018,

after discussions with the Audit Committee, management re-evaluated the Company's historical conclusion to consolidate Pegasus Funding, LLC (“Pegasus”). Management has determined that the Company lacked the requisite control to consolidate Pegasus in its historical periods in accordance with Accounting Standards Codification (“ASC”)

810

“

Consolidation

.” Management also determined that the Company's previous treatment for certain foreign currency matters under ASC

830

“

Foreign Currency Matters

” was

not

appropriate. As such, the Company has subsequently revised its investment in Pegasus to the equity method, including the underlying reserve methodology; and has adjusted its financial statements to reflect the proper accounting for certain foreign currency transactions. Additionally, the Company corrected the financial statements for additional known errors consisting of (i) the adjustment of various accruals, (ii) the fair value of structured settlements, (iii) accounting for unallocated payments, and (iv) the tax effects of the adjustments mentioned above.

The “As Reported” amounts in the tables above represent the amounts reported in the Restated Form

10

-Q/A, adjusted in its presentation for the discontinued operations of the Company's wholly-owned subsidiary CBC Settlement Funding, LLC (“CBC”), which was sold on

December 13, 2017 (

see Note

8

– Discontinued Operations and Note

20

– Subsequent events).

The following errors were identified as part of the restatement:

      1. In connection with the Company determining it lacked the requisite control to consolidate Pegasus during the Non-Reliance Period, the Company has now accounted for its investment in Pegasus under the equity method in accordance with US GAAP. On the Company’s December 31, 2016 consolidated balance sheet, this resulted in (i) a decrease in cash of $1,065,000; (ii) a decrease in the investment in personal injury claims of $47,875,000; (iii) a decrease in other assets of $109,000; (iv) a decrease in other liabilities of $1,133,000; and, (v) a decrease in non-controlling interest of $804,000, offset by a corresponding increase in the equity method investment of $48,720,000. On the Company’s consolidated statement of operations, this resulted in (i) a reduction in total revenues of $2,302,000; (ii) a reduction in expenses of $2,197,000; (iii) a decrease in the income attributable to the non-controlling interest of $21,000; and (iv) a decrease in earnings from equity method investment of $84,000 for the three months ended December 31, 2016. This change to the equity method of accounting had no effect on net (loss) income attributable to Asta Funding, Inc. during the Non-Reliance Period.

      2. The Company determined that it had not previously accounted for certain foreign currency gains/losses on intercompany balances and transactions in accordance with US GAAP. The Company improperly accounted for the foreign currency effect of certain transactions as if they were long-term investments by including the foreign currency effect in accumulated other comprehensive income instead of properly recording the effect as operating expenses as required under ASC 830. The correction to properly apply US GAAP to these foreign currency matters resulted in increased revenue of $94,000, a decrease in other income of $93,000, and a increase in general and administrative expenses of $204,000 for the three months ended December 31, 2016.

The correction of foreign currency transaction on the consolidated balance sheet are as follows:

Increase (decrease) in:	Impact from September 30, 2016 10K/A filing			Current period impact			Cumulative net impact
Cash and cash equivalents	$	3,000		$	(10,000	)	$	(7,000	)
Consumer receivables acquired for liquidation		(245,000	)		464,000			219,000
Due from third party collection agencies and attorneys		45,000			(76,000	)		(31,000	)
Deferred income taxes		(722,000	)		(199,000	)		(921,000	)
Other assets		(33,000	)		220,000			187,000
Other liabilities		(18,000	)		216,000			198,000
Accumulated other comprehensive loss		718,000			386,000			1,104,000
Retained earnings		(1,653,000	)		(203,000	)		(1,856,000	)

3. Prior to the sale of its structured settlement business, the Company purchased periodic payments under structured settlements and annuity policies from individuals in exchange for a lump sum payment. The Company has elected to carry the structured settlements at fair value in accordance with the guidance of FASB ASC, Recognition and Measurement of Financial Assets and Financial Liabilities (ASC 822 - 10 - 50 - 28 through 50 - 22 ).

As previously disclosed in the Restated Form

10

-Q/A, the Company did

not

reflect the quarterly increase in certain underlying benchmark interest rates used in determining fair value of the Company’s structured settlements for the quarter ended

December 31, 2016

which resulted in a decrease in the fair value of the Company's structured settlements of approximately

$2.6

million (reflected in assets related to discontinued operations in this restated consolidated balance sheet) with an associated increase in prepaid income taxes and deferred tax assets of approximately

$1.0

million (reflected in the loss from discontinued operations in this consolidated statement of operations).

In connection with the Company’s filing of its Form

10

-K/A, the Company adjusted the fair value of its structured settlements to reflect the appropriate benchmark interest rates at

September 30, 2016,

which resulted in an decrease in net loss attributable to discontinued operations and an increase in assets related to discontinued operations of

$727,000.

As this increase in fair value was originally recorded during the

three

month period ended

December 31, 2016,

this Amendment includes an increase in both the retained earnings and the net loss attributable to discontinued operations of

$727,000.

4. The Company determined that it had not accounted for certain unallocated payments reported on its consolidated balance sheet properly during the Non-Reliance Period. The correction of this error resulted in a decrease to consumer receivables acquired for liquidation of $648,000 and retained earnings of $648,000 as of September 30, 2016 and is therefore included in the net adjustment to retained earnings as of December 31, 2016.

      5. The Company discovered that it did not properly record an amortizable asset and related liability in conjunction with an asset purchase agreement entered into in June 2015 with a related party. The correction of this error resulted in a decrease in income from discontinued operations of $60,000 for the three months ended December 31, 2016.

The correction of these errors on the consolidated balance sheet are as follows:

Increase (decrease) in:	Impact from September 30 , 2016 10K/A filing			Current period impact			Cumulative net impact
Assets related to discontinued operations	$	307,000		$	(161,000	)	$	146,000
Liabilities related to discontinued operations		756,000			(103,000	)		653,000
Retained earnings		(442,000	)		(60,000	)		(502,000	)

      6. The Company identified other transactions that had not been properly accounted for in the correct period and/or for improper amounts and/or improper accounts. The adjustments of these errors were immaterial on an individual basis. The correction of these errors resulted in decreased general and administrative expense of $270,000 for the three months ended December 31, 2016.

The correction of these errors on the consolidated balance sheet are as follows:

Increase (decrease) in:	Impact from September 30, 2016 10K/A filing			Current period impact			Cumulative net impact
Cash and cash equivalents	$	-		$	(2,000	)	$	(2,000	)
Other liabilities		269,000			(269,000	)		-
Retained earnings		(137,000	)		270,000			133,000
Assets related to discontinued operations		45,000			-			45,000
Additional paid in capital		8,000			-			8,000

      7. The Company identified the personal injury claims asset balance of Pegasus was determined to be understated at December 31, 2016 by $400,000. The correction of these error resulted in an increase in equity method investment of $320,000, representing the Company’s 80% financial interest, as of December 31, 2016. As a result of the correction of this error, earnings from the equity investment in Pegasus and income from continuing operations increased $320,000 for the three months ended December 31, 2016. Additionally the equity method investment was increased $101,000 to reflect the impact of related accruals in the Form 10 -K/A.

    8. Some of the corrections noted above impacted earnings (loss) before taxes which, in turn, required a calculation of the tax impact. The net impact to the Company’s consolidated balance sheet was a (i) decrease to prepaid and income taxes receivable of $371,000; and (ii) decrease to deferred tax assets of $337,000. On the Company’s consolidated statement of operations, there was (i) a net increase to income tax expense of $1,252,000; and (ii) an increase to income tax benefit from discontinued operations of $363,000 for the three months ended December 31, 2016.

All of the following notes to consolidated financial statements have been revised to reflect the effects of the above mentioned restatements.

XML

Note 2 - Business and Basis of Presentation

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]

Note

2

—Business and Basis of Presentatio

n

Business

 

Asta Funding, Inc., together with its wholly owned significant operating subsidiaries Palisades Collection, LLC, Palisades Acquisition XVI, LLC (“Palisades XVI”), Palisades Acquisition XIX, LLC (“Palisades XIX”), Palisades Acquisition XXIII, LLC (“Palisades XIX”), VATIV Recovery Solutions LLC (“VATIV”), EMIRIC, LLC (“EMIRIC”), ASFI Pegasus Holdings, LLC (“APH”), Fund Pegasus, LLC (“Fund Pegasus”), GAR Disability Advocates, LLC (“GAR Disability Advocates”), Five Star Veterans Disability, LLC (“Five Star”), Simia Capital, LLC (“Simia”) and other subsidiaries, which are

not

all wholly owned (the “Company,” “we” or “us”), is engaged in several business segments in the financial services industry including funding of personal injury claims, through our

80%

owned,

50%

controlled equity investment in Pegasus Funding, LLC (“Pegasus”) and our wholly owned subsidiary Simia, social security and disability advocacy through our wholly owned subsidiaries GAR Disability Advocates and Five Star and the business of purchasing, managing for its own account and servicing distressed consumer receivables, including charged off receivables, and semi-performing receivables. 

Consumer receivables

The Company started out in the consumer receivable business in

1994.

Recently, our effort has been in the international areas (mainly South America), as we have curtailed our active purchasing of consumer receivables in the United States. We define consumer receivables as primary charged-off, semi-performing and distressed depending on their collectability. We acquire these consumer receivables at substantial discounts to their face values, based on the characteristics of the underlying accounts of each portfolio.

Personal injury claims

Simia and our equity method investment in Pegasus conduct their business solely in the United States. These companies obtain their business from external brokers and internal sales professionals soliciting individuals with personal injury claims. Business is also obtained from the their websites and through attorneys.

Social security benefit advocacy

GAR Disability Advocates provides its disability advocacy services throughout the United States. It relies upon search engine optimization (“SEO”) to bring awareness to its intended market.

Discontinued Operations

US GAAP requires the results of operations of a component of an entity that either has been disposed of or is classified as held for sale to be reported as discontinued operations in the consolidated financial statements if the sale or disposition represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results.

On

December 13, 2017,

the Company sold all of the issued and outstanding equity capital of CBC, its wholly owned subsidiary engaging in structured settlements. As a result of this sale all prior periods presented in the Company’s consolidated financial statements will account for CBC as a discontinued operation. This determination resulted in the reclassification of assets and liabilities comprising the structured settlements business to assets and liabilities related to discontinued operations in the consolidated balance sheets, and a corresponding adjustment to our consolidated statements of operations to reflect discontinued operations for all periods presented.

Basis of Presentation

 

The consolidated balance sheet as of

December 31, 2016,

the consolidated statements of operations for the

three

month periods ended

December 31, 2016

and

2015,

the consolidated statements of comprehensive (loss) income for the

three

month periods ended

December 31, 2016

and

2015,

the consolidated statements of stockholders’ equity as of and for the

three

months ended

December 31, 2016

and

2015,

and the consolidated statements of cash flows for the

three

month periods ended

December 31, 2016

and

2015,

are unaudited. The

September 

30,

2016

financial information included in this Amendment was derived from our audited financial statements included in our Annual Report on Form

10

-K/A for the fiscal year ended

September 

30,

2016.

In the opinion of management, all adjustments necessary to present fairly our financial position at

December 31, 2016,

the results of operations for the

three

month periods ended

December 31, 2016

and

2015

and cash flows for the

three

month periods ended

December 31, 2016

and

2015

have been made. The results of operations for the

three

month periods ended

December 31, 2016

and

2015

are

not

necessarily indicative of the operating results for any other interim period or the full fiscal year. The consolidated financial statements are prepared in accordance with US GAAP and industry practices.

The accompanying unaudited consolidated financial statements have been prepared in accordance with Rule 

10

-

01

of Regulation S-

X

promulgated by the Securities and Exchange Commission and therefore do

not

include all information and note disclosures required under generally accepted accounting principles. The Company suggests that these financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form

10

-K/A for the fiscal year ended

September 

30,

2016

filed with the SEC.

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates including management’s estimates of future cash flows and the resulting rates of return.

Principles of Consolidation  

The consolidated financial statements include the accounts of Asta Funding, Inc. and its wholly owned and majority owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Concentration of Credit Risk – Cash

and Restricted Cash

The Company considers all highly liquid investments with a maturity date of

three

months or less at the date of purchase to be cash equivalents.  

Cash balances are maintained at various depository institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company had cash balances with

five

banks at

December 31, 2016

that exceeded the balance insured by the FDIC by approximately

$1.4

million. Additionally,

three

foreign banks with an aggregate balance of

$0.5

million are

not

FDIC insured. There is an

$8.2

million and

$10

million aggregate balance in a domestic bank as of

December 31, 2016

and

September 30, 2016,

respectively, that is also

not

FDIC insured and has been reclassified to restricted cash in the balance sheets since these assets serve as collateral for the line of credit (see Note

7

– Non Recourse Debt). The Company does

not

believe it is exposed to any significant credit risk due to concentration of cash.

Equity method investment

Investee companies that are

not

consolidated, but over which the Company exercises significant influence, are accounted for under the equity method of accounting. Whether or

not

the Company exercises significant influence with respect to an investee depends on an evaluation of several factors including, among others, representation on the investee company's board of directors and ownership level, which is generally a

20%

to

50%

interest in voting securities of the investee company. Under the equity method of accounting, an investee company's accounts are

not

reflected within the Company's consolidated balance sheets and statements of operations, however, the Company's share of the earnings of the investee company is reflected as earnings and loss from equity method investment in the Company's consolidated statement of operations. The Company's carrying value in an equity method investee company is reflected on the Company's consolidated balance sheet, as equity method investment.

Pegasus is the Company's

50%

controlled equity investment with Pegasus Legal Funding (“PLF”). Under the operating agreement, the Company and PLF, each maintain

50%

voting rights of the entity, and the Company is

80%

owned by Asta. Based on these shared voting rights with PLF, the Company lacks requisite control of Pegasus, and therefore accounts for its investment in Pegasus under the equity method of accounting.

Serlefin BPO&O Peru S.A.C. (“Serlefin Peru”) is the Company's

49%

owned joint venture. The other

51%

is owned by

three

individuals who share common ownership with Serlefin BPO&O Serlefin S.A. (“Serlefin”). Each owner maintains voting rights equivalent to their share ownership, and the

51%

shareholders collectively manage the operations of the business. Based on the Company's ownership and voting rights, the Company lacks requisite control of Serlefin Peru, and therefore accounts for its investment in Serlefin Peru under the equity method of accounting.

Additionally, the Company and Serlefin jointly purchase international consumer debt portfolios under a purchase agreement. The Company and Serlefin purchase the portfolios on a pro-rata basis of

80%

and

20%,

respectively. The purchased portfolios are transferred to an administrative and payment trust, where the Company and Serlefin are trustees. Serlefin provides collection services to the trust, and receives a performance fee determined by the parties for each loan portfolio acquired. Serlefin received approximately

$0.2

million and

$0

in performance fees for the

three

months ended

December 31, 2016

and

2015,

respectively.

The carrying value of the investment in Serlefin Peru was

$0.2

million as of

December 31, 2016

and

September 30, 2016.

The Company has included the carrying value of this investment in other assets on its consolidated balance sheets. The cumulative net loss from our investment in Serlefin Peru through

December 31, 2016

was approximately

$0.1

million, and was

not

significant to the Company's consolidated statement of operations.

When the Company's carrying value in an equity method investee company is reduced to zero,

no

further losses are recorded in the Company's consolidated financial statements unless the Company guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will

not

record its share of such income until it equals the amount of its share of losses

not

previously recognized. There were

no

impairment losses recorded on our equity method investments for the

three

months ended 

December 

31,

2016

and

2015.

Personal Injury Claim Advances

Management assesses the quality of the personal injury claims portfolio through an analysis of the underlying personal injury fundings on a case by case basis. Cases are reviewed through periodic updates with attorneys handling the cases, as well as with

third

party research tools which monitor public filings, such as motions or judgments rendered on specific cases. The Company specifically reserves for those fundings where the underlying cases are identified as uncollectible, due to anticipated non-favorable verdicts and/or settlements at levels where recovery of the advance outstanding is unlikely. For cases that have

not

exhibited any specific negative collection indicators, the Company establishes reserves based on the historical collection rates of the Company’s fundings. Fee income on advances is reserved for on all cases where a specific reserve is established on the initially funded amount. In addition, management also monitors its historical collection rates on fee income and establishes reserves on fee income consistent with the historically experienced collection rates. Management regularly analyzes and updates the historical collection rates of its initially funded cases as well as its fee income.

Goodwill

Goodwill represents the excess of the purchase price over the fair value of the net assets acquired in a business combination, and is accounted for under ASC

350.

Goodwill has an indefinite useful life and is evaluated for impairment at the reporting-unit level on an annual basis during the

fourth

quarter or more frequently if events or changes in circumstances indicate potential impairment between annual measurement dates. The Company has the option of performing a qualitative assessment of impairment to determine whether any further quantitative testing for impairment is necessary. The initial qualitative approach assesses whether the existence of events or circumstances lead to a determination that it is more likely than

not

that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, the Company determines it is more likely than

not

that the fair value is less than carrying value, a

two

step quantitative impairment test is performed. A step

1

analysis involves calculating the fair value of the associated reporting unit and comparing it to the reporting unit’s carrying value. If the fair value of the reporting unit exceeds the carrying value of the reporting unit including goodwill and the carrying value of the reporting unit is positive, goodwill is considered

not

to be impaired and

no

further analysis is required. If the fair value of the reporting unit is less than its carrying value, step

2

of the impairment test must be performed. Step

2

involves calculating and comparing the implied fair value of the reporting unit’s goodwill with its carrying value. Impairment is recognized if the estimated fair value of the reporting unit is less than its net book value. Such loss is calculated as the difference between the estimated impaired fair value of goodwill and its carrying amount. The goodwill of the Company consists of

$1.4

million from the purchase of VATIV. Additionally, the Company has goodwill of

$1.4

million from the purchase of CBC, which is included under assets related to discontinued operations on the consolidated balance sheet.

Reclassifications

Certain prior period amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year presentation. These reclassifications had

no

effect on previously reported net loss or shareholders’ equity.

Recent Accounting Pronouncements

  

In

May 2014,

the FASB issued an update to ASC

606,

Revenue from Contracts with Customers, that will supersede virtually all existing revenue guidance. Under this update, an entity is required to recognize revenue upon transfer of promised goods or services to customers, in an amount that reflects the entitled consideration received in exchange for those goods or services. The guidance also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from the customer contracts. This update is effective for annual reporting periods beginning after

December 

15,

2017

including interim periods within that reporting period. Early application is permitted for annual reporting periods beginning after

December 

15,

2016,

including interim periods within that reporting period. Given the changes in the Company's business management is continuing to assess this new standard and the impact it will have on accounting for its revenues. 

In

January 2016,

the FASB issued ASU

No.

 

2016

-

01,

Financial Instruments-Overall (Subtopic

825

-

10

): Recognition and Measurement of Financial Assets and Financial Liabilities. The main objective in developing this update is enhancing the reporting model for financial instruments to provide users of financial statements with more decision-useful information. The amendments in this update address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. The effective date for this update is for annual reporting periods beginning after

December 

15,

2017,

including interim periods within that reporting period. The Company is currently evaluating the impact this update will have on its consolidated financial statements. 

In

February 2016,

the FASB issued ASU

No.

2016

-

02

Leases (Topic

842

) to amend lease accounting requirements and requires entities to generally recognize on the balance sheet operating and financing lease liabilities and corresponding right-of-use assets. The new standard will require significant additional disclosures about the amount, timing and uncertainty of cash flows from leases. The standard update is effective for fiscal years beginning after

December 

15,

2018

and interim periods within those years and early adoption is permitted. The standard is to be applied using a modified retrospective approach and includes a number of optional practical expedients that entities

may

elect to apply. The Company is currently evaluating the impact of adopting this update on its consolidated financial statements and expects that most of its operating leases will be subject to the accounting standard update and will recognize as operating lease liabilities and right-of-use assets upon adoption.  

In

March 2016,

the FASB issued ASU

No.

 

2016

-

09,

Compensation-Stock Compensation (Topic

718

): Improvements to Employee Share Based Payment Accounting, to simplify and improve areas of generally accepted accounting principles for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided to users of financial statements. The effective date for this update is for annual reporting periods beginning after

December 

15,

2016,

including interim periods within that reporting period. The Company is currently evaluating the impact this update will have on its consolidated financial statements.  

In

June 2016,

the FASB issued ASU

2016

-

13,

Financial Instruments-Credit Losses (Topic

326

): Measurement of Credit Losses on Financial Instruments.  The ASU requires an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Additionally, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration.  For the Company, this update will be effective for interim periods and annual periods beginning after

December 15, 2019.

Upon adoption, the Company will accelerate the recording of its credit losses in its financial statements. 

In

August 2016,

the FASB issued ASU 

2016

-

15,

Statement of Cash Flows (Topic

230

): Classification of Certain Cash Receipts and Cash Payments.  This ASU will make

eight

targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The new standard is effective for fiscal years beginning after

December 15, 2017.

Early adoption is permitted. The new standard will require adoption on a retrospective basis unless it is impracticable to apply, in which case the Company would be required to apply the amendments prospectively as of the earliest date practicable. The Company is in the process of evaluating the provisions of the ASU, but does

not

expect it to have a material effect on the Company’s consolidated statements of cash flows.

In

November 2016,

the FASB issued ASU

No.

2016

-

18,

Restricted Cash ("ASU

2016

-

18"

), to require that restricted cash and restricted cash equivalents be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total cash amounts shown on the statement of cash flows. Consequently, transfers between cash and restricted cash will

not

be presented as a separate line item in the operating, investing or financing sections of the cash flow statement. ASU

2016

-

18

does

not

provide a definition of restricted cash or restricted cash equivalents. The new guidance will only be applicable to amounts described by the Company as restricted cash. We adopted ASU

2016

-

18

on

October 1, 2016,

the effect of which was a change in presentation on our consolidated statement of cash flows, but

not

on our consolidated financial results.

In

January 2017,

the FASB issued ASU

2017

-

04

Intangibles – Goodwill and Other (Topic

350

): Simplifying the Test for Goodwill Impairment. The objective of this update is to simplify the subsequent measurement of goodwill, by eliminating step

2

from the goodwill impairment test. The amendments in this update are effective for annual periods beginning after

December 15, 2019,

and interim periods within those fiscal years. The Company does

not

believe this update will have a material impact on its consolidated financial statements.

XML

Note 3 - Available-for-sale Investments

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Available-for-sale Investments [Text Block]

Note

3—Available

-for-Sale Investments

Investments classified as available-for-sale at

December 31, 2016

and

September 

30,

2016,

consist of the following:

	Amortized Cost		Unrealized Gains		Unrealized Losses			Fair Value
December 31, 2016	$	56,115,000	$	29,000	$	(1,099,000	)	$	55,045,000
September 30, 2016	$	55,723,000	$	1,089,000	$	(49,000	)	$	56,763,000

The available-for-sale investments do

not

have any contractual maturities. The Company sold

two

investments during the

three

months ended

December 31, 2016,

with a realized loss of

$45,000.

The Company received

$177,000

in capital gains distributions during the

three

months ended

December 31, 2016.

For the

three

months ended

December 31, 2015,

the Company sold

two

investments with a realized loss of

$31,000

and also received

$47,000

in capital gains distributions during that period. The Company recorded an aggregate realized gain of

$132,000

and

$16,000

related to its available-for-sale securities for the

three

months ended

December 31, 2016

and

2015,

respectively.

At

December 31, 2016,

there were

seven

investments,

five

of which were in unrealized loss positions that had existed for

12

months or more. All of these securities are considered to be acceptable credit risks. Based on the evaluation of the available evidence, including recent changes in market rates and credit rating information, management believes the aggregate decline in fair value for these instruments is temporary. In addition, management has the ability to hold these investment securities for a period of time sufficient to allow for an anticipated recovery or maturity. Should the impairment of any of these securities become other than temporary, the cost basis of the investment will be reduced and the resulting loss recognized in net income in the period in which the other-than-temporary impairment is identified.  

Unrealized holding gains and losses on available-for-sale securities are included in other comprehensive income within stockholders’ equity. Realized gains (losses) on available-for-sale securities are included in other income and, when applicable, are reported as a reclassification adjustment in other comprehensive income.

XML

Note 4 - Consumer Receivables Acquired for Liquidation

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

Note

4—Consumer

Receivables Acquired for Liquidation

Accounts acquired for liquidation are stated at their net estimated realizable value and consist primarily of defaulted consumer loans of individuals primarily throughout the United States and South America.

The Company

may

account for its investments in consumer receivable portfolios, using either:

• the interest method; or

• the cost recovery method.

Prior to

October 

1,

2013,

the Company accounted for certain of its investments in finance receivables using the interest method in accordance with the guidance of ASC

310,

Receivables. Under the guidance of ASC

310

-

30,

static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision. Effective

October 

1,

2013,

due to the substantial reduction of portfolios reported under the interest method, and the ability to reasonably estimate cash collections required to account for those portfolios under the interest method, the Company concluded the cost recovery method is the appropriate accounting method in the circumstances.

Although the Company has switched to the cost recovery method on its current inventory of portfolios, the Company must still analyze a portfolio upon acquisition to ensure which method is appropriate, and once a static pool is established for a quarter, individual receivable accounts are

not

added to the pool (unless replaced by the seller) or removed from the pool (unless sold or returned to the seller).

The Company uses the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method,

no

income is recognized until the cost of the portfolio has been fully recovered. A pool can become fully amortized (

zero

carrying balance on the balance sheet) while still generating cash collections. In this case, all cash collections are recognized as revenue when received.

The Company has extensive liquidating experience in the field of distressed credit card receivables, telecommunication receivables, consumer loan receivables, retail installment contracts, consumer receivables, and auto deficiency receivables.

The Company aggregates portfolios of receivables acquired sharing specific common characteristics which were acquired within a given quarter. In addition, the Company uses a variety of qualitative and quantitative factors to estimate collections and the timing thereof. The Company obtains and utilizes, as appropriate, input, including but

not

limited to, monthly collection projections and liquidation rates, from

third

party collection agencies and attorneys, as further evidentiary matter, to assist in evaluating and developing collection strategies and in evaluating and modeling the expected cash flows for a given portfolio.

The following tables summarize the changes in the consolidated balance sheet account of consumer receivables acquired for liquidation during the following periods:

	For the Three Months Ended December 31,
	2016 (restated)			2015
Balance, beginning of period	$	13,427,000		$	15,056,000
Acquisitions of receivable portfolios		2,213,000			6,051,000
Net cash collections from collection of consumer receivables acquired for liquidation		(6,015,000	)		(7,377,000	)
Net cash collections represented by account sales of consumer receivables acquired for liquidation		(190,000	)		—
Effect of foreign currency translation		(68,000	)		(27,000	)
Finance income recognized		4,095,000			5,106,000
Balance, end of period	$	13,462,000		$	18,809,000
Finance income as a percentage of collections		66.00	%		69.22	%

 During the

three

month periods ended

December 31, 2016,

the Company purchased

$35.0

 million of face value portfolios at a cost of

$2.2

million. During the

three

months ended

December 31, 2015,

the Company purchased

$97.7

million of face value portfolios, at a cost of

$6.1

million.

As of

December 31, 2016,

the Company held consumer receivables acquired for liquidation from Peru and Colombia of

$5.0

million and

$4.6

million, respectively. The total amount of foreign consumer receivables acquired for liquidation was

$9.6

million, or

71.1%

of the total consumer receivables held of

$13.5

million at

December 31, 2016.

As of

December 31, 2015,

the Company held consumer receivables acquired for liquidation from Peru and Colombia of

$4.7

million and

$4.0

million, respectively. The total amount of foreign consumer receivables acquired for liquidation was

$8.7

million, or

46.3%

of the total consumer receivables held of

$18.8

million at

December 31, 2015. 

The following table summarizes collections received by the Company’s

third

party collection agencies and attorneys, less commissions and direct costs, for the

three

month periods ended

December 31, 2016

and

2015,

respectively.

	For the Three Months Ended December 31 ,
	2016 (restated)		2015
Gross collections (1)	$	11,400,000	$	12,245,000
Commissions and fees (2)		5,195,000		4,868,000
Net collections	$	6,205,000	$	7,377,000

( 1 ) Gross collections include: collections from third  party collection agencies and attorneys, collections from in-house efforts, and collections represented by account sales.

( 2 ) Commissions are earned by third party collection agencies and attorneys, and include direct costs associated with the collection effort, generally court costs. In December 2007 an arrangement was consummated with one servicer who also receives a 3% fee on gross collections received by the Company in connection with the related Portfolio Purchase.. The fee is charged for asset location, skip tracing and ultimately suing debtors in connection with this portfolio purchase.

XML

Note 5 - Litigation Funding

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Other Investments Disclosure [Text Block]

Note

5

—Litigation Funding

Equity Method Investment

 

On

December 

28,

2011,

the Company entered into a joint venture, Pegasus Funding, LLC ("Pegasus") with Pegasus Legal Funding, LLC (“PLF”). The Company has an

80%

non-controlling interest in the joint venture. Pegasus purchases interests in claims from claimants who are a party to personal injury litigation. Pegasus advances, to each claimant, funds, on a non-recourse basis at an agreed upon interest rate, in anticipation of a future settlement. The interest in each claim purchased by Pegasus consists of the right to receive, from such claimant, part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claims. Pegasus earned

$2.3

million and

$3.1

million in interest and fees during the

first

quarter of fiscal years

2017

and

2016,

respectively. The Company had a net invested balance in personal injury claims of

$49.1

million and

$48.6

million on

December 

31,

2016

and

September 

30,

2016,

respectively.

Equity method investments as of

December 31, 2016

and

September 30, 2016

are as follows:

	December 31, 2016					September 30, 2016
	Carrying Value		Ownership Percentage			Carrying Value		Ownership Percentage
Pegasus Funding, LLC	$	49,141,000		80	%	$	48,582,000		80	%

The carrying value of the Company's equity investment at

December 31, 2016

was

$49,141,000,

an increase of

$559,000

over the prior year's carrying value of

$48,582,000.

The increase in carrying value was attributed to the Company's equity earnings of

$404,000

for the

three

months ended

December 31, 2016,

plus loan advances made to Pegasus classified on its balance sheet as due to Asta of

$155,000

for the

three

months ended

December 31, 2016.

The carrying value of the Company's equity investment at

September 30, 2016

was

$48,582,000,

an increase of

$7,831,000

over the prior year's carrying value of

$40,751,000.

The increase in carrying value was attributed to the Company's current year equity earnings of

$10,551,000,

less loan repayments made to Asta which are classified on its balance sheet as due to Asta of

$2,720,000

during fiscal

2016.

On

November 8, 2016,

the Company entered into a binding Term Sheet (the “Term Sheet”) with ASFI Pegasus Holdings, LLC, Fund Pegasus, LLC, Pegasus Funding, LLC, Pegasus Legal Funding, LLC, Max Alperovich and Alexander Khanas. Pegasus is currently the Company’s personal injury claims funding business and is a joint venture that is

80%

owned by the Company and

20%

owned by PLF. The Company and PLF have decided

not

to renew the Pegasus joint venture that, by its terms, terminated on

December 28, 2016.

The Term Sheet amends certain provisions to Pegasus’ operating agreement dated as of

December 28, 2011 (

as amended, the “Operating Agreement”) and governs the terms relating to the collection of its existing Pegasus portfolio (the “Portfolio”).

Pursuant to the Term Sheet, the parties thereto have agreed that Pegasus will continue in existence in order to collect advances on its existing Portfolio. The Company will fund overhead expenses relating to the collection of its Portfolio based on a budget agreed upon by the Company and PLF. Any cash received by Pegasus will be distributed to its members in the order provided for in the Operating Agreement. The Company will be repaid an amount equal to

20%

of all principal collected on each investment paid back beginning

October 1, 2016

and continuing through the collection of the Portfolio, which will be applied against the outstanding balance of overhead expenses previously advanced by the Company to Pegasus. After

January 2, 2017,

additional overhead expenses advanced will be paid back monthly as incurred by the Company prior to the calculation and distribution of any profits. 

In connection with the Term Sheet, the parties thereto have also entered into a customary mutual release and non-disparagement agreement as well as a release from the non-competition obligations under the Operating Agreement. See Note

20

- Subsequent Events. 

The results of operations and financial position of the Company’s equity investment in Pegasus are summarized below:

	Condensed S tatement of O perations I nformation
	Three months ended
	December 31, 2016		December 31 , 201 5
Personal injury claims income	$	2,302,000	$	3,085,000
Operating expenses		1,797,000		1,218,000
Income from operations	$	505,000	$	1,867,000
Earnings from equity method investment	$	404,000	$	1,494,000

	Condensed Balance Sheet I nformation
	December 31, 2016		September 30, 2016
Cash	$	1,065,000	$	539,000
Investment in personal injury claims		48,275,000		48,289,000
Other assets		109,000		188,000
Total Assets	$	49,449,000	$	49,016,000
Due to Asta	$	34,560,000	$	34,404,000
Other liabilities		1,006,000		1,053,000
Equity		13,883,000		13,559,000
Total Liabilities and Equity	$	49,449,000	$	49,016,000

Matrimonial Claims (included in Other Assets)

On

May 

8,

2012,

the Company formed EMIRIC, LLC, a wholly owned subsidiary of the Company. EMIRIC, LLC entered into a joint venture with California-based Balance Point Divorce Funding, LLC (“BP Divorce Funding”) to create the operating subsidiary BP Case Management, LLC (“BPCM”). BPCM is

60%

owned by the Company and

40%

owned by BP Divorce Funding. BPCM provides non-recourse funding to a spouse in a matrimonial action. The Company provided a

$1.0

million revolving line of credit to partially fund BPCM’s operations, with such loan bearing interest at the prevailing prime rate, with an initial term of

twenty-four

months. In

September 2014,

the agreement was revised to extend the term of the loan to

August 2016,

increase the credit line to

$1.5

million and include a personal guarantee of the principal of BP Divorce Funding. Effective

August 14, 2016,

the Company extended its revolving line of credit with BP Divorce Funding until

March 31, 2017,

at substantially the same terms as the

September 2014

amendment. The loan balance at

December 

31,

2016

was approximately

$1.5

million. The revolving line of credit is collateralized by BP Divorce Funding’s profits share in BPCM and other assets. As of

December 

31,

2016,

the Company’s investment in cases through BPCM was approximately

$2.5

million. There was

no

income recognized in the

three

month periods ended

December 31, 2016

and

2015.

   

XML

Note 6 - Furniture and Equipment

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Property, Plant and Equipment Disclosure [Text Block]

Note

6

—Furniture & Equipment

Furniture and equipment consist of the following as of the dates indicated:

	December 31 , 2016		September 30, 2016
Furniture	$	273,000	$	273,000
Equipment		235,000		235,000
Software		1,356,000		1,350,000
		1,864,000		1,858,000
Less accumulated depreciation and amortization		1,688,000		1,662,000
Balance, end of period	$	176,000	$	196,000

XML

Note 7- Non Recourse Debt

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Debt Disclosure [Text Block]

Note

7

—Non Recourse Debt

Non-Recourse Debt –Bank of Montreal (“BMO”)

In

March 2007,

Palisades XVI borrowed approximately

$227

 million under the Receivables Financing Agreement, as amended in

July 2007, 

December 2007, 

May 2008, 

February 2009, 

October 2010

and

August 2013 (

the “RFA”) from BMO, in order to finance the Great Seneca Portfolio Purchase (the “Portfolio Purchase”) which had a purchase price of

$300

million. The original term of the agreement was

three

years. This term was extended by each of the Second, Third, Fourth and Fifth Amendments and the most recent agreement signed in

August 2013.

On

August 

7,

2013,

Palisades XVI, a

100%

owned bankruptcy remote subsidiary, entered into a Settlement Agreement and Omnibus Amendment (the “Settlement Agreement”) with BMO as an amendment to the RFA. In consideration for a

$15

million prepayment funded by the Company, BMO agreed to significantly reduce minimum monthly collection requirements and the interest rate. If and when BMO receives the next

$15

million of collections from the Portfolio Purchase or from voluntary prepayments by Asta Funding, Inc., less certain credits for payments made prior to the consummation of the Settlement Agreement (the “Remaining Amount”), Palisades XVI and its affiliates would be automatically released from liability in connection with the RFA (subject to customary exceptions). A condition to the release was Palisade XVI’s agreement to grant BMO, as of the time of the payment of the Remaining Amount, the right to receive

30%

of net collections from the Portfolio Purchase once Palisades XVI has received from future net collections, the sum of

$15

million plus voluntary prepayments included in the payment of the Remaining Amount (the “Income Interest”). On

June 

3,

2014,

Palisades XVI paid the Remaining Amount. The final principal payment of

$2.9

million included a voluntary prepayment of

$1.9

million provided from funds of the Company. Accordingly, Palisades XVI was entitled to receive

$16.9

million of future collections from the Portfolio Purchase before BMO would be entitled to receive any payments with respect to its Income Interest.

During the month of

June, 2016,

the Company received the balance of the

$16.9

million, and, as of

December 31, 2016,

the Company recorded a liability to BMO of approximately

$179,000,

which has been recorded in other liabilities in the Company’s consolidated balance sheet. The funds were subsequently remitted to BMO on

January 10, 2017.

The liability to BMO is recorded when actual collections are received.

Bank Hapoalim B.M. (“Bank Hapoalim”) Line of Credit

On

May 

2,

2014,

the Company obtained a

$20

million line of credit facility from Bank Hapoalim, pursuant to a Loan Agreement (the “Loan Agreement”) among the Company and its subsidiary, Palisades Collection, LLC, as borrowers (the “Borrowers”), and Bank Hapoalim, as agent and lender. The Loan Agreement provides for a

$20.0

million committed line of credit and an accordion feature providing an increase in the line of credit of up to

$30

million, at the discretion of the lenders. The facility is for a term of

three

years at an interest rate of either LIBOR plus

275

basis points or prime, at the Company’s option. The Loan Agreement includes covenants that require the Company to maintain a minimum net worth of

$150

million and pay an unused line fee. The facility is secured pursuant to a Security Agreement among the parties to the Loan Agreement, with property of the Borrowers serving as collateral. On

March 

30,

2016,

the Company signed the First Amendment to the Loan Agreement (the “First Amendment”) with Bank Hapoalim which amended certain terms of their banking arrangement. The First Amendment includes (a) the reduction of the interest rate to LIBOR plus

225

basis points; (b) a decrease in the minimum net worth requirement by

$50

million, to

$100

million and (c) modifies the

No

Net Loss requirement from a quarterly to an annual basis. All other terms of the original agreement remain in effect. There is an

$8.2

million and

$10

million aggregate balance as of

December 31, 2016

and

September 30, 2016,

respectively, in Bank Hapoalim which has been reclassified as restricted cash in the consolidated balance sheets since these assets serve as collateral for the line of credit (see Note

2

– Business and Basis of Presentation). The Company has

not

borrowed against the facility and

no

amounts were outstanding as of

December 31, 2016.

XML

Note 8 - Discontinued Operations

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

Note

8

—Discontinued Operations

On

December 

31,

2013,

the Company acquired

80%

ownership of CBC and its affiliate, CBC Management Services, LLC for approximately

$5.9

million.

On

December 

31,

2015,

the Company acquired the remaining

20%

ownership of CBC for

$1,800,000,

through the issuance of restricted stock valued at approximately 

$1,000,000

and

$800,000

in cash. Each of the

two

original principals received

61,652

shares of restricted stock at a fair market value of

$7.95

per share and

$400,000

in cash. An aggregate of

123,304

shares of restricted stock were issued as part of the transaction. These shares are subject to a

one

year lock-up period in which the holders cannot sell the shares. In addition, the shares are subject to certain sales restrictions following the initial lock-up period, which expired on

December 31, 2016 (

see Note 

13

– Stock Based Compensation).

On

January 

1,

2016,

the Company renewed the expiring

two

-year employment agreements of the

two

CBC principals for

one

year terms. The employment contracts of the original

two

principals expired at the end of

December 2016.

The Company did

not

renew those contracts. Ryan Silverman has been appointed CEO/General Counsel effective

January 1, 2017.

On

December 13, 2017,

the Company entered into a Securities Purchase Agreement (the “Purchase Agreement) with CBC Holdings LLC, a Delaware limited liability company (the “Buyer”). Under the Purchase Agreement, the Company sold all of the issued and outstanding equity capital of CBC for an aggregate purchase price of approximately

$10.5

million. Of the aggregate purchase price, approximately

$4.49

million was paid in cash, and

$5.75

million was paid under a promissory note at an annual interest rate of

7%

to be paid quarterly to the Company and secured by a

first

priority security interest in and lien on such Buyer’s affiliates’ rights to certain servicing fees. The remaining amount of the aggregate purchase price was paid as reimbursement of certain invoices of CBC. The Company subsequently recognized a loss of approximately

$1.9

million on the above sale of CBC as of

September 30, 2017.

As a result of this sale all prior periods presented in the Company's consolidated financial statements will account for CBC as a discontinued operation. This determination resulted in the reclassification of the assets and liabilities comprising the structured settlement business to assets related to discontinued operations in the consolidated balance sheets, and a corresponding adjustment to our consolidated statements of operations to reflect discontinued operations for all periods presented.

As of

December 

31,

2016,

the components of the Company designated as discontinued operations had assets and liabilities of

$94.5

million and

$74.2

million, respectively. As of

September 30, 2016,

the components of the Company designated as discontinued operations had assets and liabilities of

$91.5

million and

$69.2

million, respectively. For the

three

months ended

December 31, 2016

and

2015,

the Company designated as discontinued operations reported a (loss) income, net of income taxes of (

$1.3

) million and

$0.3

million, respectively.

The following table presents the operating results, for the 

three

months ended

December 

31,

 

2016

 and 

2015,

for the components of the Company designated as discontinued operations:

	Three months ended
	December 31, 201 6			December 31, 201 5
Revenues:
Unrealized (loss) gain on structured settlements	$	(1,682,000	)	$	1,527,000
Interest income on structured settlements		1,901,000			1,227,000
Total revenues		219,000			2,754,000
Other income		15,000			—
		234,000			2,754,000
Expenses:
General and administrative expenses		1,488,000			1,379,000
Interest expense		932,000			726,000
		2,420,000			2,105,000
(Loss) income from discontinued operations before income tax		(2,186,000	)		649,000
Income tax (benefit) expense from discontinued operations		(928,000	)		273,000
(Loss) income from discontinued operations before non-controlling interest		(1,258,000	)		376,000
Non-controlling interest		—			104,000
(Loss) income from discontinued operations, net of income tax	$	(1,258,000	)	$	272,000

The major components of assets and liabilities related to discontinued operations are summarized below:

	Dec ember 3 1 , 201 6			Sept ember 3 0 , 2016
Cash and cash equivalents	$	1,241,000	(1)	$	1,198,000
Restricted cash		499,000			499,000
Structured settlements		88,277,000			86,091,000
Furniture and equipment, net		43,000			47,000
Goodwill		1,405,000			1,405,000
Other assets		3,061,000			2,266,000
Total assets related to discontinued operations	$	94,526,000		$	91,506,000
Other debt - CBC		71,566,000			67,435,000
Other liabilities		2,603,000			1,803,000
Total liabilities related to discontinued operations	$	74,169,000		$	69,238,000

(

1

) Cash balance with

one

bank at

December 31, 2016

that exceeded the balance insured by the FDIC by approximately

$0.7

million.

Structured Settlements

Prior to our sale of CBC, CBC purchased periodic payments under structured settlements and annuity policies from individuals in exchange for a lump sum payment. The Company elected to carry the structured settlements at fair value. Unearned income on structured settlements is recognized as interest income using the effective interest method over the life of the related structured settlement. Changes in fair value are recorded in unrealized gain (loss) on structured settlements in the Company’s statements of operations. Unrealized gains on structured settlements is comprised of both unrealized gains resulting from fair market valuation at the date of acquisition of the structured settlements and the subsequent fair value adjustments resulting from the change in the discount rate. Of the

$1.7

million of unrealized losses recognized in the

three

month period ended

December 31, 2016,

approximately

$2.1

million is due to day

one

gains on new structured settlements financed during the period, offset by a decrease of

$0.5

million in realized gains recognized as realized interest income on structured settlements, and a reduction in fair value of

$3.3

million during the period.

The Company elected the fair value treatment under ASC

825

-

10

-

50

-

28

through

50

-

32

to be transparent to the user regarding the underlying fair value of the structured settlement which collateralizes the debt of CBC. The Company believes any change in fair value is driven by market risk as opposed to credit risk associated with the underlying structured settlement annuity issuer.

The purchased personal injury structured settlements result in payments over time through an annuity policy. Most of the annuities acquired involve guaranteed payments with specific defined ending dates. CBC also purchased a small number of life contingent annuity payments with specific ending dates but the actual payments to be received could be less due to the mortality risk associated with the measuring life. CBC records a provision for loss each period. The life contingent annuities are

not

a material portion of assets at

December 31, 2016

and revenue for the

three

month period ended

December 31, 2016.

Structured settlements consist of the following as of

December 31, 2016

and

September 

30,

2016:

	December 31 , 2016			September 30, 2016
Maturity (1) (2)	$	143,544,000		$	133,059,000
Unearned income		(55,267,000	)		(46,968,000	)
Structured settlements, net	$	88,277,000		$	86,091,000

( 1 ) The maturity value represents the aggregate unpaid principal balance at December 31, 2016 and September  30, 2016.

( 2 ) There are no amounts of structured settlements that are past due, or in nonaccrual status at December 31, 2016 and September  30, 2016.

Encumbrances on structured settlements as of

December 31, 2016

and

September 

30,

2016

are as follows:

	Interest Rate			December 31 , 2016		September 30, 2016
Notes payable secured by settlement receivables with principal and interest outstanding payable until June 2025		8.75	%	$	1,817,000	$	1,862,000
Notes payable secured by settlement receivables with principal and interest outstanding payable until August 2026		7.25	%		4,138,000		4,242,000
Notes payable secured by settlement receivables with principal and interest outstanding payable until April 2032		7.125	%		3,948,000		3,987,000
Notes payable secured by settlement receivables with principal and interest outstanding payable until February 2037		5.39	%		18,601,000		18,978,000
Notes payable secured by settlement receivables with principal and interest outstanding payable until March 2034		5.07	%		14,193,000		14,507,000
Notes payable secured by settlement receivables with principal and interest outstanding payable until February 2043		4.85	%		13,605,000		13,705,000
$25,000,000 revolving line of credit		4.1	%		15,264,000		10,154,000
Encumbered structured settlements					71,566,000		67,435,000
Structured settlements not encumbered					16,711,000		18,656,000
Total structured settlements				$	88,277,000	$	86,091,000

At

December 31, 2016,

the expected cash flows of structured settlements based on maturity value are as follows:

September 30, 2017 (9 months)	$	7,635,000
September 30, 2018		8,556,000
September 30, 2019		8,914,000
September 30, 2020		8,371,000
September 30, 2021		9,105,000
Thereafter		100,963,000
Total	$	143,544,000

The Company assumed

$25.9

million of debt related to the CBC acquisition on

December 

31,

2013,

including a

$12.5

million line of credit with an interest rate floor of

5.5%.

Between

March 

27,

2014

and

September 

29,

2014,

CBC entered into

three

amendments (Sixth Amendment through Eighth Amendment), resulting in the line of credit increasing to

$22.0

million and the interest rate floor reduced to

4.75%.

On

March 

11,

2015,

CBC entered into the Ninth Amendment. This amendment, effective

March 

1,

2015,

extended the maturity date on its credit line from

February 

28,

2015

to

March 

1,

2017.

Additionally, the credit line was increased from

$22.0

million to

$25.0

 million and the interest rate floor was decreased from

4.75%

to

4.1%.

Other terms and conditions were materially unchanged. On

November 

26,

2014,

CBC completed its

fourth

private placement, backed by structured settlement and fixed annuity payments. CBC issued, through its subsidiary, BBR IV, LLC, approximately

$21.8

million of fixed rate asset-backed notes with a yield of

5.4%.

On

September 

25,

2015,

CBC completed its

fifth

private placement, backed by structured settlement and fixed annuity payments. CBC issued, through its subsidiary, BBR V, LLC, approximately

$16.6

million of fixed rate asset-backed notes with a yield of

5.1%.

On

July 8, 2016,

CBC issued, through its subsidiary, BBR VI, approximately

$14.8

million of fixed rate asset-backed notes with a yield of

4.85%.

 

As of

December 31, 2016,

the remaining debt amounted to

$71.6

million, which consisted of

$15.3

million drawdown from a line of credit from an institutional source and

$56.3

million notes issued by entities

100%

-owned and consolidated by CBC. These entities are bankruptcy-remote entities created to issue notes secured by structured settlements. The fair value of this debt approximates its carrying value.

XML

Note 9 - Commitments and Contingencies

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Commitments and Contingencies Disclosure [Text Block]

Note

9

—Commitments and Contingencies

  

Employment Agreements

 

On

November 11, 2016,

the Company announced that it would continue its personal injury claims funding business through the formation of a wholly owned subsidiary Simia. In connection with its formation, Simia entered into an employment agreement (the “Employment Agreement”) with Patrick F. Preece to serve as its Chief Executive Officer. Under the Employment Agreement, Mr. Preece receives an annual base salary of

$250,000,

subject to annual increases at the discretion of the compensation committee (the “Compensation Committee”) of the Board of Directors of the Company (the “Board”). Mr. Preece is eligible to receive an annual cash or non-cash bonus in the sole and exclusive discretion of the Compensation Committee. Mr. Preece is also eligible to receive a cash or non-cash profit bonus of an aggregate amount up to

15%

of the profit of the business of Simia (the “Business”) for each fiscal year in which the Business achieves an internal rate of return of at least

18%.

In the event that the Business is sold to a

third

party solely for cash consideration during Mr. Preece’s employment period, he will be eligible to receive a cash or non-cash sale profit bonus of up to

15%

of the closing consideration received by the Company. He is also entitled to participate in any other benefit plans established by the Company for management employees. The Employment Agreement has a

five

year term. Under the Employment Agreement, Mr. Preece

may

be terminated with or without “cause” (as defined in the Employment Agreement) and

may

resign with or without “good reason” (as defined in the Employment Agreement). If Mr. Preece is terminated without “cause” or resigns for “good reason” he will receive severance equal to

two

years of his base salary. He is also entitled to a pro-rata share of the profit bonus and his deferred compensation will vest immediately. Mr. Preece is also subject to a non-compete and non-solicitation provision during the term of his employment and, unless his employment is terminated without “cause” or he resigns for “good reason,” for

two

years thereafter. See Note

20

- Subsequent Events.

The employment contracts of the original

two

CBC principals expired at the end of

December 2016.

The Company did

not

renew those contracts. Ryan Silverman has been appointed CEO/General Counsel effective

January 1, 2017.

Leases

  

The Company leases its facilities in Englewood Cliffs, NJ, Houston, TX, New York, NY, and Conshohocken, PA.  

Legal Matters

 

In

June 2015,

a putative class action complaint was filed against the Company, and

one

of its

third

party law firm servicers, alleging violation of the federal Fair Debt Collection Practices Act and Racketeer Influenced and Corrupt Organizations Act (“RICO”) and state law arising from debt collection activities and default judgments obtained against certain debtors.  

The Company filed a motion to strike the class action allegations and compel arbitration or, to the extent the court declines to order arbitration, to dismiss the RICO claims. On or about

March 

31,

2015,

the court denied the Company’s motion. The Company filed an appeal with the United States Court of Appeals for the Second Circuit. A mediation session was held in

July 2015,

at which the Company agreed to settle the action on an individual basis for a payment of

$13,000

to each named plaintiff, for a total payment of

$39,000.

Payment was made on or about

July 

24,

2015.

The

third

party law firm servicer has

not

yet settled and remains a defendant in the case.  

The plaintiffs’ attorneys advised that they were contemplating the filing of another putative class action complaint against the Company alleging substantially the same claims as those that were asserted in this matter. In anticipation of such an eventuality, the Company agreed to non-binding mediation in order to reach a global settlement with other putative class members, which would avert the possibility of further individual or class actions with respect to the affected accounts. Through

March 31, 2016,

the parties had attended

two

mediation sessions and were continuing to discuss a global settlement. In connection with such discussions, the parties agreed in principle to settle the action for a payment of

$3.9

million (which would be split equally between the Company and the law firm servicer). The Company and law firm servicer had also agreed to cease collection activity on the affected accounts. Accordingly, the Company set up a reserve for settlement costs of

$2.0

million during the

three

months ended

March 31, 2016,

which was included in general and administrative expenses in the Company’s consolidated statement of operations.  

The Company reassessed the situation as of

September 30, 2016

and deemed that an additional

$0.3

million was necessary to account for legal expenses, which were made during the

three

month period ended

September 30, 2016. 

The Company reviewed this case as of

December 31, 2016

and deemed that the

$2.3

million reserve remains valid. See Note

20

- Subsequent Events.

In the ordinary course of the Company’s business, it is involved in numerous legal proceedings. The Company regularly initiates collection lawsuits, using its network of

third

party law firms, against consumers. Also, consumers occasionally initiate litigation against the Company, in which they allege that the Company has violated a federal or state law in the process of collecting their account. The Company does

not

believe that these ordinary course matters are material to its business and financial condition. The Company is

not

involved in any other material litigation in which it is a defendant. 

XML

Note 10 - Income Recognition, Impairments, and Commissions and Fees

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Income Recognition, Impairments, and Commissions and Fees [Text Block]

Note

1

0

—Income Recognition, Impairments, and Commissions and Fees

 

Income Recognition

The Company accounts for certain of its investments in finance receivables using the guidance of FASB Accounting Standards Codification (“ASC”), Receivables — Loans and Debt Securities Acquired with Deteriorated Credit Quality (“ASC

310”

). Under the guidance of ASC

310,

static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision. Due to the substantial reduction of portfolios reported under the interest method, and the inability to reasonably estimate cash collections required to account for those portfolios under the interest method the Company concluded the cost recovery method is the appropriate accounting method under the circumstances.  

Under the guidance of ASC

310

-

30,

the Company must analyze a portfolio upon acquisition to ensure which method is appropriate, and once a static pool is established for a quarter, individual receivable accounts are

not

added to the pool (unless replaced by the seller) or removed from the pool (unless sold or returned to the seller).  

The Company uses the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method,

no

income is recognized until the cost of the portfolio has been fully recovered. A pool can become fully amortized (

zero

carrying balance on the balance sheet) while still generating cash collections. In this case, all cash collections are recognized as revenue when received. 

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(

R

estated)

Note

10—Income

Recognition, Impairments, and Commissions and Fees

(continued)

Income Recognition

The Company accounts for its investments in personal injury claims at an agreed upon interest rate, in anticipation of a future settlement. The interest purchased by Pegasus in each claim consists of the right to receive from such claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. Management assesses the quality of the personal injury claims portfolio through an analysis of the underlying personal injury fundings on a case by case basis. Cases are reviewed through periodic updates with attorneys handling the cases, as well as with

third

party research tools which monitor public filings, such as motions or judgments rendered on specific cases. The Company specifically reserves for those fundings where the underlying cases are identified as uncollectible, due to anticipated non-favorable verdicts and/or settlements at levels where recovery of the advance outstanding is unlikely. For cases that have

not

exhibited any specific negative collection indicators, the Company establishes reserves based on the historical collection rates of the Company’s fundings. Fee income on advances is reserved for on all cases where a specific reserve is established on the initially funded amount. In addition, management also monitors its historical collection rates on fee income and establishes reserves on fee income consistent with the historically experienced collection rates. Management regularly analyzes and updates the historical collection rates of its initially funded cases as well as its fee income.

The funding of matrimonial actions is on a non-recourse basis. Revenue from matrimonial actions is recognized under the cost recovery method. 

The Company recognizes revenue for GAR Disability Advocates when disability claimant's cases close with the social security administration and the applicable fees are collected.

Impairments

 

The Company accounts for its impairments in accordance with ASC

310,

which provides guidance on how to account for differences between contractual and expected cash flows from an investor’s initial investment in loans or debt securities acquired in a transfer if those differences are attributable, at least in part, to credit quality. The recognition of income under ASC

310

is dependent on the Company having the ability to develop reasonable expectations of both the timing and amount of cash flows to be collected. In the event the Company cannot develop a reasonable expectation as to both the timing and amount of cash flows expected to be collected, ASC

310

permits the change to the cost recovery method. The Company will recognize income only after it has recovered its carrying value. If collection projections indicate the carrying value will

not

be recovered, an impairment is required. The impairment will be equal to the difference between the carrying value at the time of the forecast and the corresponding estimated remaining future collections. 

In

October 2014,

the Company invested

$5.0

million in Class A shares of the Topaz MP Fixed Income Fund (“Topaz Fund”), a closed end fund. The Topaz Fund invests indirectly in various portfolios of Non-Performing Small Consumer Loans. The objective of the fund is to obtain a fixed return cash flow representing interest on the invested capital. According to the investment memorandum of the fund, the Topaz Fund proposed to make semi-annual distributions of

14%

annual compounded interest on

June

and

December

of each year. Since

December 2015,

no

distribution has been received by the Company. The Company received letters from the fund’s General Partner explaining that the distributions were

not

made due to the negative performance of the fund for the periods. 

During the fiscal year

2016,

the Company recorded an impairment loss on this investment of

$1.0

million, which was included in general and administrative expenses in the consolidated statements of operations. The carrying value of this investment amounted to

$3.4

million at

December 31, 2016.

Commissions and fees

Commissions and fees are the contractual commissions earned by

third

party collection agencies and attorneys, and direct costs associated with the collection effort, generally court costs. The Company utilizes

third

party collection agencies and attorney networks.

XML

Note 11 - Income Taxes

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Income Tax Disclosure [Text Block]

Note

11

—Income Taxes

At the end of each interim reporting period, the Company estimates its effective income tax rate expected to be applicable for the full year. The estimate is used in providing for income taxes on a year-to-date basis and

may

change in subsequent interim periods. The Company’s effective tax rate from operations for the

three

months ended

December 31, 2016

was

70.3%,

compared to

32.8%

in the same period of the prior year. The effective rate for fiscal

2017

differed from the U.S. federal statutory rate of

34%

due to state income taxes, and other permanent differences. The effective rate for fiscal

2016

differed from the U.S. federal statutory rate of

35%

primarily due to state income taxes and other permanent differences.

The Company files income tax returns in the U.S federal jurisdiction, various state jurisdictions, and various foreign countries. The Company does

not

have any uncertain tax positions. The Company’s amended tax returns for the years ended

September 30, 2014

and

2015

are currently being audited by the Internal Revenue Service.

ASTA FUNDING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(

R

estated)

XML

Note 12 - Net (Loss) Income Per Share

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Earnings Per Share [Text Block]

 

Note

12—Net

(loss) Income per Share

Basic per share data is calculated by dividing net (loss) income by the weighted average shares outstanding during the period. Diluted earnings per share is calculated similarly, except that it includes the dilutive effect of the assumed exercise of securities, including the effect of shares issuable under the Company’s stock based compensation plans. With respect to the assumed proceeds from the exercise of dilutive options, the treasury stock method is calculated using the average market price for the period.

The following table presents the computation of basic and diluted per share data for the

three

months ended

December 31, 2016

and

2015:

	Three Months Ended December 31, 2016								Three Months Ended December 31, 2015
	Net Loss			Weighted Average Shares		Per Share Amount			Net Income		Weighted Average Shares		Per Share Amount
Net (loss) income from continuing operations	$	(1,688,000	)		11,876,224	$	(0.14	)	$	1,291,000		12,155,421	$	0.11
Net (loss) income from discontinued operations		(1,258,000	)		11,876,224		(0.11	)		272,000		12,155,421		0.02
	$	(2,946,000	)			$	(0.25	)	$	1,563,000			$	0.13
Effect of Dilutive Stock					—		—					276,465		—
Diluted	$	(2,946,000	)		11,876,224	$	(0.25	)	$	1,563,000		12,431,886	$	0.13

For the

three

months ended

December 31, 2015,

454,205

options at a weighted average exercise price of

$9.47

were

not

included in the diluted earnings per share calculation as they were anti-dilutive. 

XML

Note 13 - Stock Based Compensation

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

Note

1

3

—Stock Based Compensation

The Company accounts for stock-based employee compensation under ASC

718,

Compensation — Stock Compensation (“ASC

718”

). ASC

718

requires that compensation expense associated with stock options and other stock based awards be recognized in the consolidated statement of operations, rather than a disclosure in the notes to the Company’s consolidated financial statements.

On

December 

16,

2015,

the Compensation Committee granted

67,100

stock options to non-officer employees of the Company, of which

9,100

options vested immediately and the remaining

58,000

stock options vest in

three

equal annual installments and accounted for as

one

graded vesting award. The exercise price of these options was at the market price on that date. The weighted average assumptions used in the option pricing model were as follows:

Risk-free interest rate	0.24	%
Expected term (years)	6.25
Expected volatility	23.4	%
Dividend yield	0.00	%

On

December 

16,

 

2015,

the Compensation Committee granted

5,000

restricted shares to a non-officer employee of the Company. These shares vested fully. On

December 

31,

2015,

the Company issued an aggregate of

123,304

shares to the

two

former CBC principals (see Note

5

– Acquisition of CBC). These shares are subject to a

one

year lock up period in which the holders cannot sell the shares. In addition, the shares are subject to certain sales restrictions following the initial lock-up period which expired on

December 31, 2016 (

see Note

5

– Acquisition of CBC).

XML

Note 14 - Stock Option Plans

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Stock Option Plans [Text Block]

Note

1

4

—Stock Option Plans

2012

Stock Option and Performance Award Plan

 On

February 

7,

2012,

the Board adopted the Company’s

2012

Stock Option and Performance Award Plan (the

“2012

Plan”), which was approved by the stockholders of the Company on

March 

21,

2012.

The

2012

Plan replaced the Equity Compensation Plan (as defined below).

 The

2012

Plan provides the Company with flexibility with respect to equity awards by providing for grants of stock awards (i.e. restricted or unrestricted), stock purchase rights and stock appreciation rights, in addition to the granting of stock options.

 The Company authorized

2,000,000

shares of Common Stock for issuance under the

2012

Plan. Under the

2012

Plan, the Company has granted options to purchase an aggregate of

484,200

shares, an award of

245,625

shares of restricted stock, and has cancelled

66,568

options, leaving

1,336,743

shares available as of

December 31, 2016.

At

December 31, 2016,

129

of the Company’s employees were able to participate in the

2012

Plan.

Equity Compensation Plan

On

December 

1,

2005,

the Board adopted the Company’s Equity Compensation Plan (the “Equity Compensation Plan”), which was approved by the stockholders of the Company on

March 

1,

2006.

The Equity Compensation Plan was adopted to supplement the Company’s

2002

Stock Option Plan (as defined below).

In addition to permitting the grant of stock options as are permitted under the

2002

Stock Option Plan, the Equity Compensation Plan allowed the Company flexibility with respect to equity awards by also providing for grants of stock awards (i.e. restricted or unrestricted), stock purchase rights and stock appreciation rights.

The Company authorized

1,000,000

shares of Common Stock for issuance under the Equity Compensation Plan. As of

March 

21,

2012,

no

more awards could be issued under this plan.

2002

Stock Option Plan

 

On

March 

5,

2002,

the Board adopted the Company’s

2002

Stock Option Plan (the

“2002

Plan”), which was approved by the stockholders of the Company on

May 

1,

2002.

The

2002

Plan was adopted in order to attract and retain qualified directors, officers and employees of, and consultants to, the Company. 

The

2002

Plan authorized the granting of incentive stock options (as defined in Section 

422

of the Internal Revenue Code of

1986,

as amended (the “Code”)) and non-qualified stock options to eligible employees of the Company, including officers and directors of the Company (whether or

not

employees) and consultants of the Company. 

The Company authorized

1,000,000

shares of Common Stock authorized for issuance under the

2002

Plan. As of

March 

5,

2012,

no

more awards could be issued under this plan.

Summary of the Plans

Compensation expense for stock options and restricted stock is recognized over the vesting period. Compensation expense for restricted stock is based upon the market price of the shares underlying the awards on the grant date.

The following table summarizes stock option transactions under the

2012

Plan, the

2002

Plan, and the Equity Compensation Plan:

	Three Months Ended December 31 ,
	2016					2015
	Number Of Shares			Weighted Average Exercise Price		Number of Shares		Weighted Average Exercise Price
Outstanding options at the beginning of period		949,667		$	8.47		1,043,566	$	8.47
Options granted		—			—		67,100		7.93
Options exercised		—			—		—		—
Options forfeited/cancelled		(52,500	)		14.16		—		—
Outstanding options at the end of period		897,167		$	8.14		1,110,666	$	8.43
Exercisable options at the end of period		844,829		$	8.15		965,325	$	8.46

The following table summarizes information about the

2012

Plan,

2002

Plan, and the Equity Compensation Plan outstanding options as of

December 31, 2016:

			Options Outstanding						Options Exercisable
Range of Exercise Price			Number of Shares Outstanding		Weighted Remaining Contractual Life (in Years)		Weighted Average Exercise Price		Number of Shares Exercisable		Weighted Average Exercise Price
$2.8751	-	$5.7500		3,800		2.3	$	2.95		3,800	$	2.95
$5.7501	-	$8.6250		768,867		5.2		7.96		716,529		7.96
$8.6251	-	$11.5000		124,500		6.1		9.40		124,500		9.40
				897,167		5.3	$	8.14		844,829	$	8.15

The Company recognized (

$6,000

) and

$196,000

of compensation (benefit) expense related to the stock option grants during the

three

month periods ended

December 31, 2016

and

2015,

respectively. As of

December 31, 2016,

there was

$76,000

of unrecognized compensation cost related to stock option awards. The weighted average period over which such costs are expected to be recognized is

1.8

years. The intrinsic value of the outstanding and exercisable options as of

December 31, 2016

was approximately

$1,490,000

and

$1,398,000,

respectively. The weighted average remaining contractual life of exercisable options is

5.1

years. There were

no

options exercised during the

three

month periods ended

December 31, 2016

and

2015.

The fair value of the stock options that vested during the

three

month periods ended

December 31, 2016

and

2015

was approximately

$657,000

and

$830,000,

respectively. There were

no

options granted during the

three

month period ended

December 31, 2016.

The fair value of the options granted during the

three

month period ended

December 31, 2015

was approximately

$532,000.

The following table summarizes information about restricted stock transactions: 

	Three Months Ended December 31 ,
	2016				2015
	Number of Shares		Weighted Average Grant Date Fair Value		Number of Shares			Weighted Average Grant Date Fair Value
Unvested at the beginning of period		—	$	—		44,107		$	9.28
Awards granted		—		—		5,000			7.89
Vested		—		—		(34,107	)		9.57
Forfeited		—		—		—			—
Unvested at the end of period		—	$	—		15,000		$	7.92

The Company recognized

$0

and

$87,000

of compensation expense related to the restricted stock awards during the

three

month periods ended

December 31, 2016

and

2015,

respectively. As of

December 31, 2016,

there was

no

unrecognized compensation cost related to restricted stock awards.

No

restricted stock was granted during the

three

month period ended

December 31, 2016.

An aggregate of

5,000

shares of restricted stock was granted during the

three

month period ended

December 31, 2015.

The fair value of the awards vested during the

three

month periods ended

December 31, 2016

and

2015

was

$0

and

$40,000,

respectively.

The Company recognized an aggregate total of (

$6,000

) and

$283,000

in compensation (benefit) expense for the

three

month periods ended

December 31, 2016

and

2015,

respectively, for the stock options and restricted stock grants. As of

December 31, 2016,

there was a total of

$76,000

of unrecognized compensation cost related to unvested stock options and restricted stock grants. The method used to calculate stock based compensation is the straight line pro-rated method.

XML

Note 15 - Stockholders' Equity

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Stockholders' Equity Note Disclosure [Text Block]

Note

1

5

—Stockholders’ Equity

Dividends are declared at the discretion of the Board and depend upon the Company’s financial condition, operating results, capital requirements and other factors that the Board deems relevant. In addition, agreements with the Company’s lenders

may,

from time to time, restrict the ability to pay dividends. As of

December 31, 2016,

there were

no

such restrictions.

No

dividends were declared during the

three

month periods ended

December 31, 2016

and

2015.

 

On

August 

11,

2015,

the Board approved the repurchase of up to

$15,000,000

of the Company’s common stock and authorized management of the Company to enter into the Shares Repurchase Plan under Sections

10b

-

18

and

10b5

-

1

of the Securities Exchange Act (the “Shares Repurchase Plan”). The Shares Repurchase Plan was to have been effective to

December 

31,

2015.

On

December 

17,

2015

the Board approved the extension of the Plan to

March 

31,

2016

and reset the maximum to an additional

$15

million in repurchases. On

March 

17,

2016,

having repurchased approximately

$9.9

million of the Company’s common stock, the Board approved further extension of the Plan to

December 

31,

2016

and reset the maximum to 

$15

million in repurchases. On

March 

22,

2016,

a Company shareholder commenced a tender offer on the Company’s common stock. Per the provisions of the Shares Repurchase Plan, it terminated immediately, and

no

further purchases were permitted under the Shares Repurchase Plan. Through

September 30, 2016,

the Company purchased approximately

1,186,000

shares at an aggregate cost of approximately

$10.1

million under the Shares Repurchase Plan. 

On

May 

25,

2016,

the Company entered into a Mutual Confidentiality Agreement (the “Agreement”) with MPF InvestCo

4,

LLC, a wholly owned subsidiary of The Mangrove Partners Master Fund, Ltd. (“Mangrove”), pursuant to which Mangrove and the Company agreed to (

1

) provide certain Confidential Information (as defined below) to the other party to the Agreement and the other party’s representatives, (

2

) the confidentiality of the Confidential Information, and (

3

) certain restrictions on the activities of the parties to the Agreement.  

As of

December 31, 2016,

and for the

three

month periods ended

December 31, 2015

and

2016,

Mangrove due to their ownership in the Company's common stock, which was acquired in a series of OTC transactions, was deemed to be a related party. 

Pursuant to the Agreement, the Company made available to Mangrove and its representatives certain confidential information relating to the Company or its subsidiaries, and Mangrove agreed to make available to the Company and its representatives certain confidential information relating to Mangrove and its affiliates (collectively, the “Confidential Information”). The Company and Mangrove agreed

not

to disclose the Confidential Information, and to cause each of their representatives, respectively,

not

to disclose the Confidential Information, except as required by law. Pursuant to the Agreement, the Company provided information requested by Mangrove to

one

or more of Mangrove’s representatives and such representatives prepared summaries of such information (the “Summaries”). The Company approved the Summaries, and the approved Summaries were provided to Mangrove. The Company agreed to release the approved Summaries publicly on or prior to the end of the Extended Period (as defined in the Agreement), to the extent that the information contained in the Summaries has

not

already been disclosed. 

Further, under the terms of the Agreement, Mangrove and the Company agreed to certain restrictions during the Discussion Period, which began on

May 25, 2016 

and the Extended Period, including that, unless consented to by the other party to the Agreement or required by applicable law, neither party will, and shall cause its affiliates and representatives

not

to, (i) commence any litigation against the other party, (ii) make any filing with the Securities and Exchange Commission of proxy solicitation materials, preliminary proxy statement, definitive proxy statement or otherwise or call any annual or special meeting of stockholders of the Company, (iii) publicly refer to: (a) the Confidential Information or Discussion Information (as defined in the Agreement), (b) any annual or special meetings of stockholders of the Company or (c) any prior discussions between the parties, including in any filing with the Securities and Exchange Commission (including any proxy solicitation materials, preliminary proxy statement, definitive proxy statement or otherwise), in any press release or in any other written or oral disclosure to a

third

party, (iv) make any purchases of the Company’s securities, including, but

not

limited to, pursuant to any stock buyback plans, tender offers, open-market purchases, privately negotiated transactions or otherwise, (v) make any demand under Section 

220

of the Delaware General Corporation Law, (vi) make or propose to make any amendments to the Company’s Certificate of Incorporation, as amended, or By-laws, as amended, (vii) adopt, renew, propose or otherwise enter into a Shareholder Rights Plan with respect to the Company’s securities, (viii) adopt or propose any changes to the Company’s capital structure or (ix) negotiate, discuss, enter into, propose or otherwise transact in any extraordinary transactions with respect to the Company, outside the ordinary course of business, including, but

not

limited to, any mergers, asset sales or asset purchases. 

On

November 21, 2016,

Mangrove notified the Company that Mangrove was terminating the Agreement with the Company. Under the Agreement, the Company and Mangrove agreed to (

1

) provide certain Confidential Information (as defined below) to the other party to the Agreement and the other party’s representatives, (

2

) maintain the confidentiality of the Confidential Information, and (

3

) certain restrictions on the activities of the parties to the Agreement. Upon termination of the Discussion Period, the agreement provides for a period of

30

days thereafter (the “Extended Period”). Throughout the Extended Period of the Agreement, the parties are subject to the standstill provisions of the Agreement. Following the Discussion Period and the Extended Period, nothing in the Agreement shall prohibit any party from taking any of the activities referred to as the Restricted Activities, and specifically nothing shall restrict Mangrove or its representatives from calling a special meeting, nominating

one

or more candidates to serve as directors of the Company or commencing, or announcing its intention to commence, a “solicitation” of “proxies” (as such terms are used in Regulation

14A

of the Securities Exchange Act of

1934,

as amended) to vote with respect to any meeting of stockholders of the Company. The effective termination date of this Agreement was

January 6, 2017 (

see Note

20

– Subsequent Events).

XML

Note 16 - Fair Value of Financial Measurements and Disclosures

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Fair Value Disclosures [Text Block]

Note

1

6

—Fair Value of Financial Measurements and Disclosures

 

Fair Value Hierarchy

The Company recorded its available-for-sale investments at estimated fair value on a recurring basis. The accompanying consolidated financial statements include estimated fair value information regarding its available-for-sale investments as of

December 31, 2016,

as required by FASB ASC

820,

Fair Value Measurements and Disclosures (“ASC

820”

). ASC

820

defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants on the measurement date. ASC

820

also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s level within the fair value hierarchy is based on the lowest level of input significant to the fair value measurement. 

Level

1

– Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to assess at the measurement date. 

Level

2

– Observable inputs other than Level

1

prices, such as quoted prices for similar assets or liabilities in active markets; quoted prices in markets that are

not

active for identical or similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. 

Level

3

– Unobservable inputs that are supported by little or

no

market activity and significant to the fair value of the liabilities that are developed using the reporting entities’ estimates and assumptions, which reflect those that market participants would use. 

Disclosures about Fair Value of Financial Instruments

 

FASB ASC

825,

Financial Instruments, (“ASC

825”

), requires disclosure of fair value information about financial instruments, whether or

not

recognized on the balance sheet, for which it is practicable to estimate that value. Because there are a limited number of market participants for certain of the Company’s assets and liabilities, fair value estimates are based upon judgments regarding credit risk, investor expectation of economic conditions, normal cost of administration and other risk characteristics, including interest rate and prepayment risk. These estimates are subjective in nature and involve uncertainties and matters of judgment, which significantly affect the estimates. 

The estimated fair value of the Company’s financial instruments is summarized as follows:

	December 31, 2016				September 30, 2016
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets
Cash equivalents (Level 1)	$	936,000	$	936,000	$	923,000	$	923,000
Other investment, net (Level 1)		3,354,000		3,354,000		3,590,000		3,590,000
Available-for-sale investments (Level 1)		55,045,000		55,045,000		56,763,000		56,763,000
Consumer receivables acquired for liquidation (Level 3)		13,462,000		45,061,000		13,427,000		47,233,000

The following assets have been reclassified to discontinued operations as of

December 31, 2016

and

September 30, 2016:

	December 31, 2016				September 30, 2016
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial asset
Structured settlements (Level 3)		88,277,000		88,277,000		86,091,000		86,091,000

Disclosure of the estimated fair values of financial instruments often requires the use of estimates. The Company uses the following methods and assumptions to estimate the fair value of financial instruments: 

Cash equivalents – The Company considers all highly liquid debt instruments purchased with an original maturity of Three months or less to be cash equivalents. The carrying amount of cash equivalents approximates fair value.

Available-for-sale investments – The available-for-sale securities consist of mutual funds that are valued based on quoted prices in active markets. 

Other investments – The Company estimated the fair value using the net asset value per share of the investment. There are

no

unfunded commitments and the investment cannot be redeemed for

5

years from the date of the initial investment (

October 2014). 

Consumer receivables acquired for liquidation – The Company computed the fair value of the consumer receivables acquired for liquidation using its proprietary forecasting model. The Company’s forecasting model utilizes a discounted cash flow analysis. The Company’s cash flows are an estimate of collections for consumer receivables based on variables fully described in Note

4

- Consumer Receivables Acquired for Liquidation. These cash flows are discounted to determine the fair value. 

Structured settlements – The Company determined the fair value based on the discounted forecasted future collections of the structured settlements. Unrealized gains on structured settlements is comprised of both unrealized gains resulting from fair market valuation at the date of acquisition of the structured settlements and the subsequent fair value adjustments resulting from the change in the discount rate. Of the

$1.7

million of unrealized losses recognized in the

three

month period ended

December 31, 2016,

approximately

$2.1

million is due to day

one

gains on new structured settlements financed during the period, offset by a decrease of

$0.5

million in realized gains recognized as realized interest income on structured settlements and a reduction in fair value of

$3.3

million during the period. 

A significant unobservable input used in the fair value measurement of structured settlements is the discount rate. Significant increases and decreases in the discount rate used to estimate the fair value of structured settlements could decrease or increase the fair value measurement of the structured settlements. The discount rate could be affected by factors, which include, but are

not

limited to, creditworthiness of insurance companies, market conditions, specifically competitive factors, credit quality of receivables purchased, the diversity of the payers of the receivables purchased, the weighted average life of receivables, current benchmark rates (i.e.

10

year treasury or swap rate) and the historical portfolio performance of the originator and/or servicer. 

The Company’s available-for-sale investments are classified as Level

1

financial instruments based on the classifications described above. The Company did

not

have transfers into or (out of) Level

1

investments during the

three

month period ended

December 31, 2016.

The Company had

no

Level

2

or Level

3

available-for-sale investments during the

first

three

months of fiscal year

2017.

 

The following table sets forth the Company’s quantitative information about its Level

3

fair value measurements as of

December 31, 2016, (

which are classified in the consolidated financial statements as assets related to discontinued operations):

	Fair Value		Valuation Technique	Significant Unobservable Input	Weighted Average Rate
Structured settlements at fair value	$	88,277,000	Discounted cash flow	Discount rate	4.83%	-	5.36%

A significant unobservable input used in the fair value measurement of the Company's structured settlements measured at fair value using unobservable inputs (Level

3

) is the discount rate. The inputs comprising the discount rate include A-rated U.S. Financial yield curve, plus illiquidity spread, and cash flows of the portfolio are adjusted to take into consideration survival probabilities, if applicable.

The changes in financial instruments at fair value using significant unobservable inputs (Level

3

) during the

three

months ended

December 31, 2016

were as follows:

	Structured Settlement
Balance at September 30, 2016	$	86,091,000
Fair value adjustment		(3,611,000	)
Total gains included in earnings		1,598,000
Purchases		4,595,000
Interest accreted		1,567,000
Payments received		(1,963,000	)
Total	$	88,277,000
The amount of total losses for the three month period included in earnings attributable to the change in unrealized losses relating to assets held at December 31, 2016	$	(1,682,000	)

Realized and unrealized losses included in earnings in the accompanying consolidated statements of operations for the

three

months ended

December 31, 2016

are reported in the following revenue categories:

Total losses included in the three months ended December 31, 2016	$	(1,682,000	)
Change in unrealized losses relating to assets still held at December 31, 2016	$	(1,682,000	)

XML

Note 17 - Segment Reporting

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note

1

7

—Segment Reporting

The Company operates through strategic business units that are aggregated into

three

reportable segments: consumer receivables, personal injury claims, and GAR. The

three

reportable segments consist of the following:

• Consumer receivables -   This segment is engaged in the business of purchasing, managing for its own account and servicing distressed consumer receivables, including judgment receivables, charged off receivables and semi-performing receivables. Judgment receivables are accounts where outside attorneys have secured judgments directly against the consumer. Primary charged-off receivables are accounts that have been written-off by the originators and may have been previously serviced by collection agencies. Semi-performing receivables are accounts where the debtor is currently making partial or irregular monthly payments, but the accounts may have been written-off by the originators. Distressed consumer receivables are the unpaid debts of individuals to banks, finance companies and other credit providers. A large portion of our distressed consumer receivables are MasterCard ® , Visa ® and other credit card accounts which were charged-off by the issuers or providers for non-payment. We acquire these and other consumer receivable portfolios at substantial discounts to their face values. The discounts are based on the characteristics (issuer, account size, debtor location and age of debt) of the underlying accounts of each portfolio. The business conducts its activities primarily under the name Palisades Collection, LLC.

• Personal injury claims (Equity Method of Accounting)    – Pegasus Funding, LLC, purchases interests in personal injury claims from claimants who are a party to personal injury litigation. Pegasus advances to each claimant funds on a non-recourse basis at an agreed upon interest rate, in anticipation of a future settlement. The interest in each claim purchased by Pegasus consists of the right to receive, from such claimant, part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. Effective January 2017, Simia commenced funding personal injury settlement claims while Pegasus will not fund any new advances, and will remain in operation to liquidate its current portfolio of advances.

• Social Security benefit advocacy – GAR Disability Advocates is an advocacy group which represents individuals nationwide in their claims for social security disability and supplemental security income benefits from the Social Security Administration.

Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, available-for-sale securities, property and equipment, goodwill, deferred taxes and other assets. 

The following table shows results by reporting segment for the

three

month periods ended

December 31, 2016

and

2015.

The Company eliminates any revenue between the segments.

(Dollars in millions)	Consumer Receivables		GAR Disability Advocates			(Equity Investment) Personal Injury Claims (2)		Corporate (3)			Total
Three Months Ended December 31, 2016:
Revenues	$	4.1	$	1.4		$	—	$	—		$	5.5
Other income		—		—			—		0.4			0.4
Segment profit (loss)		3.2		(0.9	)		0.4		(3.7	)		(1.0	)
Segment Assets(1)		17.6		1.4			49.2		188.3	(4)		256.5
2015:
Revenues		5.1		0.7			—		—			5.8
Other income		—		—			—		0.4			0.4
Segment profit (loss)		4.7		(1.8	)		1.5		(2.5	)		1.9
Segment Assets(1)		24.8		2.4			36.42		174.2	(4)		237.8

The Company does

not

have any intersegment revenue transactions.

( 1 ) Includes other amounts in other line items on the consolidated balance sheet.

( 2 ) The Company records Pegasus as an equity investment in its consolidated financial statements. For segment reporting the Company has included its pro-rated share of the earnings and losses from its investment under the Personal Injury Claims segment.

( 3 ) Corporate is not part of the three reportable segments, as certain expenses and assets are not earmarked to any specific operating segment.

( 4 ) Included in Corporate are approximately $94.5 million and $74.6 million of assets related to discontinued operations as of December 31, 2016 and 2015, respectively.

XML

Note 18 - Accumulated Other Comprehensive (Loss) Income

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Comprehensive Income (Loss) Note [Text Block]

Note

18

- Accumulated Other Comprehensive (Loss) Income

 

Accumulated other comprehensive (loss) income consists of:

	Three Months ended December 31, 201 6								Year Ended September 30, 2016
	Unrealized gain (loss) on marketable securities			Foreign currency translation, net		Total			Unrealized gain (loss) on marketable securities			Foreign currency translation, net			Total
Beginning Balance	$	624,000		$	179,000	$	803,000		$	(205,000	)	$	225,000		$	20,000
Change in unrealized (losses) gains on foreign currency translation, net of tax benefit/(expense) of ($12,000) and $25,000 at December 31 2016, and September 30, 2016, respectively.		-			18,000		18,000			-			(46,000	)		(46,000	)
Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense) of $826,000 and ($529,000) at December 31 2016, and September 30, 2016, respectively.		(1,239,000	)		-		(1,239,000	)		867,000			-			867,000
Amount reclassified from accumulated other comprehensive loss, net of tax benefit of $18,000 and $24,000 at December 31 2016, and September 30, 2016, respectively.		(27,000	)		-		(27,000	)		(38,000	)		-			(38,000	)
Net current-period other comprehensive (loss) income		(1,266,000	)		18,000		(1,248,000	)		829,000			(46,000	)	$	783,000
Ending balance	$	(642,000	)	$	197,000	$	(445,000	)	$	624,000		$	179,000		$	803,000

XML

Note 19 - Related Party Transactions

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Related Party Transactions Disclosure [Text Block]

Note

19

—Related Party Transactions

On

September 

17,

2015,

the Company and Piccolo Business Advisory (“Piccolo”), which is owned by Louis Piccolo, a director of the Company, entered into a Consulting Agreement, pursuant to which Piccolo provides consulting services which included, but is

not

limited to, analysis of proposed debt and equity transactions, due diligence and financial analysis and management consulting services (“services”). The Consulting Agreement is for a period of

two

years, which ends on

September 17, 2017.

For the

three

months ended

December 

31,

2016,

the Company booked a liability of

$20,000

to Piccolo for such services which was paid on

January 6, 2017.

In addition, A. L. Piccolo & Co., Inc. (“ALP”), which is also owned by Louis Piccolo, received a fee from Pegasus which was calculated based on amounts loaned to Pegasus by Fund Pegasus up to maximum of

$700,000.

The fee is payable over

six

years including interest at

4%

per annum from Pegasus during the term of the Pegasus Operating Agreement that expired on

December 28, 2016.

Thereafter, it is payable by PLF and its affiliates.  Pegasus paid ALP

$33,000

for the

three

months ended

December 31, 2016.

In

June 2015,

CBC entered into an asset purchase agreement with Fortress Funding, LLC (“Fortress”) to acquire an interest in certain tangible and intangible assets of Fortress, which included customer lists, equipment and other intellectual property. In consideration for these assets CBC agreed to pay Fortress

$0.5

million, as well as up to an additional

$1.2

million based on conversion of customers from the acquired lists obtained in the transaction. Fortress is owned by Michelle Silverman, the wife of Ryan Silverman, who in connection with the agreement was offered employment as General Counsel of CBC.

For the

three

months ended

December 31, 2016

and

2015,

the Company paid Fortress

$100,000

and

$42,000,

respectively. As of

December 31, 2016

and

September 30, 2016,

the Company had a liability due to Fortress of

$0.7

million and

$0.8

million, respectively.

XML

Note 20 - Subsequent Events

3 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Subsequent Events [Text Block]

Note

20—Subsequent

Events

 

Mangrove Matter

On

March 22, 2016,

Mangrove a Company shareholder commenced a tender offer on the Company's common stock. See Note

15

- Stockholders' Equity.

On

January 6, 2017,

the Company entered into a settlement agreement (the “Settlement Agreement”) with Mangrove and, for limited purposes stated therein, Gary Stern, Ricky Stern, Emily Stern, Arthur Stern, Asta Group, Incorporated and GMS Family Investors LLC (collectively, the “ Stern Family ”). 

The Settlement Agreement provided that, within

ten

business days following the date of the Settlement Agreement, the Company will commence a self-tender offer (“ Tender Offer ”) to repurchase for cash

5,314,009

shares of its common stock at a purchase price of

$10.35

per share. The Tender Offer will expire

no

later than

February 28, 2017.

Pursuant to the Settlement Agreement, Mangrove will tender its

4,005,701

shares for purchase by the Company. The Stern Family has agreed

not

to tender any of their shares in the Tender Offer. In addition, pursuant to a securities purchase agreement dated

January 6, 2017

between Mangrove and Gary Stern (the “Purchase Agreement”), Gary Stern will purchase any remaining shares owned by Mangrove

eleven

business days following the closing of the Tender Offer for

$10.35

per share.   

The Settlement Agreement includes customary standstill and related provisions. Mangrove and the Company also agreed on a mutual release of claims. Additionally, the Company indemnified Mangrove from and against any excise tax imposed as a result of this Settlement Agreement.  

The Settlement Agreement was terminable by either the Company or Mangrove by written notice at any time after the close of business on the

second

anniversary of the Settlement Agreement. The Settlement Agreement will also terminate if the Tender Offer does

not

close on or before

February 28, 2017

or the Company amends the terms of the Tender Offer in a manner adverse to Mangrove.   

In connection with the Settlement Agreement, the Company also entered into a Voting Agreement dated

January 6, 2017 (

the “ Voting Agreement ”) with Gary Stern, Ricky Stern, Emily Stern, Asta Group, Incorporated and GMS Family Investors LLC (collectively, the “ Stern Stockholders ”). The Voting Agreement provides that the Stern Stockholders will

not

have the right to vote more than

49%

of the Company’s total outstanding shares, and any additional shares held by the Stern Stockholders will be voted in a manner proportionate to the votes of the outstanding shares

not

held by the Stern Stockholders. 

On

January 19, 2017,

the Company commenced a self-tender offer to purchase for cash up to

5,314,009

shares of its common stock at a purchase price of

$10.35

per share, less applicable withholding taxes and without interest. The Company made the tender offer pursuant to the Settlement Agreement dated as of

January 6, 2017,

by and among the Company, Mangrove and certain of their respective affiliates, pursuant to which Mangrove and its affiliates would tender their

4,005,701

shares. The tender offer would reduce the number of shares in the public market.  

If more than

5,314,009

shares had been tendered, the Company would have purchased all tendered shares on a pro rata basis, subject to the conditional tender provisions described in the Offer to Purchase. Pursuant to the Settlement Agreement, Gary Stern (or his permitted assignees) had unconditionally agreed to purchase from Mangrove and its affiliates any shares owned by Mangrove and its affiliates that the Company did

not

purchase in the tender offer. 

The tender offer expired on

February 15, 2017,

at

11:59

p.m., New York City time. Based on the final count by American Stock Transfer & Trust Company, LLC ("AMSTOCK"), the depositary for the tender offer, a total of approximately

6,022,253

shares of the Company’s common stock were validly tendered and

not

validly withdrawn. Because the tender offer was oversubscribed by

708,244

shares, the Company purchased only a prorated portion of the shares properly tendered by each tendering stockholder. The depositary had informed the Company that the final proration factor for the tender offer was approximately

88.24%

of the shares validly tendered and

not

validly withdrawn. AMSTOCK promptly issued payment for the

5,314,009

shares accepted pursuant to the tender offer and returned all other shares tendered and

not

purchased. The shares acquired represented approximately

44.7%

of the total number of shares of the Company’s common stock issued and outstanding as of

February 6, 2017.

As a result of this tender offer, the Company recorded during the

second

quarter of fiscal year

2017

an additional

$54.2

million in treasury stock, and

$797,000

was charged to general and administrative expenses in the consolidated statements of operations which represent the excess of the current market price of the Company’s common stock on

January 18, 2017

of

$10.20

per share. Additionally, the Ricky Stern Family

2012

Trust (as Gary Stern's permitted assignee), acquired

471,086

Shares under the Purchase Agreement on

March 10, 2017

for

$4.9

million.

Simia

Effective

November 11, 2016,

the Company entered into a

five

year employment agreement with Mr. Preece that

may

be terminated with or without “cause” (as defined in the Employment Agreement) and

may

resign with or without “good reason” (as defined in the Employment Agreement). If Mr. Preece is terminated without “cause” or resigns for “good reason” he will receive severance equal to

two

years of his base salary. See Note

5

- Litigation Funding.

As of

July 17, 2017,

Mr. Preece was

no

longer employed as Chief Executive Officer of Simia. On an interim basis Gary Stern, Chairman, Chief Executive Officer and President of the Company, will undertake the responsibilities of Simia’s Chief Executive Officer. 

No

amounts were paid to Mr. Preece under the severance or bonus provisions of his contract.

Pegasus

The Company filed for arbitration with the American Arbitration Association ("AAA") against Pegasus in

April 2017

for breaches in the Operating and Term Sheet. On

April 18, 2017,

the Company was granted an Emergent Award restraining the cash in Pegasus, until a formal arbitration panel is confirmed and can review the case. As of

June 30, 2017

there was approximately

$24.7

million in cash that was restrained under the Emergent Award, and is classified as restricted on the Company's consolidated balance sheet. The Company has as equity method investment in Pegasus. See Note

5

- Litigation Funding.

On

July 17, 2017,

an arbitration panel was confirmed, and a hearing date has been scheduled for

August 25, 2017

on the Company's motion to have PLF removed from managing Pegasus and replacing them with Company designated representatives, and to permit disbursements to the Company in accordance with the Operating and Liquidation Agreements.

On

January 12, 2018,

the Company, ASFI and Fund Pegasus entered into a Settlement Agreement and Release (the “Settlement Agreement”) by and among the Company, ASFI, Fund Pegasus, Pegasus, the Seller, Max Alperovich, Alexander Khanas, Larry Stoddard, III, Louis Piccolo and A.L. Piccolo & Co., Inc., a New York corporation. The Settlement Agreement releases certain claims in exchange for, among other things, the parties' entry into the Purchase Agreement.

Additionally, on

January 12, 2018,

ASFI Pegasus Holdings, LLC (“ASFI”), a Delaware limited liability company and a subsidiary of Asta Funding, Inc. (the “Company” or “Asta”), a Delaware corporation, entered into a Membership Interest Purchase Agreement (the “Purchase Agreement) with Pegasus Legal Funding, LLC, a Delaware limited liability company (the “Seller”). Under the Purchase Agreement, ASFI bought the Seller’s ownership interests of Pegasus Funding, LLC (“Pegasus”), which was

20%

of the issued and outstanding limited liability company interests of Pegasus, for an aggregate purchase price of

$1,800,000.

As a result of the execution of the Purchase Agreement, ASFI became the owner of

100%

of the limited liability company interests of Pegasus.

As a result of the purchase of the Seller’s

20%

interest in Pegasus on

January 12, 2018

under the Purchase Agreement, beginning with the quarter ended

March 31, 2018,

the Company will consolidate the financial statements of Pegasus. The Company currently accounts for its investment in Pegasus under the equity method of accounting. See Note

5

- Litigation Funding.

Legal Matters

A competitor of the Company’s former subsidiary CBC Settlement Funding, LLC (“CBC”) alleged that CBC had unlawfully purchased certain of the competitor’s trade secrets and customer lists from intermediaries who allegedly arranged and/or paid for said materials from the competitor. CBC denied any wrongdoing and disclaimed liability. The parties settled the matter for a payment by the Company of

$500,000

on or about

November 22, 2017,

in exchange for a complete release.

On

November 24, 2017,

the Company paid

$0.8

million as a settlement in conjunction with the lawsuit filed against the Company in Montana state court alleging, fraud and abuse of process arising from the Company's business relationship with an entity that finances divorce proceedings. 

On

January 23, 2018,

the Company paid

$2.3

million as a global settlement in conjunction with the punitive class action complaint filed against the Company, and

one

of its

third

-party law firm servicers. This payment represented the Company's portion of the total settlement of

$4.6

million, which was split with the

third

-party law firm. See Note

9

- Commitments and Contingencies.

Special Dividend

On

February 5, 2018,

the Board of Directors of the Company declared a special cash dividend in the amount of

$5.30

per share with respect to its Common Stock, payable on

February 28, 2018

to holders of record of the Company’s Common Stock at the close of business on

February 16, 2018,

with an ex-dividend date of

March 1, 2018.

The aggregate payment to shareholders was approximately

$35

million.

IRS Examination

The Company's amended federal tax return for the year ended

September 30, 2014

and

2015

is currently being audited by the Internal Revenue Service.

US Tax Reform

 

On

December 22, 2017

the Tax Cuts and Jobs Act (the “Act”) was signed into law. Among other provisions, the Act reduces the Federal statutory corporate income tax rate from

35%

to

21%.

This rate reduction is expected to have a significant impact on our provisions for income taxes for periods beginning after

September 30, 2017,

including a

one

-time impact resulting from the revaluation of our deferred tax assets and liabilities to reflect the new lower rate. While we have

not

yet determined the net amount of the revaluation, we expect that it will be a significant component of our income tax provision for the

first

quarter of fiscal

2018.

XML

Significant Accounting Policies (Policies)

3 Months Ended

Dec. 31, 2016

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Basis of Presentation

 

The consolidated balance sheet as of

December 31, 2016,

the consolidated statements of operations for the

three

month periods ended

December 31, 2016

and

2015,

the consolidated statements of comprehensive (loss) income for the

three

month periods ended

December 31, 2016

and

2015,

the consolidated statements of stockholders’ equity as of and for the

three

months ended

December 31, 2016

and

2015,

and the consolidated statements of cash flows for the

three

month periods ended

December 31, 2016

and

2015,

are unaudited. The

September 

30,

2016

financial information included in this Amendment was derived from our audited financial statements included in our Annual Report on Form

10

-K/A for the fiscal year ended

September 

30,

2016.

In the opinion of management, all adjustments necessary to present fairly our financial position at

December 31, 2016,

the results of operations for the

three

month periods ended

December 31, 2016

and

2015

and cash flows for the

three

month periods ended

December 31, 2016

and

2015

have been made. The results of operations for the

three

month periods ended

December 31, 2016

and

2015

are

not

necessarily indicative of the operating results for any other interim period or the full fiscal year. The consolidated financial statements are prepared in accordance with US GAAP and industry practices.

The accompanying unaudited consolidated financial statements have been prepared in accordance with Rule 

10

-

01

of Regulation S-

X

promulgated by the Securities and Exchange Commission and therefore do

not

include all information and note disclosures required under generally accepted accounting principles. The Company suggests that these financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form

10

-K/A for the fiscal year ended

September 

30,

2016

filed with the SEC.

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates including management’s estimates of future cash flows and the resulting rates of return.

Consolidation, Policy [Policy Text Block]

Principles of Consolidation  

The consolidated financial statements include the accounts of Asta Funding, Inc. and its wholly owned and majority owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

Concentration Risk, Credit Risk, Policy [Policy Text Block]

Concentration of Credit Risk – Cash

and Restricted Cash

The Company considers all highly liquid investments with a maturity date of

three

months or less at the date of purchase to be cash equivalents.  

Cash balances are maintained at various depository institutions and are insured by the Federal Deposit Insurance Corporation (“FDIC”). The Company had cash balances with

five

banks at

December 31, 2016

that exceeded the balance insured by the FDIC by approximately

$1.4

million. Additionally,

three

foreign banks with an aggregate balance of

$0.5

million are

not

FDIC insured. There is an

$8.2

million and

$10

million aggregate balance in a domestic bank as of

December 31, 2016

and

September 30, 2016,

respectively, that is also

not

FDIC insured and has been reclassified to restricted cash in the balance sheets since these assets serve as collateral for the line of credit (see Note

7

– Non Recourse Debt). The Company does

not

believe it is exposed to any significant credit risk due to concentration of cash.

Equity Method Investments [Policy Text Block]

Equity method investment

Investee companies that are

not

consolidated, but over which the Company exercises significant influence, are accounted for under the equity method of accounting. Whether or

not

the Company exercises significant influence with respect to an investee depends on an evaluation of several factors including, among others, representation on the investee company's board of directors and ownership level, which is generally a

20%

to

50%

interest in voting securities of the investee company. Under the equity method of accounting, an investee company's accounts are

not

reflected within the Company's consolidated balance sheets and statements of operations, however, the Company's share of the earnings of the investee company is reflected as earnings and loss from equity method investment in the Company's consolidated statement of operations. The Company's carrying value in an equity method investee company is reflected on the Company's consolidated balance sheet, as equity method investment.

Pegasus is the Company's

50%

controlled equity investment with Pegasus Legal Funding (“PLF”). Under the operating agreement, the Company and PLF, each maintain

50%

voting rights of the entity, and the Company is

80%

owned by Asta. Based on these shared voting rights with PLF, the Company lacks requisite control of Pegasus, and therefore accounts for its investment in Pegasus under the equity method of accounting.

Serlefin BPO&O Peru S.A.C. (“Serlefin Peru”) is the Company's

49%

owned joint venture. The other

51%

is owned by

three

individuals who share common ownership with Serlefin BPO&O Serlefin S.A. (“Serlefin”). Each owner maintains voting rights equivalent to their share ownership, and the

51%

shareholders collectively manage the operations of the business. Based on the Company's ownership and voting rights, the Company lacks requisite control of Serlefin Peru, and therefore accounts for its investment in Serlefin Peru under the equity method of accounting.

Additionally, the Company and Serlefin jointly purchase international consumer debt portfolios under a purchase agreement. The Company and Serlefin purchase the portfolios on a pro-rata basis of

80%

and

20%,

respectively. The purchased portfolios are transferred to an administrative and payment trust, where the Company and Serlefin are trustees. Serlefin provides collection services to the trust, and receives a performance fee determined by the parties for each loan portfolio acquired. Serlefin received approximately

$0.2

million and

$0

in performance fees for the

three

months ended

December 31, 2016

and

2015,

respectively.

The carrying value of the investment in Serlefin Peru was

$0.2

million as of

December 31, 2016

and

September 30, 2016.

The Company has included the carrying value of this investment in other assets on its consolidated balance sheets. The cumulative net loss from our investment in Serlefin Peru through

December 31, 2016

was approximately

$0.1

million, and was

not

significant to the Company's consolidated statement of operations.

When the Company's carrying value in an equity method investee company is reduced to zero,

no

further losses are recorded in the Company's consolidated financial statements unless the Company guaranteed obligations of the investee company or has committed additional funding. When the investee company subsequently reports income, the Company will

not

record its share of such income until it equals the amount of its share of losses

not

previously recognized. There were

no

impairment losses recorded on our equity method investments for the

three

months ended 

December 

31,

2016

and

2015.

Personal Injury Claim Advances [Policy Text Block]

Personal Injury Claim Advances

Management assesses the quality of the personal injury claims portfolio through an analysis of the underlying personal injury fundings on a case by case basis. Cases are reviewed through periodic updates with attorneys handling the cases, as well as with

third

party research tools which monitor public filings, such as motions or judgments rendered on specific cases. The Company specifically reserves for those fundings where the underlying cases are identified as uncollectible, due to anticipated non-favorable verdicts and/or settlements at levels where recovery of the advance outstanding is unlikely. For cases that have

not

exhibited any specific negative collection indicators, the Company establishes reserves based on the historical collection rates of the Company’s fundings. Fee income on advances is reserved for on all cases where a specific reserve is established on the initially funded amount. In addition, management also monitors its historical collection rates on fee income and establishes reserves on fee income consistent with the historically experienced collection rates. Management regularly analyzes and updates the historical collection rates of its initially funded cases as well as its fee income.

Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]

Goodwill

Goodwill represents the excess of the purchase price over the fair value of the net assets acquired in a business combination, and is accounted for under ASC

350.

Goodwill has an indefinite useful life and is evaluated for impairment at the reporting-unit level on an annual basis during the

fourth

quarter or more frequently if events or changes in circumstances indicate potential impairment between annual measurement dates. The Company has the option of performing a qualitative assessment of impairment to determine whether any further quantitative testing for impairment is necessary. The initial qualitative approach assesses whether the existence of events or circumstances lead to a determination that it is more likely than

not

that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, the Company determines it is more likely than

not

that the fair value is less than carrying value, a

two

step quantitative impairment test is performed. A step

1

analysis involves calculating the fair value of the associated reporting unit and comparing it to the reporting unit’s carrying value. If the fair value of the reporting unit exceeds the carrying value of the reporting unit including goodwill and the carrying value of the reporting unit is positive, goodwill is considered

not

to be impaired and

no

further analysis is required. If the fair value of the reporting unit is less than its carrying value, step

2

of the impairment test must be performed. Step

2

involves calculating and comparing the implied fair value of the reporting unit’s goodwill with its carrying value. Impairment is recognized if the estimated fair value of the reporting unit is less than its net book value. Such loss is calculated as the difference between the estimated impaired fair value of goodwill and its carrying amount. The goodwill of the Company consists of

$1.4

million from the purchase of VATIV. Additionally, the Company has goodwill of

$1.4

million from the purchase of CBC, which is included under assets related to discontinued operations on the consolidated balance sheet.

Reclassification, Policy [Policy Text Block]

Reclassifications

Certain prior period amounts in the accompanying consolidated financial statements have been reclassified to conform to the current year presentation. These reclassifications had

no

effect on previously reported net loss or shareholders’ equity.

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements

  

In

May 2014,

the FASB issued an update to ASC

606,

Revenue from Contracts with Customers, that will supersede virtually all existing revenue guidance. Under this update, an entity is required to recognize revenue upon transfer of promised goods or services to customers, in an amount that reflects the entitled consideration received in exchange for those goods or services. The guidance also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from the customer contracts. This update is effective for annual reporting periods beginning after

December 

15,

2017

including interim periods within that reporting period. Early application is permitted for annual reporting periods beginning after

December 

15,

2016,

including interim periods within that reporting period. Given the changes in the Company's business management is continuing to assess this new standard and the impact it will have on accounting for its revenues. 

In

January 2016,

the FASB issued ASU

No.

 

2016

-

01,

Financial Instruments-Overall (Subtopic

825

-

10

): Recognition and Measurement of Financial Assets and Financial Liabilities. The main objective in developing this update is enhancing the reporting model for financial instruments to provide users of financial statements with more decision-useful information. The amendments in this update address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. The effective date for this update is for annual reporting periods beginning after

December 

15,

2017,

including interim periods within that reporting period. The Company is currently evaluating the impact this update will have on its consolidated financial statements. 

In

February 2016,

the FASB issued ASU

No.

2016

-

02

Leases (Topic

842

) to amend lease accounting requirements and requires entities to generally recognize on the balance sheet operating and financing lease liabilities and corresponding right-of-use assets. The new standard will require significant additional disclosures about the amount, timing and uncertainty of cash flows from leases. The standard update is effective for fiscal years beginning after

December 

15,

2018

and interim periods within those years and early adoption is permitted. The standard is to be applied using a modified retrospective approach and includes a number of optional practical expedients that entities

may

elect to apply. The Company is currently evaluating the impact of adopting this update on its consolidated financial statements and expects that most of its operating leases will be subject to the accounting standard update and will recognize as operating lease liabilities and right-of-use assets upon adoption.  

In

March 2016,

the FASB issued ASU

No.

 

2016

-

09,

Compensation-Stock Compensation (Topic

718

): Improvements to Employee Share Based Payment Accounting, to simplify and improve areas of generally accepted accounting principles for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided to users of financial statements. The effective date for this update is for annual reporting periods beginning after

December 

15,

2016,

including interim periods within that reporting period. The Company is currently evaluating the impact this update will have on its consolidated financial statements.  

In

June 2016,

the FASB issued ASU

2016

-

13,

Financial Instruments-Credit Losses (Topic

326

): Measurement of Credit Losses on Financial Instruments.  The ASU requires an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Additionally, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration.  For the Company, this update will be effective for interim periods and annual periods beginning after

December 15, 2019.

Upon adoption, the Company will accelerate the recording of its credit losses in its financial statements. 

In

August 2016,

the FASB issued ASU 

2016

-

15,

Statement of Cash Flows (Topic

230

): Classification of Certain Cash Receipts and Cash Payments.  This ASU will make

eight

targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The new standard is effective for fiscal years beginning after

December 15, 2017.

Early adoption is permitted. The new standard will require adoption on a retrospective basis unless it is impracticable to apply, in which case the Company would be required to apply the amendments prospectively as of the earliest date practicable. The Company is in the process of evaluating the provisions of the ASU, but does

not

expect it to have a material effect on the Company’s consolidated statements of cash flows.

In

November 2016,

the FASB issued ASU

No.

2016

-

18,

Restricted Cash ("ASU

2016

-

18"

), to require that restricted cash and restricted cash equivalents be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total cash amounts shown on the statement of cash flows. Consequently, transfers between cash and restricted cash will

not

be presented as a separate line item in the operating, investing or financing sections of the cash flow statement. ASU

2016

-

18

does

not

provide a definition of restricted cash or restricted cash equivalents. The new guidance will only be applicable to amounts described by the Company as restricted cash. We adopted ASU

2016

-

18

on

October 1, 2016,

the effect of which was a change in presentation on our consolidated statement of cash flows, but

not

on our consolidated financial results.

In

January 2017,

the FASB issued ASU

2017

-

04

Intangibles – Goodwill and Other (Topic

350

): Simplifying the Test for Goodwill Impairment. The objective of this update is to simplify the subsequent measurement of goodwill, by eliminating step

2

from the goodwill impairment test. The amendments in this update are effective for annual periods beginning after

December 15, 2019,

and interim periods within those fiscal years. The Company does

not

believe this update will have a material impact on its consolidated financial statements.

XML

Note 1 - Restatement of Financial Statements (Tables)

3 Months Ended

Dec. 31, 2016

Notes Tables

Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]

	Consolidated Balance Sheet
	December 31, 2016
	As Reported			De-Consolidation of Pegasus ( 1 )			Adjustments				Restated
ASSETS
Cash and cash equivalents	$	4,770,000		$	(1,065,000	)	$	(9,000	)	(2)(6)	$	3,696,000
Restricted cash		8,165,000			—			—				8,165,000
Available for sale investments (at fair value)		55,045,000			—			—				55,045,000
Consumer receivables acquired for liquidation (at net realizable value)		13,243,000			—			219,000		(2)		13,462,000
Investment in personal injury claims, net		47,875,000			(47,875,000	)		—				—
Other investments, net		3,354,000			—			—				3,354,000
Due from third party collection agencies and attorneys		1,035,000			—			(31,000	)	(2)		1,004,000
Prepaid and income taxes receivable		5,267,000			—			(371,000	)	(8)		4,896,000
Furniture and equipment, net		176,000			—			—				176,000
Equity method investment		—			48,720,000			421,000		(7)		49,141,000
Deferred income taxes		16,585,000			—			(1,258,000	)	(2)(8)		15,327,000
Goodwill		1,410,000			—			—				1,410,000
Other assets		6,203,000			(109,000	)		187,000		(2)		6,281,000
Assets related to discontinued operations		94,335,000			—			191,000		(5)(6)		94,526,000
Total assets	$	257,463,000		$	(329,000	)	$	(651,000	)		$	256,483,000
LIABILITIES
Other liabilities		5,666,000			(1,133,000	)		198,000		(2)		4,731,000
Liabilities related to discontinued operations		73,516,000			—			653,000		(5)		74,169,000
Total liabilities		79,182,000			(1,133,000	)		851,000				78,900,000
Commitments and contingencies
STOCKHOLDERS’ EQUITY
Preferred stock		—			—			—				—
Common stock		133,000			—			—				133,000
Additional paid-in capital		67,020,000			—			8,000		(6)		67,028,000
Retained earnings		126,406,000			—			(2,614,000	)	(2)(3) (4)(5) (6)(7)(8)		123,792,000
Accumulated other comprehensive loss		(1,549,000	)		—			1,104,000		(2)		(445,000	)
Treasury stock (at cost)		(12,925,000	)		—			—				(12,925,000	)
Non-controlling interest		(804,000	)		804,000			—				—
Total stockholders’ equity		178,281,000			804,000			(1,502,000	)			177,583,000
Total liabilities and stockholders’ equity	$	257,463,000		$	(329,000	)	$	(651,000	)		$	256,483,000

	As Reported			De-Consolidation of Pegasus ( 1 )			Adjustments				Restated
Revenues:
Finance income, net	$	4,001,000		$	—		$	94,000		(2)	$	4,095,000
Personal injury claims income		2,302,000			(2,302,000	)		—
Disability fee income		1,354,000			—			—				1,354,000
Total revenues		7,657,000			(2,302,000	)		94,000				5,449,000
Other income		544,000			—			(93,000	)	(2)		451,000
		8,201,000			(2,302,000	)		1,000				5,900,000
General and administrative		9,556,000			(2,195,000	)		(66,000	)	(2)(6)		7,295,000
Interest		2,000			(2,000	)		—				—
Earnings from equity method investment		—			(84,000	)		(320,000	)	(7)		(404,000	)
		9,558,000			(2,281,000	)		(386,000	)			6,891,000
(Loss) from continuing operations before income tax		(1,357,000	)		(21,000	)		387,000				(991,000	)
Income tax (benefit)/expense		(555,000	)		—			1,252,000		(8)		697,000
Net (loss) income from continuing operations		(802,000	)		(21,000	)		(865,000	)			(1,688,000	)
Net loss from discontinued operations, net of income tax		(834,000	)		—			(424,000	)	(3)(5)(8)		(1,258,000	)
Less: net income attributable to non-controlling interests		21,000			(21,000	)
Net loss attributable to Asta Funding, Inc.	$	(1,657,000	)	$	—		$	(1,289,000	)		$	(2,946,000	)
Basic and diluted loss per share:
Continuing operations	$	(0.07	)								$	(0.14	)
Discontinued operations		(0.07	)									(0.11	)
	$	(0.14	)								$	(0.25	)

				Consolidated Statement of Comprehensive Loss
				For the Three Months Ended December 31, 2016
	As Reported			De-Consolidation of Pegasus (1 )		Adjustments				Restated
Comprehensive income (loss) is as follows:
Net loss	$	(1,657,000	)	$	—	$	(1,289,000	)		$	(2,946,000	)
Net unrealized securities (loss) gain, net of tax		(1,239,000	)		—		—				(1,239,000	)
Reclassification adjustments for securities sold, net of tax		(27,000	)		—		—				(27,000	)
Foreign currency translation, net of tax		(369,000	)		—		387,000		(2)(6)		18,000
Other comprehensive loss		(1,635,000	)		—		387,000				(1,248,000	)
Total comprehensive loss	$	(3,292,000	)	$	—	$	(902,000	)		$	(4,194,000	)

Consolidated Statement of Cash Flows For the Three Months Ended December 31, 2016
	As Reported			Adjustments				Restated
Cash flows from operating activities:
Net loss from continuing operations	$	(823,000	)	$	(865,000	)		$	(1,688,000	)
Net loss from discontinued operations		(834,000	)		(424,000	)			(1,258,000	)
		(1,657,000	)		(1,289,000	)			(2,946,000	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		105,000			(79,000	)			26,000
Deferred income taxes		(211,000	)		631,000		(2)(8)		420,000
Stock based compensation		(6,000	)		—				(6,000	)
Loss on sale of available-for-sale securities		45,000			—				45,000
Unrealized gain on other investments		(18,000	)		—				(18,000	)
Unrealized foreign exchange loss on other investments		254,000			—				254,000
Earnings from equity method investment		—			(404,000	)	(7)		(404,000	)
Changes in:
Prepaid and income taxes receivable		(4,387,000	)		205,000		(8)		(4,182,000	)
Due from third party collection agencies and attorneys		(30,000	)		70,000		(2)		40,000
Other assets		498,000			(191,000	)	(2)		307,000
Income tax payable		(252,000	)		252,000		(8)		—
Other liabilities		373,000			388,000		(2)		761,000
Non-controlling interest		21,000			(21,000	)	(1)		—
Net cash used in operating activities of discontinued operations		(391,000	)		760,000		(3)(5)		369,000
Net cash used in operating activities		(5,656,000	)		322,000				(5,334,000	)
Cash flows from investing activities:
Purchase of consumer receivables acquired for liquidation		(2,213,000	)		—				(2,213,000	)
Principal collected on receivables acquired for liquidation		2,641,000			(512,000	)	(2)(4)(5)(6)		2,129,000
Purchase of available-for-sale securities		(7,568,000	)		—				(7,568,000	)
Proceeds from sales of available-for-sale securities		7,132,000			—				7,132,000
Investments in personal injury claims — advances		(5,178,000	)		5,178,000		(1)		—
Investments in personal injury claims — receipts		5,592,000			(5,592,000	)	(1)		—
Increase in equity method investment		—			(155,000	)	(1)		(155,000	)
Capital expenditures		(6,000	)		—				(6,000	)
Cash flows from investing activities related to discontinued operations		(2,632,000	)		—				(2,632,000	)
Net cash used in investing activities		(2,232,000	)		(1,081,000	)			(3,313,000	)
Cash flows from financing activities:
Distributions to non-controlling interest		(180,000	)		180,000		(1)		—
Cash flows from financing activities related to discontinued operations		4,131,000			—				4,131,000
Net cash used in financing activities		3,951,000			180,000				4,131,000
Foreign currency effect on cash		—			52,000		(2)		52,000
Net decrease in cash, cash equivalents and restricted cash including cash, cash equivalents classified within assets related to discontinued operations		(3,937,000	)		(527,000	)			(4,464,000	)
Less: net increase in cash, cash equivalents and restricted cash classified within assets related to discontinued operations		43,000			—				43,000
Net decrease in cash , cash equivalents and restricted cash		(3,894,000	)		(527,000	)	(1)(2)(3)(4)(5)(6)(7)(8)		(4,421,000	)
Cash , cash equivalents and restricted cash at beginning of period		16,829,000			(547,000	)			16,282,000
Cash , cash equivalents and restricted cash at end of period	$	12,935,000		$	(1,074,000	)		$	11,861,000

Increase (decrease) in:	Impact from September 30, 2016 10K/A filing			Current period impact			Cumulative net impact
Cash and cash equivalents	$	3,000		$	(10,000	)	$	(7,000	)
Consumer receivables acquired for liquidation		(245,000	)		464,000			219,000
Due from third party collection agencies and attorneys		45,000			(76,000	)		(31,000	)
Deferred income taxes		(722,000	)		(199,000	)		(921,000	)
Other assets		(33,000	)		220,000			187,000
Other liabilities		(18,000	)		216,000			198,000
Accumulated other comprehensive loss		718,000			386,000			1,104,000
Retained earnings		(1,653,000	)		(203,000	)		(1,856,000	)

Increase (decrease) in:	Impact from September 30 , 2016 10K/A filing			Current period impact			Cumulative net impact
Assets related to discontinued operations	$	307,000		$	(161,000	)	$	146,000
Liabilities related to discontinued operations		756,000			(103,000	)		653,000
Retained earnings		(442,000	)		(60,000	)		(502,000	)

Increase (decrease) in:	Impact from September 30, 2016 10K/A filing			Current period impact			Cumulative net impact
Cash and cash equivalents	$	-		$	(2,000	)	$	(2,000	)
Other liabilities		269,000			(269,000	)		-
Retained earnings		(137,000	)		270,000			133,000
Assets related to discontinued operations		45,000			-			45,000
Additional paid in capital		8,000			-			8,000

XML

Note 3 - Available-for-sale Investments (Tables)

3 Months Ended

Dec. 31, 2016

Notes Tables

Available-for-sale Securities [Table Text Block]

	Amortized Cost		Unrealized Gains		Unrealized Losses			Fair Value
December 31, 2016	$	56,115,000	$	29,000	$	(1,099,000	)	$	55,045,000
September 30, 2016	$	55,723,000	$	1,089,000	$	(49,000	)	$	56,763,000

XML

Note 4 - Consumer Receivables Acquired for Liquidation (Tables)

3 Months Ended

Dec. 31, 2016

Notes Tables

Schedule of Consumer Receivables after Liquidation [Table Text Block]

	For the Three Months Ended December 31,
	2016 (restated)			2015
Balance, beginning of period	$	13,427,000		$	15,056,000
Acquisitions of receivable portfolios		2,213,000			6,051,000
Net cash collections from collection of consumer receivables acquired for liquidation		(6,015,000	)		(7,377,000	)
Net cash collections represented by account sales of consumer receivables acquired for liquidation		(190,000	)		—
Effect of foreign currency translation		(68,000	)		(27,000	)
Finance income recognized		4,095,000			5,106,000
Balance, end of period	$	13,462,000		$	18,809,000
Finance income as a percentage of collections		66.00	%		69.22	%

Schedule of Collections on Gross Basis [Table Text Block]

	For the Three Months Ended December 31 ,
	2016 (restated)		2015
Gross collections (1)	$	11,400,000	$	12,245,000
Commissions and fees (2)		5,195,000		4,868,000
Net collections	$	6,205,000	$	7,377,000

XML

Note 5 - Litigation Funding (Tables)

3 Months Ended

Dec. 31, 2016

Notes Tables

Equity Method Investments [Table Text Block]

	December 31, 2016					September 30, 2016
	Carrying Value		Ownership Percentage			Carrying Value		Ownership Percentage
Pegasus Funding, LLC	$	49,141,000		80	%	$	48,582,000		80	%

Equity Method Investment, Summarized Financial Information [Table Text Block]

	Condensed S tatement of O perations I nformation
	Three months ended
	December 31, 2016		December 31 , 201 5
Personal injury claims income	$	2,302,000	$	3,085,000
Operating expenses		1,797,000		1,218,000
Income from operations	$	505,000	$	1,867,000
Earnings from equity method investment	$	404,000	$	1,494,000

	Condensed Balance Sheet I nformation
	December 31, 2016		September 30, 2016
Cash	$	1,065,000	$	539,000
Investment in personal injury claims		48,275,000		48,289,000
Other assets		109,000		188,000
Total Assets	$	49,449,000	$	49,016,000
Due to Asta	$	34,560,000	$	34,404,000
Other liabilities		1,006,000		1,053,000
Equity		13,883,000		13,559,000
Total Liabilities and Equity	$	49,449,000	$	49,016,000

XML

Note 6 - Furniture and Equipment (Tables)

3 Months Ended

Dec. 31, 2016

Notes Tables

Property, Plant and Equipment [Table Text Block]

	December 31 , 2016		September 30, 2016
Furniture	$	273,000	$	273,000
Equipment		235,000		235,000
Software		1,356,000		1,350,000
		1,864,000		1,858,000
Less accumulated depreciation and amortization		1,688,000		1,662,000
Balance, end of period	$	176,000	$	196,000

XML

Note 8 - Discontinued Operations (Tables)

3 Months Ended

Dec. 31, 2016

Notes Tables

Disposal Groups, Including Discontinued Operations [Table Text Block]

	Three months ended
	December 31, 201 6			December 31, 201 5
Revenues:
Unrealized (loss) gain on structured settlements	$	(1,682,000	)	$	1,527,000
Interest income on structured settlements		1,901,000			1,227,000
Total revenues		219,000			2,754,000
Other income		15,000			—
		234,000			2,754,000
Expenses:
General and administrative expenses		1,488,000			1,379,000
Interest expense		932,000			726,000
		2,420,000			2,105,000
(Loss) income from discontinued operations before income tax		(2,186,000	)		649,000
Income tax (benefit) expense from discontinued operations		(928,000	)		273,000
(Loss) income from discontinued operations before non-controlling interest		(1,258,000	)		376,000
Non-controlling interest		—			104,000
(Loss) income from discontinued operations, net of income tax	$	(1,258,000	)	$	272,000

	Dec ember 3 1 , 201 6			Sept ember 3 0 , 2016
Cash and cash equivalents	$	1,241,000	(1)	$	1,198,000
Restricted cash		499,000			499,000
Structured settlements		88,277,000			86,091,000
Furniture and equipment, net		43,000			47,000
Goodwill		1,405,000			1,405,000
Other assets		3,061,000			2,266,000
Total assets related to discontinued operations	$	94,526,000		$	91,506,000
Other debt - CBC		71,566,000			67,435,000
Other liabilities		2,603,000			1,803,000
Total liabilities related to discontinued operations	$	74,169,000		$	69,238,000

Structured Settlements [Table Text Block]

	December 31 , 2016			September 30, 2016
Maturity (1) (2)	$	143,544,000		$	133,059,000
Unearned income		(55,267,000	)		(46,968,000	)
Structured settlements, net	$	88,277,000		$	86,091,000

Schedule of Fair Value of Debt [Table Text Block]

	Interest Rate			December 31 , 2016		September 30, 2016
Notes payable secured by settlement receivables with principal and interest outstanding payable until June 2025		8.75	%	$	1,817,000	$	1,862,000
Notes payable secured by settlement receivables with principal and interest outstanding payable until August 2026		7.25	%		4,138,000		4,242,000
Notes payable secured by settlement receivables with principal and interest outstanding payable until April 2032		7.125	%		3,948,000		3,987,000
Notes payable secured by settlement receivables with principal and interest outstanding payable until February 2037		5.39	%		18,601,000		18,978,000
Notes payable secured by settlement receivables with principal and interest outstanding payable until March 2034		5.07	%		14,193,000		14,507,000
Notes payable secured by settlement receivables with principal and interest outstanding payable until February 2043		4.85	%		13,605,000		13,705,000
$25,000,000 revolving line of credit		4.1	%		15,264,000		10,154,000
Encumbered structured settlements					71,566,000		67,435,000
Structured settlements not encumbered					16,711,000		18,656,000
Total structured settlements				$	88,277,000	$	86,091,000

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]

September 30, 2017 (9 months)	$	7,635,000
September 30, 2018		8,556,000
September 30, 2019		8,914,000
September 30, 2020		8,371,000
September 30, 2021		9,105,000
Thereafter		100,963,000
Total	$	143,544,000

XML

Note 12 - Net (Loss) Income Per Share (Tables)

3 Months Ended

Dec. 31, 2016

Notes Tables

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	Three Months Ended December 31, 2016								Three Months Ended December 31, 2015
	Net Loss			Weighted Average Shares		Per Share Amount			Net Income		Weighted Average Shares		Per Share Amount
Net (loss) income from continuing operations	$	(1,688,000	)		11,876,224	$	(0.14	)	$	1,291,000		12,155,421	$	0.11
Net (loss) income from discontinued operations		(1,258,000	)		11,876,224		(0.11	)		272,000		12,155,421		0.02
	$	(2,946,000	)			$	(0.25	)	$	1,563,000			$	0.13
Effect of Dilutive Stock					—		—					276,465		—
Diluted	$	(2,946,000	)		11,876,224	$	(0.25	)	$	1,563,000		12,431,886	$	0.13

XML

Note 13 - Stock Based Compensation (Tables)

3 Months Ended

Dec. 31, 2016

Notes Tables

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

Risk-free interest rate	0.24	%
Expected term (years)	6.25
Expected volatility	23.4	%
Dividend yield	0.00	%

XML

Note 14 - Stock Option Plans (Tables)

3 Months Ended

Dec. 31, 2016

Notes Tables

Share-based Compensation, Stock Options, Activity [Table Text Block]

	Three Months Ended December 31 ,
	2016					2015
	Number Of Shares			Weighted Average Exercise Price		Number of Shares		Weighted Average Exercise Price
Outstanding options at the beginning of period		949,667		$	8.47		1,043,566	$	8.47
Options granted		—			—		67,100		7.93
Options exercised		—			—		—		—
Options forfeited/cancelled		(52,500	)		14.16		—		—
Outstanding options at the end of period		897,167		$	8.14		1,110,666	$	8.43
Exercisable options at the end of period		844,829		$	8.15		965,325	$	8.46

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

			Options Outstanding						Options Exercisable
Range of Exercise Price			Number of Shares Outstanding		Weighted Remaining Contractual Life (in Years)		Weighted Average Exercise Price		Number of Shares Exercisable		Weighted Average Exercise Price
$2.8751	-	$5.7500		3,800		2.3	$	2.95		3,800	$	2.95
$5.7501	-	$8.6250		768,867		5.2		7.96		716,529		7.96
$8.6251	-	$11.5000		124,500		6.1		9.40		124,500		9.40
				897,167		5.3	$	8.14		844,829	$	8.15

Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]

	Three Months Ended December 31 ,
	2016				2015
	Number of Shares		Weighted Average Grant Date Fair Value		Number of Shares			Weighted Average Grant Date Fair Value
Unvested at the beginning of period		—	$	—		44,107		$	9.28
Awards granted		—		—		5,000			7.89
Vested		—		—		(34,107	)		9.57
Forfeited		—		—		—			—
Unvested at the end of period		—	$	—		15,000		$	7.92

XML

Note 16 - Fair Value of Financial Measurements and Disclosures (Tables)

3 Months Ended

Dec. 31, 2016

Notes Tables

Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]

	December 31, 2016				September 30, 2016
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets
Cash equivalents (Level 1)	$	936,000	$	936,000	$	923,000	$	923,000
Other investment, net (Level 1)		3,354,000		3,354,000		3,590,000		3,590,000
Available-for-sale investments (Level 1)		55,045,000		55,045,000		56,763,000		56,763,000
Consumer receivables acquired for liquidation (Level 3)		13,462,000		45,061,000		13,427,000		47,233,000

	December 31, 2016				September 30, 2016
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial asset
Structured settlements (Level 3)		88,277,000		88,277,000		86,091,000		86,091,000

Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]

	Fair Value		Valuation Technique	Significant Unobservable Input	Weighted Average Rate
Structured settlements at fair value	$	88,277,000	Discounted cash flow	Discount rate	4.83%	-	5.36%

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

	Structured Settlement
Balance at September 30, 2016	$	86,091,000
Fair value adjustment		(3,611,000	)
Total gains included in earnings		1,598,000
Purchases		4,595,000
Interest accreted		1,567,000
Payments received		(1,963,000	)
Total	$	88,277,000
The amount of total losses for the three month period included in earnings attributable to the change in unrealized losses relating to assets held at December 31, 2016	$	(1,682,000	)

Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Table Text Block]

Total losses included in the three months ended December 31, 2016	$	(1,682,000	)
Change in unrealized losses relating to assets still held at December 31, 2016	$	(1,682,000	)

XML

Note 17 - Segment Reporting (Tables)

3 Months Ended

Dec. 31, 2016

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

(Dollars in millions)	Consumer Receivables		GAR Disability Advocates			(Equity Investment) Personal Injury Claims (2)		Corporate (3)			Total
Three Months Ended December 31, 2016:
Revenues	$	4.1	$	1.4		$	—	$	—		$	5.5
Other income		—		—			—		0.4			0.4
Segment profit (loss)		3.2		(0.9	)		0.4		(3.7	)		(1.0	)
Segment Assets(1)		17.6		1.4			49.2		188.3	(4)		256.5
2015:
Revenues		5.1		0.7			—		—			5.8
Other income		—		—			—		0.4			0.4
Segment profit (loss)		4.7		(1.8	)		1.5		(2.5	)		1.9
Segment Assets(1)		24.8		2.4			36.42		174.2	(4)		237.8

XML

Note 18 - Accumulated Other Comprehensive (Loss) Income (Tables)

3 Months Ended

Dec. 31, 2016

Notes Tables

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

	Three Months ended December 31, 201 6								Year Ended September 30, 2016
	Unrealized gain (loss) on marketable securities			Foreign currency translation, net		Total			Unrealized gain (loss) on marketable securities			Foreign currency translation, net			Total
Beginning Balance	$	624,000		$	179,000	$	803,000		$	(205,000	)	$	225,000		$	20,000
Change in unrealized (losses) gains on foreign currency translation, net of tax benefit/(expense) of ($12,000) and $25,000 at December 31 2016, and September 30, 2016, respectively.		-			18,000		18,000			-			(46,000	)		(46,000	)
Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense) of $826,000 and ($529,000) at December 31 2016, and September 30, 2016, respectively.		(1,239,000	)		-		(1,239,000	)		867,000			-			867,000
Amount reclassified from accumulated other comprehensive loss, net of tax benefit of $18,000 and $24,000 at December 31 2016, and September 30, 2016, respectively.		(27,000	)		-		(27,000	)		(38,000	)		-			(38,000	)
Net current-period other comprehensive (loss) income		(1,266,000	)		18,000		(1,248,000	)		829,000			(46,000	)	$	783,000
Ending balance	$	(642,000	)	$	197,000	$	(445,000	)	$	624,000		$	179,000		$	803,000

XML

Note 1 - Restatement of Financial Statements (Details Textual) - USD ($)		3 Months Ended		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2016
Cash and Cash Equivalents, at Carrying Value, Ending Balance		$ 3,696,000		$ 6,282,000
Other Long-term Investments
Other Assets, Total		6,281,000		6,585,000
Other Liabilities, Total		4,731,000		3,987,000
Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance
Equity Method Investments		49,141,000		48,582,000
Revenues, Total		5,900,000	$ 6,157,000
General and Administrative Expense, Total		7,295,000	5,729,000
Net Income (Loss) Attributable to Noncontrolling Interest, Total
Income (Loss) from Equity Method Investments, Total		404,000	1,494,000
Revenue, Net (Deprecated 2018-01-31)		5,449,000	5,765,000
Other Nonoperating Income		451,000	392,000
Disposal Group, Including Discontinued Operation, Assets, Total		94,526,000		91,506,000
Retained Earnings (Accumulated Deficit), Ending Balance		123,792,000		126,738,000
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net		13,462,000	18,800,000	13,427,000
Income Taxes Receivable		4,896,000		714,000
Deferred Tax Assets, Net of Valuation Allowance, Total		15,327,000		14,903,000
Income Tax Expense (Benefit), Total		697,000	$ 631,000
Pegasus Funding LLC [Member]
Equity Method Investments		$ 49,141,000		$ 48,582,000
Equity Method Investment, Ownership Percentage		80.00%		80.00%
Restatement Adjustment [Member]
Income (Loss) from Equity Method Investments, Total	[1]	$ 404,000
Restatement Adjustment [Member] | Accounting For Investment in Pegasus Under The Equity Method [Member]
Cash and Cash Equivalents, at Carrying Value, Ending Balance	[2],[3],[4]	(1,065,000)
Other Long-term Investments	[2]	(47,875,000)
Other Assets, Total	[2]	(109,000)
Other Liabilities, Total	[2]	(1,133,000)
Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance	[2]	804,000
Equity Method Investments	[2]	48,720,000
Revenues, Total	[2]	(2,302,000)
General and Administrative Expense, Total		(2,197,000)
Net Income (Loss) Attributable to Noncontrolling Interest, Total	[2]	(21,000)
Income (Loss) from Equity Method Investments, Total	[2]	84,000
Revenue, Net (Deprecated 2018-01-31)	[2]	(2,302,000)
Other Nonoperating Income	[2]
Disposal Group, Including Discontinued Operation, Assets, Total	[2]
Retained Earnings (Accumulated Deficit), Ending Balance	[2]
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net	[2]
Income Taxes Receivable	[2]
Deferred Tax Assets, Net of Valuation Allowance, Total	[2]
Income Tax Expense (Benefit), Total	[2]
Restatement Adjustment [Member] | Foreign Currency Gains/Losses On Intercompany Balances and Transactions Corrections [Member]
General and Administrative Expense, Total		204,000
Revenue, Net (Deprecated 2018-01-31)		94,000
Other Nonoperating Income		(93,000)
Restatement Adjustment [Member] | Revision of The Fair Market of The Structured Settlements [Member]
Structured Settlements, Fair Value		(2,600,000)
Prepaid Income Taxes and Deferred Tax Assets		1,000,000
Disposal Group, Including Discontinued Operation, Assets, Total				$ 727,000
Retained Earnings (Accumulated Deficit), Ending Balance		727,000
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest, Total		(727,000)		727,000
Restatement Adjustment [Member] | Addition of Certain Unallocated Payments [Member]
Retained Earnings (Accumulated Deficit), Ending Balance				(648,000)
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net				$ (648,000)
Restatement Adjustment [Member] | Correction Of An Amortizable Asset and Related Liability In Conjunction With An Asset Purchase Agreement Entered Into In June 2015 With a Related Party [Member]
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest, Total		(60,000)
Restatement Adjustment [Member] | Correction of Other Liabilities That Had Not Been Properly Accrued To The Correct Period And/Or In Improper Amounts [Member]
General and Administrative Expense, Total		(270,000)
Restatement Adjustment [Member] | Correction of Personal Injury Claims Assets Balance of Equity Investment [Member] | Pegasus Funding LLC [Member]
Equity Method Investments		320,000
Income (Loss) from Equity Method Investments, Total		320,000
Personal Injury Claims Assets		400,000
Restatement Adjustment [Member] | Correction of Personal Injury Claims Assets Balance of Equity Investment, Impact of Related Accruals [Member] | Pegasus Funding LLC [Member]
Equity Method Investments		101,000
Restatement Adjustment [Member] | Tax Impact of Errors Correction [Member]
Income Taxes Receivable		(371,000)
Deferred Tax Assets, Net of Valuation Allowance, Total		(337,000)
Income Tax Expense (Benefit), Total		1,252,000
Discontinued Operation, Tax Effect of Discontinued Operation, Total		$ (363,000)

[1] The Company identified the personal injury claims asset balance of Pegasus was determined to be understated at December 31, 2016 by $400,000. The correction of these error resulted in an increase in equity method investment of $320,000, representing the Company's 80% financial interest, as of December 31, 2016. As a result of the correction of this error, earnings from the equity investment in Pegasus and income from continuing operations increased $320,000 for the three months ended December 31, 2016. Additionally the equity method investment was increased $101,000 to reflect the impact of related accruals in the September 30, 2016 10K/A.

[2] In connection with the Company determining it lacked the requisite control to consolidate Pegasus during the Non-Reliance Period, the Company has now accounted for its investment in Pegasus under the equity method in accordance with US GAAP. On the Company's December 31, 2016 consolidated balance sheet, this resulted in (i) a decrease in cash of $1,065,000; (ii) a decrease in the investment in personal injury claims of $47,875,000; (iii) a decrease in other assets of $109,000; (iv) a decrease in other liabilities of $1,133,000; (v) an decrease in non-controlling interest of $804,000, offset by a corresponding increase in the equity method investment of $48,720,000. On the Company's consolidated statement of operations, this resulted in (i) a reduction in total revenues of $2,302,000; (ii) a reduction in expenses of $2,197,000; (iii) a decrease in the income attributable to the non-controlling interest of $21,000; and (iv) a decrease in earnings from equity method investment of $84,000 for the three months ended December 31, 2016. This change to the equity method of accounting had no effect on net (loss) income during the Non-Reliance Period.

[3] The Company determined that it had not previously accounted for certain foreign currency gains/losses on intercompany balances and transactions in accordance with US GAAP. The Company improperly accounted for the foreign currency effect of certain transactions as if they were long-term investments by including the foreign currency effect in accumulated other comprehensive income instead of properly recording the effect as operating expenses as required under ASC 830. The correction to properly apply US GAAP to these foreign currency matters resulted in increased revenue of $94,000, a decrease in other income of $93,000, and a increase in general and administrative expenses of $204,000 for the three months ended December 31, 2016. ASTA FUNDING, INC. AND SUBSIDIARIES The correction of foreign currency transaction on the consolidated balance sheet are as follows: Increase (decrease) in: Impact from September 30, 2016 10K/A filing Current period impact Cumulative net impact Cash and cash equivalents $ 3,000 $ (10,000 ) $ (7,000 ) Consumer receivables acquired for liquidation (245,000 ) 464,000 219,000 Due from third party collection agencies and attorneys 45,000 (76,000 ) (31,000 ) Deferred income taxes (722,000 ) (199,000 ) (921,000 ) Other assets (33,000 ) 220,000 187,000 Other liabilities (18,000 ) 216,000 198,000 Accumulated other comprehensive loss 718,000 386,000 1,104,000 Retained earnings (1,653,000 ) (203,000 ) (1,856,000 )

[4] The Company identified other transactions that had not been properly accounted for in the correct period and/or for improper amounts and/or improper accounts. The adjustments of these errors were immaterial on an individual basis. The correction of this error resulted in decreased general and administrative expense of $270,000 for the three months ended December 31, 2016. The correction of these errors on the consolidated balance sheet are as follows: Increase (decrease) in: Impact from September 30, 2016 10K/A filing Current period impact Cumulative net impact Cash and cash equivalents $ - $ (2,000 ) $ (2,000 ) Other liabilities 269,000 (269,000) - Retained earnings (137,000 ) 270,000 133,000 Assets related to discontinued operations 45,000 - 45,000 Additional paid in capital 8,000 - 8,000

XML

Note 1 - Restatement of Financial Statements - Adjustments to the Financial Statements (Details) - USD ($)		3 Months Ended				12 Months Ended
		Dec. 31, 2016		Dec. 31, 2015		Sep. 30, 2016	Sep. 30, 2015
Cash and cash equivalents		$ 3,696,000				$ 6,282,000
Restricted cash		8,165,000	[1]			10,000,000
Available for sale investments (at fair value)		55,045,000				56,763,000
Consumer receivables acquired for liquidation (at net realizable value)		13,462,000		$ 18,800,000		13,427,000
Investment in personal injury claims, net
Other investments, net		3,354,000				3,590,000
Due from third party collection agencies and attorneys		1,004,000				1,050,000
Prepaid and income taxes receivable		4,896,000				714,000
Furniture and equipment, net		176,000				196,000
Equity method investment		49,141,000				48,582,000
Deferred income taxes		15,327,000				14,903,000
Goodwill		1,410,000				1,410,000
Other assets		6,281,000				6,585,000
Assets related to discontinued operations		94,526,000				91,506,000
Total assets		256,483,000		237,800,000	[2]	255,008,000
Other liabilities		4,731,000				3,987,000
Liabilities related to discontinued operations		74,169,000				69,238,000
Total liabilities		78,900,000				73,225,000
Commitments and contingencies
Preferred stock
Common stock		133,000				133,000
Additional paid-in capital		67,028,000				67,034,000
Retained earnings		123,792,000				126,738,000
Accumulated other comprehensive (loss) income		(445,000)				803,000
Treasury stock (at cost)		(12,925,000)				(12,925,000)
Non-controlling interest
Total stockholders’ equity		177,583,000		177,696,000		181,783,000	$ 183,407,000
Total liabilities and stockholders’ equity		256,483,000				255,008,000
Finance income, net		4,095,000		5,106,000
Personal injury claims income
Disability fee income		1,354,000		659,000
Total revenues		5,449,000		5,765,000
Other Nonoperating Income		451,000		392,000
Revenues, Total		5,900,000		6,157,000
General and administrative		7,295,000		5,729,000
Interest
Earnings from equity method investment		(404,000)		(1,494,000)
		6,891,000		4,235,000
(Loss) from continuing operations before income tax		(991,000)
Income Tax Expense (Benefit), Total		697,000		631,000
Net (loss) income from continuing operations		(1,688,000)		1,291,000
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent, Total		(1,258,000)		272,000
Net Income (Loss) Attributable to Noncontrolling Interest, Total
Net loss attributable to Asta Funding, Inc.		$ (2,946,000)
Continuing operations (in dollars per share)		$ (0.14)
Discontinued operations (in dollars per share)		(0.11)
(in dollars per share)		$ (0.25)
Net loss		$ (2,946,000)		1,563,000
Net unrealized securities (loss) gain, net of tax		(1,239,000)		330,000
Amount reclassified from other comprehensive loss		(27,000)		(20,000)
Foreign currency translation, net		18,000		14,000
Other comprehensive loss		(1,248,000)		324,000
Total comprehensive loss		(4,194,000)		1,887,000
Net (loss) income from continuing operations		(1,688,000)		1,291,000
Net (loss) income from discontinued operations, net of income tax		(1,258,000)		272,000
Net (loss) income		(2,946,000)		1,563,000
Depreciation and amortization		26,000		90,000
Deferred income taxes		420,000		95,000
Stock based compensation		(6,000)		278,000
Loss on sale of available-for-sale securities		45,000		31,000
Unrealized gain on other investments		(18,000)		(62,000)
Unrealized foreign exchange loss on other investments		254,000		118,000
Earnings from equity method investment		(404,000)		(1,494,000)
Prepaid and income taxes receivable		(4,182,000)		819,000
Due from third party collection agencies and attorneys		40,000		352,000
Other assets		307,000		(2,360,000)
Income tax payable
Other liabilities		761,000		(493,000)
Non-controlling interest
Net cash provided by (used in) operating activities of discontinued operations		369,000		(479,000)
Net cash used in operating activities		(5,334,000)		(1,542,000)
Purchase of consumer receivables acquired for liquidation		(2,213,000)		(6,051,000)
Principal collected on receivables acquired for liquidation		2,129,000		2,299,000
Purchase of available-for-sale securities		(7,568,000)		(7,136,000)
Proceeds from sale of available-for-sale securities		7,132,000		12,303,000
Investments in personal injury claims — advances
Investments in personal injury claims — receipts
(Increase) decrease in equity method investment		(155,000)		5,827,000
Capital expenditures		(6,000)
Net cash used in investing activities of discontinued operations		(2,632,000)		(2,544,000)
Net cash used in investing activities		(3,313,000)		3,898,000
Distributions to non-controlling interest
Net cash provided by financing activities of discontinued operations		4,131,000		4,306,000
Net cash used in financing activities		4,131,000		(2,874,000)
Foreign currency effect on cash		52,000
Net decrease in cash, cash equivalents and restricted cash including cash, cash equivalents classified within assets related to discontinued operations		(4,464,000)		(518,000)
Less: net increase (decrease) in cash, cash equivalents and restricted cash classified within assets related to discontinued operations		43,000		(312,000)
Net decrease in cash, cash equivalents and restricted cash		(4,421,000)		(830,000)
Cash, cash equivalents and restricted cash at beginning of period		16,282,000		19,947,000		19,947,000
Cash, cash equivalents and restricted cash at end of period		11,861,000		$ 19,117,000		16,282,000
Correction of Foreign Currency Transaction, Impact from September 30, 2016 10K/A Filing [Member]
Cash and cash equivalents		3,000
Consumer receivables acquired for liquidation (at net realizable value)		(245,000)
Due from third party collection agencies and attorneys		45,000
Deferred income taxes		(722,000)
Other assets		(33,000)
Other liabilities		(18,000)
Retained earnings		(1,653,000)
Accumulated other comprehensive (loss) income		718,000
Correction of Foreign Currency Transaction, Current Period Impact [Member]
Cash and cash equivalents		(10,000)
Consumer receivables acquired for liquidation (at net realizable value)		464,000
Due from third party collection agencies and attorneys		(76,000)
Deferred income taxes		(199,000)
Other assets		220,000
Other liabilities		216,000
Retained earnings		(203,000)
Accumulated other comprehensive (loss) income		386,000
Correction of Foreign Currency Transaction, Cumulative Net Impact [Member]
Cash and cash equivalents		(7,000)
Consumer receivables acquired for liquidation (at net realizable value)		219,000
Due from third party collection agencies and attorneys		(31,000)
Deferred income taxes		(921,000)
Other assets		187,000
Other liabilities		198,000
Retained earnings		(1,856,000)
Accumulated other comprehensive (loss) income		1,104,000
Correction of Amortizable Asset and Related Liability, Impact from September 30, 2016 10K/A Filing [Member]
Assets related to discontinued operations		307,000
Liabilities related to discontinued operations		756,000
Retained earnings		(442,000)
Correction of Amortizable Asset and Related Liability, Current Period Impact [Member]
Assets related to discontinued operations		(161,000)
Liabilities related to discontinued operations		(103,000)
Retained earnings		(60,000)
Correction of Amortizable Asset and Related Liability, Cumulative Net Impact [Member]
Assets related to discontinued operations		146,000
Liabilities related to discontinued operations		653,000
Retained earnings		(502,000)
Correction of Other Transactions, Impact from September 30, 2016 10K/A Filing [Member]
Cash and cash equivalents
Assets related to discontinued operations		45,000
Other liabilities		269,000
Retained earnings		(137,000)
Additional paid in capital		8,000
Correction of Other Transactions, Current Period Impact [Member]
Cash and cash equivalents		(2,000)
Assets related to discontinued operations
Other liabilities		(269,000)
Retained earnings		270,000
Additional paid in capital
Correction of Other Transactions, Cumulative Net Impact [Member]
Cash and cash equivalents		(2,000)
Assets related to discontinued operations		45,000
Other liabilities
Retained earnings		133,000
Additional paid in capital		8,000
Previously Reported [Member]
Cash and cash equivalents	[1],[3],[4]	4,770,000
Restricted cash	[1]	8,165,000
Available for sale investments (at fair value)		55,045,000
Consumer receivables acquired for liquidation (at net realizable value)		13,243,000
Investment in personal injury claims, net		47,875,000
Other investments, net		3,354,000
Due from third party collection agencies and attorneys		1,035,000
Prepaid and income taxes receivable		5,267,000
Furniture and equipment, net		176,000
Equity method investment
Deferred income taxes		16,585,000
Goodwill		1,410,000
Other assets		6,203,000
Assets related to discontinued operations		94,335,000
Total assets		257,463,000
Other liabilities		5,666,000
Liabilities related to discontinued operations		73,516,000
Total liabilities		79,182,000
Commitments and contingencies
Preferred stock
Common stock		133,000
Additional paid-in capital		67,020,000
Retained earnings		126,406,000
Accumulated other comprehensive (loss) income		(1,549,000)
Treasury stock (at cost)		(12,925,000)
Non-controlling interest		(804,000)
Total stockholders’ equity		178,281,000				181,783,000
Total liabilities and stockholders’ equity		257,463,000
Finance income, net		4,001,000
Personal injury claims income		2,302,000
Disability fee income		1,354,000
Total revenues		7,657,000
Other Nonoperating Income		544,000
Revenues, Total		8,201,000
General and administrative		9,556,000
Interest		2,000
Earnings from equity method investment
		9,558,000
(Loss) from continuing operations before income tax		(1,357,000)
Income Tax Expense (Benefit), Total		(555,000)
Net (loss) income from continuing operations		(802,000)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent, Total		(834,000)
Net Income (Loss) Attributable to Noncontrolling Interest, Total		21,000
Net loss attributable to Asta Funding, Inc.		$ (1,657,000)
Continuing operations (in dollars per share)		$ (0.07)
Discontinued operations (in dollars per share)		(0.07)
(in dollars per share)		$ (0.14)
Net loss		$ (1,657,000)
Net unrealized securities (loss) gain, net of tax		(1,239,000)
Amount reclassified from other comprehensive loss		(27,000)
Foreign currency translation, net		(369,000)
Other comprehensive loss		(1,635,000)
Total comprehensive loss		(3,292,000)
Net (loss) income from continuing operations		(802,000)
Net (loss) income from discontinued operations, net of income tax		(834,000)
Net (loss) income		(1,657,000)
Depreciation and amortization		105,000
Deferred income taxes		(211,000)
Stock based compensation		(6,000)
Loss on sale of available-for-sale securities		45,000
Unrealized gain on other investments		(18,000)
Unrealized foreign exchange loss on other investments		254,000
Earnings from equity method investment
Prepaid and income taxes receivable		(4,387,000)
Due from third party collection agencies and attorneys		(30,000)
Other assets		498,000
Income tax payable		(252,000)
Other liabilities		373,000
Non-controlling interest		21,000
Net cash provided by (used in) operating activities of discontinued operations		(391,000)
Net cash used in operating activities		(5,656,000)
Purchase of consumer receivables acquired for liquidation		(2,213,000)
Principal collected on receivables acquired for liquidation		2,641,000
Purchase of available-for-sale securities		(7,568,000)
Proceeds from sale of available-for-sale securities		7,132,000
Investments in personal injury claims — advances		(5,178,000)
Investments in personal injury claims — receipts		5,592,000
(Increase) decrease in equity method investment
Capital expenditures		(6,000)
Net cash used in investing activities of discontinued operations		(2,632,000)
Net cash used in investing activities		(2,232,000)
Distributions to non-controlling interest		(180,000)
Net cash provided by financing activities of discontinued operations		4,131,000
Net cash used in financing activities		3,951,000
Foreign currency effect on cash
Net decrease in cash, cash equivalents and restricted cash including cash, cash equivalents classified within assets related to discontinued operations		(3,937,000)
Less: net increase (decrease) in cash, cash equivalents and restricted cash classified within assets related to discontinued operations		43,000
Net decrease in cash, cash equivalents and restricted cash		(3,894,000)
Cash, cash equivalents and restricted cash at beginning of period		16,829,000
Cash, cash equivalents and restricted cash at end of period		12,935,000				16,829,000
Restatement Adjustment [Member]
Earnings from equity method investment	[5]	(404,000)
Net (loss) income from continuing operations		(865,000)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent, Total		(424,000)
Net loss		(1,289,000)
Net (loss) income from continuing operations		(865,000)
Net (loss) income from discontinued operations, net of income tax		(424,000)
Net (loss) income		(1,289,000)
Depreciation and amortization		(79,000)
Deferred income taxes	[3],[6]	631,000
Stock based compensation
Loss on sale of available-for-sale securities
Unrealized gain on other investments
Unrealized foreign exchange loss on other investments
Earnings from equity method investment	[5]	(404,000)
Prepaid and income taxes receivable	[6]	205,000
Due from third party collection agencies and attorneys	[3]	70,000
Other assets	[3]	(191,000)
Income tax payable	[6]	252,000
Other liabilities	[3]	388,000
Non-controlling interest	[1]	(21,000)
Net cash provided by (used in) operating activities of discontinued operations	[7],[8]	760,000
Net cash used in operating activities		322,000
Purchase of consumer receivables acquired for liquidation
Principal collected on receivables acquired for liquidation	[3],[4],[8],[9]	(512,000)
Purchase of available-for-sale securities
Proceeds from sale of available-for-sale securities
Investments in personal injury claims — advances	[1]	5,178,000
Investments in personal injury claims — receipts	[1]	(5,592,000)
(Increase) decrease in equity method investment	[1]	(155,000)
Capital expenditures
Net cash used in investing activities of discontinued operations
Net cash used in investing activities		(1,081,000)
Distributions to non-controlling interest	[1]	180,000
Net cash provided by financing activities of discontinued operations
Net cash used in financing activities		180,000
Foreign currency effect on cash	[3]	52,000
Net decrease in cash, cash equivalents and restricted cash including cash, cash equivalents classified within assets related to discontinued operations		(527,000)
Less: net increase (decrease) in cash, cash equivalents and restricted cash classified within assets related to discontinued operations
Net decrease in cash, cash equivalents and restricted cash	[1],[3],[4],[5],[6],[7],[8],[9]	(527,000)
Cash, cash equivalents and restricted cash at beginning of period		(547,000)
Cash, cash equivalents and restricted cash at end of period		(1,074,000)				$ (547,000)
Restatement Adjustment [Member] | Accounting For Investment in Pegasus Under The Equity Method [Member]
Cash and cash equivalents	[1],[3],[4]	(1,065,000)
Restricted cash	[1]
Available for sale investments (at fair value)	[1]
Consumer receivables acquired for liquidation (at net realizable value)	[1]
Investment in personal injury claims, net	[1]	(47,875,000)
Other investments, net	[1]
Due from third party collection agencies and attorneys	[1]
Prepaid and income taxes receivable	[1]
Furniture and equipment, net	[1]
Equity method investment	[1]	48,720,000
Deferred income taxes	[1]
Goodwill	[1]
Other assets	[1]	(109,000)
Assets related to discontinued operations	[1]
Total assets	[1]	(329,000)
Other liabilities	[1]	(1,133,000)
Liabilities related to discontinued operations	[1]
Total liabilities	[1]	(1,133,000)
Commitments and contingencies	[1]
Preferred stock	[1]
Common stock	[1]
Additional paid-in capital	[1]
Retained earnings	[1]
Accumulated other comprehensive (loss) income	[1]
Treasury stock (at cost)	[1]
Non-controlling interest	[1]	804,000
Total stockholders’ equity	[1]	804,000
Total liabilities and stockholders’ equity	[1]	(329,000)
Finance income, net	[1]
Personal injury claims income	[1]	(2,302,000)
Disability fee income	[1]
Total revenues	[1]	(2,302,000)
Other Nonoperating Income	[1]
Revenues, Total	[1]	(2,302,000)
General and administrative		(2,197,000)
Interest	[1]	(2,000)
Earnings from equity method investment	[1]	(84,000)
	[1]	(2,281,000)
(Loss) from continuing operations before income tax	[1]	(21,000)
Income Tax Expense (Benefit), Total	[1]
Net (loss) income from continuing operations	[1]	(21,000)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent, Total	[1]
Net Income (Loss) Attributable to Noncontrolling Interest, Total	[1]	(21,000)
Net loss attributable to Asta Funding, Inc.	[1]
Net loss	[1]
Net unrealized securities (loss) gain, net of tax	[1]
Amount reclassified from other comprehensive loss	[1]
Foreign currency translation, net	[1]
Other comprehensive loss	[1]
Total comprehensive loss	[1]
Net (loss) income from continuing operations	[1]	(21,000)
Net (loss) income from discontinued operations, net of income tax	[1]
Net (loss) income	[1]
Earnings from equity method investment	[1]	(84,000)
Restatement Adjustment [Member] | All Corrections Not Related to Pegasus [Member]
Cash and cash equivalents	[3],[4]	(9,000)
Restricted cash	[1]
Available for sale investments (at fair value)
Consumer receivables acquired for liquidation (at net realizable value)	[3]	219,000
Investment in personal injury claims, net
Other investments, net
Due from third party collection agencies and attorneys	[3]	(31,000)
Prepaid and income taxes receivable	[6]	(371,000)
Furniture and equipment, net
Equity method investment	[5]	421,000
Deferred income taxes	[3],[6]	(1,258,000)
Goodwill
Other assets	[3]	187,000
Assets related to discontinued operations	[4],[8]	191,000
Total assets		(651,000)
Other liabilities	[3]	198,000
Liabilities related to discontinued operations	[8]	653,000
Total liabilities		851,000
Commitments and contingencies
Preferred stock
Common stock
Additional paid-in capital	[4]	8,000
Retained earnings	[3],[4],[5],[6],[7],[8],[9]	(2,614,000)
Accumulated other comprehensive (loss) income	[3]	1,104,000
Treasury stock (at cost)
Non-controlling interest
Total stockholders’ equity		(1,502,000)
Total liabilities and stockholders’ equity		(651,000)
Finance income, net	[3]	94,000
Personal injury claims income
Disability fee income
Total revenues		94,000
Other Nonoperating Income	[3]	(93,000)
Revenues, Total		1,000
General and administrative	[3],[4]	(66,000)
Interest
Earnings from equity method investment	[5]	(320,000)
		(386,000)
(Loss) from continuing operations before income tax		387,000
Income Tax Expense (Benefit), Total	[6]	1,252,000
Net (loss) income from continuing operations		(865,000)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent, Total	[6],[7],[8]	(424,000)
Net Income (Loss) Attributable to Noncontrolling Interest, Total
Net loss attributable to Asta Funding, Inc.		(1,289,000)
Net loss		(1,289,000)
Net unrealized securities (loss) gain, net of tax
Amount reclassified from other comprehensive loss
Foreign currency translation, net	[3],[4]	387,000
Other comprehensive loss		387,000
Total comprehensive loss		(902,000)
Net (loss) income from continuing operations		(865,000)
Net (loss) income from discontinued operations, net of income tax	[6],[7],[8]	(424,000)
Net (loss) income		(1,289,000)
Earnings from equity method investment	[5]	$ (320,000)

[1] In connection with the Company determining it lacked the requisite control to consolidate Pegasus during the Non-Reliance Period, the Company has now accounted for its investment in Pegasus under the equity method in accordance with US GAAP. On the Company's December 31, 2016 consolidated balance sheet, this resulted in (i) a decrease in cash of $1,065,000; (ii) a decrease in the investment in personal injury claims of $47,875,000; (iii) a decrease in other assets of $109,000; (iv) a decrease in other liabilities of $1,133,000; (v) an decrease in non-controlling interest of $804,000, offset by a corresponding increase in the equity method investment of $48,720,000. On the Company's consolidated statement of operations, this resulted in (i) a reduction in total revenues of $2,302,000; (ii) a reduction in expenses of $2,197,000; (iii) a decrease in the income attributable to the non-controlling interest of $21,000; and (iv) a decrease in earnings from equity method investment of $84,000 for the three months ended December 31, 2016. This change to the equity method of accounting had no effect on net (loss) income during the Non-Reliance Period.

[2] Includes other amounts in other line items on the consolidated balance sheet.

[3] The Company determined that it had not previously accounted for certain foreign currency gains/losses on intercompany balances and transactions in accordance with US GAAP. The Company improperly accounted for the foreign currency effect of certain transactions as if they were long-term investments by including the foreign currency effect in accumulated other comprehensive income instead of properly recording the effect as operating expenses as required under ASC 830. The correction to properly apply US GAAP to these foreign currency matters resulted in increased revenue of $94,000, a decrease in other income of $93,000, and a increase in general and administrative expenses of $204,000 for the three months ended December 31, 2016. ASTA FUNDING, INC. AND SUBSIDIARIES The correction of foreign currency transaction on the consolidated balance sheet are as follows: Increase (decrease) in: Impact from September 30, 2016 10K/A filing Current period impact Cumulative net impact Cash and cash equivalents $ 3,000 $ (10,000 ) $ (7,000 ) Consumer receivables acquired for liquidation (245,000 ) 464,000 219,000 Due from third party collection agencies and attorneys 45,000 (76,000 ) (31,000 ) Deferred income taxes (722,000 ) (199,000 ) (921,000 ) Other assets (33,000 ) 220,000 187,000 Other liabilities (18,000 ) 216,000 198,000 Accumulated other comprehensive loss 718,000 386,000 1,104,000 Retained earnings (1,653,000 ) (203,000 ) (1,856,000 )

[4] The Company identified other transactions that had not been properly accounted for in the correct period and/or for improper amounts and/or improper accounts. The adjustments of these errors were immaterial on an individual basis. The correction of this error resulted in decreased general and administrative expense of $270,000 for the three months ended December 31, 2016. The correction of these errors on the consolidated balance sheet are as follows: Increase (decrease) in: Impact from September 30, 2016 10K/A filing Current period impact Cumulative net impact Cash and cash equivalents $ - $ (2,000 ) $ (2,000 ) Other liabilities 269,000 (269,000) - Retained earnings (137,000 ) 270,000 133,000 Assets related to discontinued operations 45,000 - 45,000 Additional paid in capital 8,000 - 8,000

[5] The Company identified the personal injury claims asset balance of Pegasus was determined to be understated at December 31, 2016 by $400,000. The correction of these error resulted in an increase in equity method investment of $320,000, representing the Company's 80% financial interest, as of December 31, 2016. As a result of the correction of this error, earnings from the equity investment in Pegasus and income from continuing operations increased $320,000 for the three months ended December 31, 2016. Additionally the equity method investment was increased $101,000 to reflect the impact of related accruals in the September 30, 2016 10K/A.

[6] Some of the corrections noted above impacted earnings (loss) before taxes which, in turn, required a calculation of the tax impact. The net impact to the Company's consolidated balance sheet was a (i) decrease to prepaid and income taxes receivable of $371,000; and (ii) decrease to deferred tax assets of $337,000. On the Company's consolidated statement of operations, there was (i) a net increase to income tax expense of $1,252,000; and (ii) an increase to income tax benefit from discontinued operations of $363,000 for the three months ended December 31, 2016.

[7] Prior to the sale of its structured settlement business, the Company purchased periodic payments under structured settlements and annuity policies from individuals in exchange for a lump sum payment. The Company has elected to carry the structured settlements at fair value in accordance with the guidance of FASB ASC, Recognition and Measurement of Financial Assets and Financial Liabilities (ASC 822-10-50-28 through 50-22). As previously disclosed in the Restated Form 10-Q/A, the Company did not reflect the quarterly increase in certain underlying benchmark interest rates used in determining fair value of the Company's structured settlements for the quarter ended December 31, 2016 which resulted in a decrease in the fair value of the Company's structured settlements of approximately $2.6 million (reflected in assets related to discontinued operations in this restated consolidated balance sheet) with an associated increase in prepaid income taxes and deferred tax assets of approximately $1.0 million (reflected in the loss from discontinued operations in this consolidated statement of operations). In connection with the Company's filing of its Annual Report on Form 10-K/A, on September 17, 2018, the Company adjusted the fair value of the Company's structured settlements to reflect the appropriate benchmark interest rates at September 30, 2016, which resulted in an decrease in net loss attributable to discontinued operations and an increase in assets related to discontinued operations of $727,000. As this increase in fair value was originally recorded during the three month period ended December 31, 2016, this Amendment includes an increase in both the retained earnings and the net loss attributable to discontinued operations of $727,000.

[8] The Company discovered that it did not properly record an amortizable asset and related liability in conjunction with an asset purchase agreement entered into in June 2015 with a related party. The correction of this error resulted in a decrease in income from discontinued operations of $60,000 for the three months ended December 31, 2016. The correction of these errors on the consolidated balance sheet are as follows: Increase (decrease) in: Impact from September 30, 2016 10K/A filing Current period impact Cumulative net impact Assets related to discontinued operations $ 307,000 $ (161,000 ) $ 146,000 Liabilities related to discontinued operations 756,000 (103,000 ) 653,000 Retained earnings (442,000 ) (60,000 ) (502,000 )

[9] The Company determined that it had not accounted for certain unallocated payments reported on its consolidated balance sheet properly during the Non-Reliance Period. The correction of this error resulted in a decrease to consumer receivables acquired for liquidation of $648,000 and retained earnings of $648,000 as of September 30, 2016 and is therefore included in the net adjustment to retained earnings as of December 31, 2016.

XML

Note 2 - Business and Basis of Presentation (Details Textual) - USD ($)	3 Months Ended			12 Months Ended
	Dec. 31, 2016		Dec. 31, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2013	Dec. 28, 2011
Cash, Uninsured Amount	$ 1,400,000
Cash, Uninsured Amount, Foreign	500,000
Restricted Cash, Total	$ 8,165,000	[1]		$ 10,000,000
International Consumer Debt Portfolios, Percentage of Ownership	80.00%
Equity Method Investments	$ 49,141,000			48,582,000
Income (Loss) from Equity Method Investments, Total	404,000		$ 1,494,000
Equity Method Investment, Other than Temporary Impairment	0		0
Goodwill, Ending Balance	1,410,000			$ 1,410,000
CBC [Member]
Equity Method Investment, Ownership Percentage				100.00%		80.00%
Goodwill, Ending Balance	1,400,000
VATIV [Member]
Goodwill, Ending Balance	$ 1,400,000
Pegasus Legal Funding LLC [Member]
Equity Method Investment, Percentage of Controlled Equity	50.00%
Equity Method Investment, Ownership Percentage	80.00%						80.00%
Equity Method Investment, Ownership Percentage, Controlled Party	20.00%
Equity Method Investments	$ 49,141,000		48,582,000	$ 48,582,000	$ 40,751,000
Income (Loss) from Equity Method Investments, Total	$ 404,000			10,551,000
Serlefin BPO&O Peru S.A.C. [Member]
Equity Method Investment, Ownership Percentage	49.00%
Equity Method Investment, Ownership Percentage, Controlled Party	51.00%
Equity Method Investments	$ 200,000			$ 200,000
Income (Loss) from Equity Method Investments, Total	$ 100,000
Pegasus Legal Funding LLC [Member]
Subsidiary of Limited Liability Company or Limited Partnership, Ownership Interest	80.00%
Serlefin BPO&O Peru S.A.C. [Member]
International Consumer Debt Portfolios, Percentage of Ownership	20.00%
Proceeds from International Consumer Debt Portfolios for Performance Fee	$ 200,000		$ 0

[1] In connection with the Company determining it lacked the requisite control to consolidate Pegasus during the Non-Reliance Period, the Company has now accounted for its investment in Pegasus under the equity method in accordance with US GAAP. On the Company's December 31, 2016 consolidated balance sheet, this resulted in (i) a decrease in cash of $1,065,000; (ii) a decrease in the investment in personal injury claims of $47,875,000; (iii) a decrease in other assets of $109,000; (iv) a decrease in other liabilities of $1,133,000; (v) an decrease in non-controlling interest of $804,000, offset by a corresponding increase in the equity method investment of $48,720,000. On the Company's consolidated statement of operations, this resulted in (i) a reduction in total revenues of $2,302,000; (ii) a reduction in expenses of $2,197,000; (iii) a decrease in the income attributable to the non-controlling interest of $21,000; and (iv) a decrease in earnings from equity method investment of $84,000 for the three months ended December 31, 2016. This change to the equity method of accounting had no effect on net (loss) income during the Non-Reliance Period.

XML

Note 3 - Available-for-sale Investments (Details Textual)	3 Months Ended
	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)
Number of Investments Sold	2	2
Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments, Total	$ (45,000)	$ (31,000)
Realized Investment Gains (Losses), Total	177,000	47,000
Available-for-sale Securities, Gross Realized Gain (Loss), Total	$ 132,000	$ 16,000
Number of Investments	7
Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year	5

XML

Note 3 - Available-for-sale Investments - Investments Classified as Available-for-sale (Details) - USD ($)	Dec. 31, 2016	Sep. 30, 2016
Amortized Cost	$ 56,115,000	$ 55,723,000
Unrealized Gains	29,000	1,089,000
Unrealized Losses	(1,099,000)	(49,000)
Fair Value	$ 55,045,000	$ 56,763,000

XML

Note 4 - Consumer Receivables Acquired for Liquidation (Details Textual) - USD ($)	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2016
Face Value of Charged-off Consumer Receivables	$ 35,000,000	$ 97,700,000
Purchased Cost of Charged-off Consumer Receivables	2,200,000	6,100,000
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net	$ 13,462,000	$ 18,800,000	$ 13,427,000
Foreign Consumer Receivables, Percentage of Total Consumer Receivable	71.10%	46.30%
Fee Charged on Portfolio Purchase	3.00%
PERU
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net	$ 5,000,000	$ 4,700,000
COLOMBIA
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net	4,600,000	4,000,000
Non-US [Member]
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount, Net	$ 9,600,000	$ 8,700,000

XML

Note 4 - Consumer Receivables Acquired for Liquidation - Changes In Balance Sheet Account of Consumer Receivables Acquired for Liquidation (Details) - USD ($)	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Balance	$ 13,427,000	$ 15,056,000
Acquisitions of receivable portfolios	2,213,000	6,051,000
Net cash collections from collection of consumer receivables acquired for liquidation	(6,015,000)	(7,377,000)
Net cash collections represented by account sales of consumer receivables acquired for liquidation	(190,000)
Effect of foreign currency translation	(68,000)	(27,000)
Finance income, net	4,095,000	5,106,000
Balance	$ 13,462,000	$ 18,809,000
Finance income as a percentage of collections	66.00%	69.22%

XML

Note 4 - Consumer Receivables Acquired for Liquidation - Collections Received Less Commissions and Direct Costs (Details) - USD ($)		3 Months Ended
		Dec. 31, 2016	Dec. 31, 2015
Gross collections (1)	[1]	$ 11,400,000	$ 12,245,000
Commissions and fees (2)	[2]	5,195,000	4,868,000
Net collections		$ 6,205,000	$ 7,377,000

[1] Gross collections include: collections from third party collection agencies and attorneys, collections from in-house efforts, and collections represented by account sales.

[2] Commissions are earned by third party collection agencies and attorneys, and include direct costs associated with the collection effort, generally court costs. In December 2007 an arrangement was consummated with one servicer who also receives a 3% fee on gross collections received by the Company in connection with the related Portfolio Purchase.. The fee is charged for asset location, skip tracing and ultimately suing debtors in connection with this portfolio purchase.

XML

Note 5 - Litigation Funding (Details Textual) - USD ($)		3 Months Ended		12 Months Ended
	May 08, 2012	Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2016	Nov. 08, 2016	Sep. 30, 2015	Sep. 30, 2014	May 02, 2014	Dec. 28, 2011
Company Investment in Personal Injury		$ 49,100,000		$ 48,600,000
Equity Method Investments		49,141,000		48,582,000
Income (Loss) from Equity Method Investments, Total		404,000	$ 1,494,000
Line of Credit Facility, Maximum Borrowing Capacity								$ 30,000,000
Valuation Allowances and Reserves, Other		2,500,000
Net Investment Income, Total		0	0
Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,000,000						$ 1,500,000
Debt Instrument, Term	2 years
Long-term Line of Credit, Total		1,500,000
Pegasus Legal Funding LLC [Member]
Earnings in Interest and Fees from Invested Venture		$ 2,300,000	3,100,000
Subsidiary of Limited Liability Company or Limited Partnership, Ownership Interest		80.00%
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners					20.00%
BP Case Management, LLC [Member]
Subsidiary of Limited Liability Company or Limited Partnership, Ownership Interest	60.00%
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	40.00%
Pegasus Legal Funding LLC [Member]
Equity Method Investment, Ownership Percentage		80.00%							80.00%
Equity Method Investments		$ 49,141,000	$ 48,582,000	48,582,000		$ 40,751,000
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions, Total		559,000		7,831,000
Income (Loss) from Equity Method Investments, Total		404,000		10,551,000
Payments to Acquire Equity Method Investments		$ 155,000
Proceeds from Equity Method Investment, Distribution, Return of Capital				$ 2,720,000
Equity Method Investment, Ownership Percentage, Controlled Party		20.00%

XML

Note 5 - Litigation Funding - Equity Method Investments (Details) - USD ($)	Dec. 31, 2016	Sep. 30, 2016
Equity Method Investments	$ 49,141,000	$ 48,582,000
Pegasus Funding LLC [Member]
Equity Method Investments	$ 49,141,000	$ 48,582,000
Equity Method Investment, Ownership Percentage	80.00%	80.00%

XML

Note 5 - Litigation Funding - Equity Method Investments Financial Statements (Details) - USD ($)	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2016
Earnings from equity method investment	$ 404,000	$ 1,494,000
Pegasus Legal Funding LLC [Member]
Personal injury claims income	2,302,000	3,085,000
Operating expenses	1,797,000	1,218,000
Income from operations	505,000	$ 1,867,000
Pegasus Funding LLC [Member]
Cash	1,065,000		$ 539,000
Investment in personal injury claims	48,275,000		48,289,000
Other assets	109,000		188,000
Total Assets	49,449,000		49,016,000
Due to Asta	34,560,000		34,404,000
Other liabilities	1,006,000		1,053,000
Equity	13,883,000		13,559,000
Total Liabilities and Equity	$ 49,449,000		$ 49,016,000

XML

Note 6 - Furniture and Equipment - Summary of Furniture and Equipment (Details) - USD ($)	Dec. 31, 2016	Sep. 30, 2016
Total	$ 1,864,000	$ 1,858,000
Less accumulated depreciation and amortization	1,688,000	1,662,000
Balance, end of period	176,000	196,000
Furniture and Fixtures [Member]
Total	273,000	273,000
Equipment [Member]
Total	235,000	235,000
Software Development [Member]
Total	$ 1,356,000	$ 1,350,000

XML

Note 7- Non Recourse Debt (Details Textual) - USD ($)						1 Months Ended
	Mar. 30, 2016	Jun. 03, 2014	May 02, 2014	Aug. 07, 2013	Mar. 31, 2007	Jun. 30, 2016	Dec. 31, 2016		Sep. 30, 2016
Portfolio Purchase					$ 300,000,000
Receivables Financing Agreement Term					3 years
Percentage of Ownership in Subsidiaries				100.00%
Prepayment Fees				$ 15,000,000
Receivable Finance Agreement, Portfolio Purchase Collections, Percentage				30.00%
Debt Instrument, Final Principal Payment		$ 2,900,000
Voluntary Debt Prepayment		1,900,000
Receivable Finance Agreement, Collections from Portfolio Purchase		$ 16,900,000				$ 16,900,000
Line of Credit Facility, Current Borrowing Capacity			$ 20,000,000
Line of Credit Facility, Maximum Borrowing Capacity			$ 30,000,000
Line of Credit Facility, Expiration Period			3 years
Debt Instrument, Basis Spread on Variable Rate			2.75%
Line of Credit Facility, Covenant Consolidated Tangible Net Worth			$ 150,000,000
Restricted Cash, Total							$ 8,165,000	[1]	$ 10,000,000
Amended Loan Agreement [Member]
Debt Instrument, Basis Spread on Variable Rate	2.25%
Line of Credit Facility, Covenant Consolidated Tangible Net Worth	$ 100,000,000
Line of Credit Facility, Covenant Decrease Consolidated Tangible Net Worth			$ 50,000,000
Long-term Line of Credit, Total							0
Bank of Montreal [Member]
Non-Recourse Debt							$ 179,000
Receivables Financing Agreement [Member]
Non-Recourse Debt					$ 227,000,000

[1] In connection with the Company determining it lacked the requisite control to consolidate Pegasus during the Non-Reliance Period, the Company has now accounted for its investment in Pegasus under the equity method in accordance with US GAAP. On the Company's December 31, 2016 consolidated balance sheet, this resulted in (i) a decrease in cash of $1,065,000; (ii) a decrease in the investment in personal injury claims of $47,875,000; (iii) a decrease in other assets of $109,000; (iv) a decrease in other liabilities of $1,133,000; (v) an decrease in non-controlling interest of $804,000, offset by a corresponding increase in the equity method investment of $48,720,000. On the Company's consolidated statement of operations, this resulted in (i) a reduction in total revenues of $2,302,000; (ii) a reduction in expenses of $2,197,000; (iii) a decrease in the income attributable to the non-controlling interest of $21,000; and (iv) a decrease in earnings from equity method investment of $84,000 for the three months ended December 31, 2016. This change to the equity method of accounting had no effect on net (loss) income during the Non-Reliance Period.

XML

Note 8 - Discontinued Operations (Details Textual) - USD ($)						3 Months Ended		6 Months Ended	12 Months Ended
	Dec. 13, 2017	Jan. 01, 2016	Dec. 31, 2015	Mar. 01, 2015	Dec. 31, 2013	Dec. 31, 2016	Dec. 31, 2015	Sep. 29, 2014	Sep. 30, 2017	Sep. 30, 2016	Jul. 08, 2016	Sep. 25, 2015	Nov. 26, 2014	May 02, 2014
Disposal Group, Including Discontinued Operation, Assets, Total						$ 94,526,000				$ 91,506,000
Disposal Group, Including Discontinued Operation, Liabilities, Total						74,169,000				69,238,000
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent, Total						(1,258,000)	$ 272,000
Cash, Uninsured Amount						1,400,000
Line of Credit Facility, Current Borrowing Capacity														$ 20,000,000
Line of Credit Facility, Maximum Borrowing Capacity														$ 30,000,000
CBC [Member]
Disposal Group, Including Discontinued Operation, Assets, Total						94,526,000				91,506,000
Disposal Group, Including Discontinued Operation, Liabilities, Total						74,169,000				$ 69,238,000
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent, Total						(1,258,000)	$ 272,000
Cash, Uninsured Amount						700,000
Structured Settlements, Unrealized Gain (Losses)						1,700,000
Structured Settlements, Gain on New Structured Settlements Financed						2,100,000
Structured Settlements, Unrealized Gain (Loss), Decrease in Realized Gains Recognized as Realized Interest Income on Structured Settlements						500,000
Structured Settlements, Reduction in Fair Value						3,300,000
CBC [Member] | Subsequent Event [Member]
Disposal Group, Including Discontinued Operation, Consideration	$ 10,500,000
Disposal Group, Including Discontinued Operation, Cash Consideration	4,490,000
Disposal Group, Including Discontinued Operation, Promissory Note Consideration	$ 5,750,000
Promissory Note Interest Rate, Discontinued Operations	7.00%
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax, Total									$ 1,900,000
Restricted Stock [Member]
Shares Lock-up Period			1 year
CBC [Member]
Equity Method Investment, Ownership Percentage					80.00%					100.00%
Business Combination, Consideration Transferred, Total			$ 1,800,000		$ 5,900,000
Business Acquisition, Percentage of Voting Interests Acquired			20.00%				20.00%
Payments to Acquire Businesses, Gross			$ 800,000
Employment Agreement Term		2 years
Employee Agreement Renewal Term		1 year
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities, Total					25,900,000
Line of Credit Facility, Current Borrowing Capacity					$ 12,500,000
Debt Instrument, Floor Interest Rate				4.10%	5.50%			4.75%
Line of Credit Facility, Maximum Borrowing Capacity				$ 25,000,000				$ 22,000,000
Other Long-term Debt, Total						71,600,000
Long-term Line of Credit, Total						15,300,000
Notes Payable, Noncurrent, Total						$ 56,300,000
CBC [Member] | Secured Debt [Member]
Debt Instrument, Face Amount											$ 14,800,000	$ 16,600,000	$ 21,800,000
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate											4.85%	5.10%	5.40%
CBC [Member] | Principal One [Member]
Payments to Acquire Businesses, Gross			400,000
CBC [Member] | Restricted Stock [Member]
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable			$ 1,000,000
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares			123,304
Shares Lock-up Period			1 year
CBC [Member] | Restricted Stock [Member] | Principal One [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares			61,652
Shares Issued, Price Per Share			$ 7.95				$ 7.95

XML

Note 8 - Discontinued Operations - Financial Statements (Details) - USD ($)	3 Months Ended
	Dec. 31, 2016		Dec. 31, 2015	Sep. 30, 2016
(Loss) income from discontinued operations, net of income tax	$ (1,258,000)		$ 272,000
Total assets related to discontinued operations	94,526,000			$ 91,506,000
Total liabilities related to discontinued operations	74,169,000			69,238,000
CBC [Member]
Unrealized (loss) gain on structured settlements	(1,682,000)		1,527,000
Interest income on structured settlements	1,901,000		1,227,000
Total revenues	219,000		2,754,000
Other income	15,000
	234,000		2,754,000
General and administrative expenses	1,488,000		1,379,000
Interest expense	932,000		726,000
	2,420,000		2,105,000
(Loss) income from discontinued operations before income tax	(2,186,000)		649,000
Income tax (benefit) expense from discontinued operations	(928,000)		273,000
(Loss) income from discontinued operations before non-controlling interest	(1,258,000)		376,000
Non-controlling interest			104,000
(Loss) income from discontinued operations, net of income tax	(1,258,000)		$ 272,000
Cash and cash equivalents	1,241,000	[1]		1,198,000
Restricted cash	499,000			499,000
Structured settlements	88,277,000			86,091,000
Furniture and equipment, net	43,000			47,000
Goodwill	1,405,000			1,405,000
Other assets	3,061,000			2,266,000
Total assets related to discontinued operations	94,526,000			91,506,000
Other debt - CBC	71,566,000			67,435,000
Other liabilities	2,603,000			1,803,000
Total liabilities related to discontinued operations	$ 74,169,000			$ 69,238,000

[1] Cash balance with one bank at December 31, 2016 that exceeded the balance insured by the FDIC by approximately $0.7 million.

XML

Note 8 - Discontinued Operations - Components of Structured Settlements (Details) - USD ($)		Dec. 31, 2016	Sep. 30, 2016
Maturity (1) (2)	[1],[2]	$ 143,544,000	$ 133,059,000
Unearned income		(55,267,000)	(46,968,000)
Structured settlements, net		$ 88,277,000	$ 86,091,000

[1] The maturity value represents the aggregate unpaid principal balance at December 31, 2016 and September 30, 2016.

[2] There are no amounts of structured settlements that are past due, or in nonaccrual status at December 31, 2016 and September 30, 2016.

XML

Note 8 - Discontinued Operations - Structured Settlements (Details) - USD ($)	Dec. 31, 2016	Sep. 30, 2016
Interest Rate
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 88,277,000	$ 86,091,000
Structured Settlement [Member]
Interest Rate	4.10%
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 15,264,000	10,154,000
Structured Settlements Encumbered By Notes Payable Due June 2025 [Member]
Interest Rate	8.75%
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 1,817,000	1,862,000
Structured Settlements Encumbered By Notes Payable Due August 2026 [Member]
Interest Rate	7.25%
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 4,138,000	4,242,000
Structured Settlements Encumbered By Notes Payable Due April 2032 [Member]
Interest Rate	7.125%
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 3,948,000	3,987,000
Structured Settlements Encumbered By Notes Payable Due February 2037 [Member]
Interest Rate	5.39%
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 18,601,000	18,978,000
Structured Settlements Encumbered By Notes Payable Due March 2034 [Member]
Interest Rate	5.07%
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 14,193,000	14,507,000
Structured Settlements Encumbered By Notes Payable Due February 2043 [Member]
Interest Rate	4.85%
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 13,605,000	13,705,000
Structured Settlements Encumbered [Member]
Interest Rate
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 71,566,000	67,435,000
Structured Settlements Not Encumbered [Member]
Interest Rate
Notes payable secured by settlement receivables with principal and interest outstanding payable, encumbered and unencumbered	$ 16,711,000	$ 18,656,000

XML

Note 8 - Discontinued Operations - Expected Cash Flows of Structured Settlements Based on Maturity Value (Details) - USD ($)		Dec. 31, 2016	Sep. 30, 2016
September 30, 2017 (9 months)		$ 7,635,000
September 30, 2018		8,556,000
September 30, 2019		8,914,000
September 30, 2020		8,371,000
September 30, 2021		9,105,000
Thereafter		100,963,000
Total	[1],[2]	$ 143,544,000	$ 133,059,000

[1] The maturity value represents the aggregate unpaid principal balance at December 31, 2016 and September 30, 2016.

[2] There are no amounts of structured settlements that are past due, or in nonaccrual status at December 31, 2016 and September 30, 2016.

XML

Note 9 - Commitments and Contingencies (Details Textual) - USD ($)			3 Months Ended
	Nov. 11, 2016	Jul. 24, 2015	Sep. 30, 2016	Mar. 31, 2016	Dec. 31, 2016
Violation of Federal Fair Debt Collection Practice Act and Racketeer Influenced and Corrupt Organization Act [Member]
Litigation Settlement, Amount Awarded to Other Party		$ 39,000
Litigation Settlement, Amount Offered, Consideration				$ 3,900,000
Estimated Litigation Liability					$ 2,300,000
Violation of Federal Fair Debt Collection Practice Act and Racketeer Influenced and Corrupt Organization Act [Member] | General and Administrative Expense [Member]
Litigation Settlement, Expense			$ 300,000	$ 2,000,000
Violation of Federal Fair Debt Collection Practice Act and Racketeer Influenced and Corrupt Organization Act [Member] | Individual Basis for a Payment to each Plaintiff [Member]
Litigation Settlement, Amount Awarded to Other Party		$ 13,000
Chief Executive Officer [Member] | Simia Capital LLC [Member]
Employment Agreement, Annual Base Salary	$ 250,000
Employment Agreement, Profit Bonus, Percentage of Profit	15.00%
Employment Agreement, Profit Bonus, Minimum Internal Rate of Return	18.00%
Employment Agreement, Profit Bonus, Percentage of Closing Consideration	15.00%
Employment Agreement Term	5 years
Employment Agreement, Severance, Years of Base Salary	2 years
Term of Non-compete and Non-solicitation Provision	2 years

XML

Note 10 - Income Recognition, Impairments, and Commissions and Fees (Details Textual) - USD ($)	1 Months Ended	12 Months Ended
	Oct. 31, 2014	Sep. 30, 2016	Dec. 31, 2016
Other than Temporary Impairment Losses, Investments, Total		$ 1,000,000
Other Investments, Total		$ 3,590,000	$ 3,354,000
Fixed Income Funds [Member]
Available-for-sale Securities, Equity Securities	$ 5,000,000
Related Party Transaction, Rate	14.00%

XML

Note 11 - Income Taxes (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Effective Income Tax Rate Reconciliation, Percent, Total	70.30%	32.80%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	34.00%	35.00%
Unrecognized Tax Benefits, Ending Balance	$ 0

XML

Note 12 - Net (Loss) Income Per Share (Details Textual)	3 Months Ended
	Dec. 31, 2015 $ / shares shares
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares	454,205
Weighted Average Exercise Price | $ / shares	$ 9.47

XML

Note 12 - Net (Loss) Income Per Share - Computation of Basic and Diluted Per Share Data (Details) - USD ($)	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Net (loss) income from continuing operations	$ (1,688,000)	$ 1,291,000
Net (loss) income from continuing operations, weighted average shares (in shares)	11,876,224	12,155,421
Net (loss) income from continuing operations, per share amount (in dollars per share)	$ (0.14)	$ 0.11
Net (loss) income from discontinued operations, net of income tax	$ (1,258,000)	$ 272,000
Net (loss) income from discontinued operations, weighted average shares (in shares)	11,876,224	12,155,421
Net (loss) income from discontinued operations, per share amount (in dollars per share)	$ (0.11)	$ 0.02
Net (loss) income	$ (2,946,000)	$ 1,563,000
(in dollars per share)	$ (0.25)	$ 0.13
Effect of Dilutive Stock, weighted average shares (in shares)		276,465
Diluted, weighted average shares (in shares)	11,876,224	12,431,886
Diluted, per share amount (in dollars per share)	$ (0.25)	$ 0.13

XML

Note 13 - Stock Based Compensation (Details Textual) - shares			3 Months Ended
	Dec. 31, 2015	Dec. 16, 2015	Dec. 31, 2016	Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		67,100	0	67,100
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	123,304	5,000	0	5,000
Shares Lock-up Period	1 year
Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares		9,100
Share-based Compensation Award, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number		58,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period		3 years

XML

Note 13 - Stock Based Compensation - Weighted Average Assumptions Used in Option Pricing Model (Details)	Dec. 16, 2015
Risk-free interest rate	0.24%
Expected term (years) (Year)	6 years 91 days
Expected volatility	23.40%
Dividend yield	0.00%

XML

Note 14 - Stock Option Plans (Details Textual)			3 Months Ended		57 Months Ended
	Dec. 31, 2015 shares	Dec. 16, 2015 shares	Dec. 31, 2016 USD ($) shares	Dec. 31, 2015 USD ($) shares	Dec. 31, 2016 USD ($) shares	Mar. 21, 2012 shares	Mar. 05, 2012 shares	Mar. 01, 2006 shares	May 01, 2002 shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		67,100	0	67,100
Allocated Share-based Compensation Expense, Total | $			$ 6,000	$ 283,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total | $			76,000		$ 76,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $			1,490,000		1,490,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | $			$ 1,398,000		1,398,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term			5 years 36 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period			0	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | $			$ 657,000	$ 830,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Total Fair Value | $				$ 532,000
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	123,304	5,000	0	5,000
Allocated Share-based Compensation Expense, Total | $			$ 0	$ 87,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total | $			0		0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | $			0	40,000
Employee Stock Option [Member]
Allocated Share-based Compensation Expense, Total | $			6,000	$ 196,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total | $			$ 76,000		$ 76,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			1 year 292 days
The 2012 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized						2,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					484,200
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period					66,568
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant			1,336,743		1,336,743
Share-based Compensation Arrangement by Share-based Payment Award, Number of Eligible Employees			129
The 2012 Plan [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period					245,625
Equity Compensation Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized								1,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant						0
The 2002 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized									1,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant							0

XML

Note 14 - Stock Option Plans - Summary of Stock Option Plans (Details) - $ / shares		3 Months Ended
	Dec. 16, 2015	Dec. 31, 2016	Dec. 31, 2015
Outstanding options at the beginning of period (in shares)		949,667	1,043,566
Outstanding options at the beginning of period (in dollars per share)		$ 8.47	$ 8.47
Options granted (in shares)	67,100	0	67,100
Options granted (in dollars per share)			$ 7.93
Options exercised (in shares)		0	0
Options exercised (in dollars per share)
Options forfeited/cancelled (in shares)		(52,500)
Options forfeited/cancelled (in dollars per share)		$ 14.16
Outstanding options at the end of period (in shares)		897,167	1,110,666
Outstanding options at the end of period (in dollars per share)		$ 8.14	$ 8.43
Options Exercisable, Number of Shares Exercisable (in shares)		844,829	965,325
Options Exercisable, Weighted Average Exercise Price (in dollars per share)		$ 8.15	$ 8.46

XML

Note 14 - Stock Option Plans - Summary of Outstanding Options (Details) - $ / shares	3 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Dec. 31, 2015	Sep. 30, 2015
Options Outstanding, Number of Shares Outstanding (in shares)	897,167	949,667	1,110,666	1,043,566
Options Outstanding, Weighted Average Remaining Contractual Life (Year)	5 years 109 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 8.14	$ 8.47	$ 8.43	$ 8.47
Options Exercisable, Number of Shares Exercisable (in shares)	844,829		965,325
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 8.15		$ 8.46
Range One [Member]
Range of Exercise Price, Lower (in dollars per share)	2.8751
Range of Exercise Price, Upper (in dollars per share)	$ 5.75
Options Outstanding, Number of Shares Outstanding (in shares)	3,800
Options Outstanding, Weighted Average Remaining Contractual Life (Year)	2 years 109 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 2.95
Options Exercisable, Number of Shares Exercisable (in shares)	3,800
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 2.95
Range Two [Member]
Range of Exercise Price, Lower (in dollars per share)	5.7501
Range of Exercise Price, Upper (in dollars per share)	$ 8.625
Options Outstanding, Number of Shares Outstanding (in shares)	768,867
Options Outstanding, Weighted Average Remaining Contractual Life (Year)	5 years 73 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 7.96
Options Exercisable, Number of Shares Exercisable (in shares)	716,529
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 7.96
Range Three [Member]
Range of Exercise Price, Lower (in dollars per share)	8.6251
Range of Exercise Price, Upper (in dollars per share)	$ 11.50
Options Outstanding, Number of Shares Outstanding (in shares)	124,500
Options Outstanding, Weighted Average Remaining Contractual Life (Year)	6 years 36 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 9.40
Options Exercisable, Number of Shares Exercisable (in shares)	124,500
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 9.40

XML

Note 14 - Stock Option Plans - Summary of Restricted Stock Transactions (Details) - Restricted Stock [Member] - $ / shares			3 Months Ended
	Dec. 31, 2015	Dec. 16, 2015	Dec. 31, 2016	Dec. 31, 2015
Unvested at the beginning of period (in shares)				44,107
Unvested at the beginning of period (in dollars per share)				$ 9.28
Awards granted (in shares)	123,304	5,000	0	5,000
Awards granted (in dollars per share)				$ 7.89
Vested (in shares)				(34,107)
Vested (in dollars per share)				$ 9.57
Forfeited (in shares)
Forfeited (in dollars per share)
Unvested at the end of period (in shares)	15,000			15,000
Unvested at the end of period (in dollars per share)	$ 7.92			$ 7.92

XML

Note 15 - Stockholders' Equity (Details Textual) - USD ($)			3 Months Ended		14 Months Ended
	Nov. 21, 2016	Mar. 17, 2016	Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2016	Dec. 17, 2015	Aug. 11, 2015
Dividends, Total			$ 0	$ 0
Treasury Stock, Value, Acquired, Cost Method				$ 7,180,000
Mangrove [Member]
Mutual Confidentiality Agreement, Extended Period	30 days
Shares Repurchase Plan [Member]
Stock Repurchase Program, Authorized Amount		$ 15,000,000					$ 15,000,000
Stock Repurchase Program, Additional Authorized Repurchase Amount						$ 15,000,000
Treasury Stock, Value, Acquired, Cost Method		$ 9,900,000			$ 10,100,000
Treasury Stock, Shares, Acquired					1,186,000

XML

Note 16 - Fair Value of Financial Measurements and Disclosures (Details Textual) - USD ($)	3 Months Ended
	Dec. 31, 2016	Sep. 30, 2016
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Redemption Restriction Period	5 years
Unrealized Gain (Loss) on Structured Settlements	$ (1,700,000)
Unrealized Gain (Loss) on Structured Settlements Due to Day One Gains on New Structured Settlements Financed	2,100,000
Unrealized Gain (Loss) on Structured Settlements Due to Change in Realized Gains	(500,000)
Assets, Fair Value Adjustment	(3,611,000)
Available-for-sale Securities, Total	55,045,000	$ 56,763,000
Fair Value, Inputs, Level 2 [Member]
Available-for-sale Securities, Total	0
Fair Value, Inputs, Level 3 [Member]
Available-for-sale Securities, Total	0
Structured Settlement [Member]
Assets, Fair Value Adjustment	$ (3,300,000)

XML

Note 16 - Fair Value of Financial Measurements and Disclosures - Fair Value of Financial Measurements (Details) - USD ($)	Dec. 31, 2016	Sep. 30, 2016
Fair Value	$ 55,045,000	$ 56,763,000
Fair Value, Inputs, Level 3 [Member]
Fair Value	0
Reported Value Measurement [Member] | Fair Value, Inputs, Level 1 [Member]
Cash equivalents (Level 1)	936,000	923,000
Other investment, net (Level 1)	3,354,000	3,590,000
Fair Value	55,045,000	56,763,000
Structured settlements (Level 3)	88,277,000	86,091,000
Reported Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member]
Consumer receivables acquired for liquidation (Level 3)	13,462,000	13,427,000
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 1 [Member]
Cash equivalents (Level 1)	936,000	923,000
Other investment, net (Level 1)	3,354,000	3,590,000
Fair Value	55,045,000	56,763,000
Structured settlements (Level 3)	88,277,000	86,091,000
Estimate of Fair Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member]
Consumer receivables acquired for liquidation (Level 3)	$ 45,061,000	$ 47,233,000

XML

Note 16 - Fair Value of Financial Measurements and Disclosures - Quantitative Information About Level 3 Fair Value Measurements (Details) - Valuation Technique, Discounted Cash Flow [Member]	Dec. 31, 2016 USD ($)
Structured Settlements, Fair Value	$ 88,277,000
Minimum [Member] | Measurement Input, Discount Rate [Member]
Rate	0.0483
Maximum [Member] | Measurement Input, Discount Rate [Member]
Rate	0.0536

XML

Note 16 - Fair Value of Financial Measurements and Disclosures - Changes in Structured Settlements at Fair Value Using Significant Unobservable Inputs (Details)	3 Months Ended
	Dec. 31, 2016 USD ($)
Balance at September 30, 2016	$ 86,091,000
Fair value adjustment	(3,611,000)
Total gains included in earnings	(1,598,000)
Purchases	4,595,000
Interest accreted	1,567,000
Payments received	(1,963,000)
Total	88,277,000
The amount of total losses for the three month period included in earnings attributable to the change in unrealized losses relating to assets held at December 31, 2016	$ (1,682,000)

XML

Note 16 - Fair Value of Financial Measurements and Disclosures - Schedule of Realized and Unrealized Gains and Losses (Details)	3 Months Ended
	Dec. 31, 2016 USD ($)
Total losses included in the three months ended December 31, 2016	$ (1,682,000)
Change in unrealized losses relating to assets still held at December 31, 2016	$ (1,682,000)

XML

Note 17 - Segment Reporting (Details Textual)	3 Months Ended
	Dec. 31, 2016 USD ($)	Sep. 30, 2016 USD ($)	Dec. 31, 2015 USD ($)
Number of Reportable Segments	3
Disposal Group, Including Discontinued Operation, Assets, Total	$ 94,526,000	$ 91,506,000
CBC [Member]
Disposal Group, Including Discontinued Operation, Assets, Total	94,526,000	$ 91,506,000
CBC [Member] | Corporate, Non-Segment [Member]
Disposal Group, Including Discontinued Operation, Assets, Total	$ 94,500,000		$ 74,600,000

XML

Note 17 - Segment Reporting - Schedule of Segment Reporting (Details) - USD ($)		3 Months Ended
		Dec. 31, 2016	Dec. 31, 2015		Sep. 30, 2016
Revenues		$ 5,449,000	$ 5,765,000
Other income		400,000	400,000
Segment profit (loss)		(991,000)	1,922,000
Segment Assets(1)		256,483,000	237,800,000	[1]	$ 255,008,000
Operating Segments [Member] | Consumer Receivables [Member]
Revenues		4,100,000	5,100,000
Other income
Segment profit (loss)		3,200,000	4,700,000
Segment Assets(1)	[1]	17,600,000	24,800,000
Operating Segments [Member] | GAR Disability Advocates [Member]
Revenues		1,400,000	700,000
Other income
Segment profit (loss)		(900,000)	(1,800,000)
Segment Assets(1)	[1]	1,400,000	2,400,000
Operating Segments [Member] | Personal Injury Claims [Member]
Revenues	[2]
Other income	[2]
Segment profit (loss)	[2]	400,000	1,500,000
Segment Assets(1)	[1],[2]	49,200,000	36,420,000
Corporate, Non-Segment [Member]
Revenues	[3]
Other income	[3]	400,000	400,000
Segment profit (loss)	[3]	(3,700,000)	(2,500,000)
Segment Assets(1)	[1],[3],[4]	$ 188,300,000	$ 174,200,000

[1] Includes other amounts in other line items on the consolidated balance sheet.

[2] The Company records Pegasus as an equity investment in its consolidated financial statements. For segment reporting the Company has included its pro-rated share of the earnings and losses from its investment under the Personal Injury Claims segment.

[3] Corporate is not part of the three reportable segments, as certain expenses and assets are not earmarked to any specific operating segment.

[4] Included in Corporate are approximately $94.5 million and $74.6 million of assets related to discontinued operations as of December 31, 2016 and 2015, respectively.

XML

Note 18 - Accumulated Other Comprehensive (Loss) Income - Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)	3 Months Ended		12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2016
Balance	$ 181,783,000	$ 183,407,000	$ 183,407,000
Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense) of $826,000 and ($529,000) at December 31 2016, and September 30, 2016, respectively.	(1,239,000)	330,000
Net current-period other comprehensive (loss) income	(1,248,000)	324,000
Balance	177,583,000	177,696,000	181,783,000
Accumulated Net Investment Gain (Loss) Attributable to Parent [Member]
Balance	624,000	(205,000)	(205,000)
Change in unrealized (losses) gains on foreign currency translation, net of tax benefit/(expense) of ($12,000) and $25,000 at December 31 2016, and September 30, 2016, respectively.
Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense) of $826,000 and ($529,000) at December 31 2016, and September 30, 2016, respectively.	(1,239,000)		867,000
Amount reclassified from accumulated other comprehensive loss, net of tax benefit of $18,000 and $24,000 at December 31 2016, and September 30, 2016, respectively.	(27,000)		(38,000)
Net current-period other comprehensive (loss) income	(1,266,000)		829,000
Balance	(642,000)		624,000
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Balance	179,000	225,000	225,000
Change in unrealized (losses) gains on foreign currency translation, net of tax benefit/(expense) of ($12,000) and $25,000 at December 31 2016, and September 30, 2016, respectively.	18,000		(46,000)
Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense) of $826,000 and ($529,000) at December 31 2016, and September 30, 2016, respectively.
Amount reclassified from accumulated other comprehensive loss, net of tax benefit of $18,000 and $24,000 at December 31 2016, and September 30, 2016, respectively.
Net current-period other comprehensive (loss) income	18,000		(46,000)
Balance	197,000		179,000
AOCI Attributable to Parent [Member]
Balance	803,000	20,000	20,000
Change in unrealized (losses) gains on foreign currency translation, net of tax benefit/(expense) of ($12,000) and $25,000 at December 31 2016, and September 30, 2016, respectively.	18,000		(46,000)
Change in unrealized (losses) gains on marketable securities, net of tax benefit/ (expense) of $826,000 and ($529,000) at December 31 2016, and September 30, 2016, respectively.	(1,239,000)		867,000
Amount reclassified from accumulated other comprehensive loss, net of tax benefit of $18,000 and $24,000 at December 31 2016, and September 30, 2016, respectively.	(27,000)		(38,000)
Net current-period other comprehensive (loss) income	(1,248,000)		783,000
Balance	$ (445,000)	$ 344,000	$ 803,000

XML

Note 18 - Accumulated Other Comprehensive (Loss) Income - Accumulated Other Comprehensive Income (Loss) (Details) (Parentheticals) - USD ($)	3 Months Ended		12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2016
Net unrealized securities gain (loss), tax benefit (expense)	$ 826,000	$ (190,000)
AOCI Attributable to Parent [Member]
Unrealized gain (loss) on foreign currency translation, tax	(12,000)		$ 25,000
Net unrealized securities gain (loss), tax benefit (expense)	826,000		(529,000)
Reclassification from accumulated other comprehensive loss, tax	$ 18,000		$ 24,000

XML

Note 19 - Related Party Transactions (Details Textual) - USD ($)		1 Months Ended	3 Months Ended
	Sep. 17, 2015	Jun. 30, 2015	Dec. 31, 2016	Dec. 31, 2015	Sep. 30, 2016	Jun. 30, 2016
Consulting Agreement Period	2 years
Payments to Acquire Productive Assets, Total			$ 6,000
Louis Piccolo [Member]
Professional Fees			20,000
Louis Piccolo [Member] | Pegasus Funding LLC [Member]
Related Party Transaction, Amounts of Transaction			$ 33,000
Louis Piccolo [Member] | Pegasus Funding LLC [Member] | Professional Fees Incurred by a Related Party [Member]
Due to Related Parties, Term			6 years
Louis Piccolo [Member] | Pegasus Funding LLC [Member] | Interest Based on Professional Fees [Member]
Related Party Transaction, Rate			4.00%
Louis Piccolo [Member] | Maximum [Member] | Pegasus Funding LLC [Member]
Professional Fees			$ 700,000
Fortress Funding, LLC [Member]
Due to Related Parties, Total			700,000		$ 800,000
Fortress Funding, LLC [Member] | Conversion of Customers From The Acquired Lists [Member]
Payments to Acquire Productive Assets, Total			$ 100,000	$ 42,000
Fortress Funding, LLC [Member] | CBC [Member]
Assets Purchase Agreement, Consideration Transferred		$ 500,000
Fortress Funding, LLC [Member] | CBC [Member] | Conversion of Customers From The Acquired Lists [Member]
Assets Purchase Agreement, Contingent Consideration						$ 1,200,000

XML

Note 20 - Subsequent Events (Details Textual) - USD ($)										3 Months Ended
	Feb. 28, 2018	Feb. 05, 2018	Jan. 23, 2018	Jan. 12, 2018	Nov. 24, 2017	Nov. 22, 2017	Mar. 10, 2017	Feb. 15, 2017	Jan. 06, 2017	Mar. 31, 2017	Dec. 31, 2015	Jun. 30, 2017	Jan. 18, 2017	Dec. 31, 2016	[1]	Nov. 08, 2016	Sep. 30, 2016
Treasury Stock, Value, Acquired, Cost Method											$ 7,180,000
Restricted Cash, Total														$ 8,165,000			$ 10,000,000
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests											$ 1,696,000
Pegasus Legal Funding LLC [Member]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners																20.00%
Subsequent Event [Member]
Share Price													$ 10.20
Dividends Payable, Amount Per Share		$ 5.30
Payments of Dividends, Total	$ 35,000,000
Dividends Payable, Date Declared		Feb. 05, 2018
Dividends Payable, Date to be Paid		Feb. 28, 2018
Dividends Payable, Date of Record		Feb. 16, 2018
Subsequent Event [Member] | Montana State Court Litigation [Member]
Payments for Legal Settlements					$ 800,000
Subsequent Event [Member] | Global Settlement [Member]
Payments for Legal Settlements			$ 2,300,000
Litigation Settlement, Amount Awarded to Other Party			$ 4,600,000
Subsequent Event [Member] | CBC [Member]
Payments for Legal Settlements						$ 500,000
Subsequent Event [Member] | Ricky Stern Family [Member] | Mangrove [Member]
Treasury Stock, Value, Acquired, Cost Method							$ 4,900,000
Treasury Stock, Shares, Acquired							471,086
Subsequent Event [Member] | Pegasus Legal Funding LLC [Member]
Restricted Cash, Total												$ 24,700,000
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests				$ 1,800,000
Subsequent Event [Member] | Stern Stockholders [Member]
Voting Agreement, Related Party Maximum Percentage of Voting Right									49.00%
Settlement Agreement [Member] | Subsequent Event [Member]
Stock Repurchase Program, Number of Shares Authorized to be Repurchased									5,314,009
Stock Repurchase Program, Purchase Price Per Share									$ 10.35
Stock Repurchase Program, Number of Share Tendered								6,022,253
Stock Repurchase Program, Number of Shares Oversubscribed								708,244
Stock Repurchase Program, Percent of Share Tendered								88.24%
Treasury Stock, Percent, Acquired								44.70%
Treasury Stock, Value, Acquired, Cost Method								$ 54,200,000
Settlement Agreement [Member] | Subsequent Event [Member] | General and Administrative Expense [Member]
Treasury Stock, Value, Acquired, Cost Method										$ 797,000
Settlement Agreement [Member] | Subsequent Event [Member] | Mangrove [Member]
Stock Repurchase Program, Number of Shares Authorized to be Repurchased									4,005,701

[1] In connection with the Company determining it lacked the requisite control to consolidate Pegasus during the Non-Reliance Period, the Company has now accounted for its investment in Pegasus under the equity method in accordance with US GAAP. On the Company's December 31, 2016 consolidated balance sheet, this resulted in (i) a decrease in cash of $1,065,000; (ii) a decrease in the investment in personal injury claims of $47,875,000; (iii) a decrease in other assets of $109,000; (iv) a decrease in other liabilities of $1,133,000; (v) an decrease in non-controlling interest of $804,000, offset by a corresponding increase in the equity method investment of $48,720,000. On the Company's consolidated statement of operations, this resulted in (i) a reduction in total revenues of $2,302,000; (ii) a reduction in expenses of $2,197,000; (iii) a decrease in the income attributable to the non-controlling interest of $21,000; and (iv) a decrease in earnings from equity method investment of $84,000 for the three months ended December 31, 2016. This change to the equity method of accounting had no effect on net (loss) income during the Non-Reliance Period.